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A randomised controlled trial of a novel cognitive training regime based on chunking was conducted in 
participants with early Alzheimer’s Disease.  Functional neuroimaging was performed to examine re-
organisation of brain activity following cognitive training. The study tested the following hypotheses: 
1) Training individuals with early AD in the use of chunking strategies would improve their working 
memory (WM) capacity. 
2) Following training in chunking, improvement in WM capacity would generalise across different 
modalities of WM tasks and measures of general cognitive functioning. 
3) Improvement in WM capacity following cognitive training would be associated with re-organisation 
of functional activity in the prefrontal cortex (PFC) and posterior parietal cortex (PPC). 
 
METHODS 
30 patients with early AD were recruited and assessed on WM and general cognitive tasks. They also 
performed a verbal WM chunking task whilst undergoing fMRI.  They were then randomised to either 
an active control group or cognitive training group. The cognitive training group had 18 sessions of 
adaptive WM training using chunking strategies, whilst the control subjects practised a non adaptive 
WM task.  All subjects were then reassessed using the same measures of cognitive function, WM and 
fMRI protocol, allowing the above hypotheses to be tested.  
 
RESULTS 
 At baseline, all participants benefitted from chunking to improve WM (p < 0.001).  Following training, 
the training group demonstrated a significant improvement on the chunking WM task (p < 0.05) 
compared with the control group.  There were also significant improvements in measures of general 
cognitive function (MMSE and ADAS-Cog) and verbal episodic memory in the training group 
compared to controls (p < 0.05).  Training was significantly associated with a reduction in activation in 





The impact of this novel approach to improving WM in early AD is discussed, in the context of existing 
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1.1 ALZHEIMER’S DISEASE (AD) - EPIDEMIOLOGY 
Dementia is characterized by progressive cognitive impairment. It is estimated that currently 44.35 
million people suffer from dementia worldwide with numbers predicted to increase to 135.46 million by 
2050
1
. Aside from the enormous personal and societal costs of the disease, in 2010 the global 





There are currently no disease modifying treatments and current licensed pharmacological agents 
provide only modest symptomatic cognitive and functional benefits
3
. There is therefore a clear and 
urgent need for efficacious, evidence - based therapies to help stabilise or improve cognitive function 
in those suffering from dementia.  
 
1.2 DIAGNOSIS AND FEATURES OF AD 
Alzheimer’s disease (AD) is the most common form of dementia
4
.  A diagnosis of Alzheimer’s disease 
requires a history of insidious onset and gradual progression, impairment of two or more cognitive 
domains and impaired instrumental activities of daily living
5
.   AD may also present with non-cognitive 
neuropsychiatric symptoms and leads to significant functional and social impairment.  A summary of 














CORE CLINICAL FEATURES OF DEMENTIA 
Decline from previous levels of functioning, not explained by delirium or major psychiatric disorder 
Cognitive impairment assessed through a combination of history taking and objective assessment 
Cognitive or behavioural impairment involves a minimum of two of: 
A) Impaired ability to acquire and remember new information 
B) Impaired reasoning and handling of complex tasks, poor judgement 
C) Impaired visuospatial abilities 
D) Impaired language function (speaking, reading, writing) 
E) Changes in personality, behaviour or comportment 
PROBABLE AD 
1) Meets criteria for dementia 
2) Insidious onset (gradual onset over months to years) 
3) History of worsening of cognition by report or observation 
The initial and most prominent cognitive deficits are either: 
A) Amnestic presentation- impairment in learning and recall. Plus evidence of dysfunction in at 
least one other cognitive domain 
B) Non-amnestic presentations: - prominent deficits in a) language, b) visuospatial function, c) 
executive function. Plus evidence of dysfunction in at least one other cognitive domain 
There should not be evidence of  
- Substantial concomitant cerebrovascular disease 
- Core features of other forms of dementia (Lewy Body Dementia, Fronto-temporal dementia, 
semantic dementia or primary progressive aphasia) 
- Evidence for another concurrent, active neurological disease or medical co morbidity, or use 
of medication that could have a substantial effect on cognition 
Increased certainty is provided by: 
- Documented evidence of progressive cognitive decline 
- Evidence of a causative AD genetic mutation  
- Biomarker evidence of the AD pathophysiological process:  (low CSF Aβ42, positive PET 
amyloid imaging, elevated CSF tau, decreased FDG uptake on PET in temporo-parietal 
cortex; disproportionate temporal atrophy on structural MRI) 
Possible AD - diagnosis  made in circumstances of: 
- Atypical course,  or 
- Etiologically mixed presentation- meets core criteria for AD plus evidence of  
- a) concomitant cerebrovascular disease or features of DLB 
- b) evidence for another neurological disease, medical co morbidity or medication use 
Table 1-1  Diagnostic criteria for Alzheimer’s disease 







As shown in Table 1-1, a diagnosis of AD is either ‘probable’, or ‘possible’, and a diagnosis of definite 




Over the last 20 years there has been an increasing recognition and characterisation of a pre-
dementia state, classified as mild cognitive impairment (MCI)
8
. This describes individuals with 
subjective and objective evidence of cognitive impairment, in the absence of functional decline.  A 
summary of the diagnostic features of MCI is presented in Table 1-2. Potential progression of MCI to 
dementia remains unclear, with different studies finding between 6% and 34% of MCI subjects 
progressing to AD over follow up times of 1-5 years
9-11
.  However increased prognostic confidence is 





1) Concern regarding deterioration in cognition 
2) Impairment in one or more cognitive domains (typically 1-1.5 SDs below the mean for age 
and education) 
Impairment can occur in a variety of cognitive domains, including memory, executive function, 
attention, language and visuospatial skills    
3) Preservation of independence in functional abilities   
4) No dementia - cognitive changes should be sufficiently mild that there is no evidence of a 
significant impairment in social or occupational functioning  
 
Features of MCI consistent with AD patho-physiological process: 
- No vascular, traumatic or medical causes of cognitive decline 
- Evidence of longitudinal decline in cognition 
- History consistent with AD genetic factors 
Table 1-2: MCI diagnostic criteria 




The most commonly described area of cognition affected in AD is episodic memory.  It has been 
suggested that early episodic memory impairment is a core diagnostic feature of AD
13
.  Episodic 
memory can be defined as ‘storage and retrieval of temporally dated, spatially located and personally 
experienced events or episodes, and temporal-spatial relations among such events’ 
14
.  
 As the diagnostic criteria indicate, deficits are also seen in other areas of cognitive function, including 
executive function, visuo-spatial function, language, attention and working memory.   
28 
 
1.3 THE WORKING MEMORY (WM) MODEL 
The working memory (WM) model of short - term memory was described by Baddeley and Hitch in 
1974
15
.  The original model described modality-specific subsidiary systems: the ‘phonological loop’ 
which holds verbal information; and the ‘visuospatial sketchpad’ which holds visual images.  These 
subsidiary systems are under the control of a ‘central executive system’ which allows for executive 
control of information within WM
16 17
.  Several cognitive roles have been attributed to the central 
executive, including shifting and dividing attention, inhibition of irrelevant information and manipulation 
of verbal and visual information within the subsidiary systems
16 18
.  A further component, the ‘episodic 
buffer’, was added to the model in 2000, to account for experimental findings including the improved 
recall seen with grouping or chunking information, which may require integration of information from 
episodic memory.  The inclusion of the episodic buffer into the model placed WM at the interface 
between episodic memory and executive function
19




Figure 1-1: Schematic diagram of components of working memory model 






1.4 WORKING MEMORY AND AD 
Although deficits in episodic memory characterise Alzheimer’s disease (AD), there is increasing 
evidence that WM is also impaired at the earliest stages of the disease
17
.  The ability to hold and 
manipulate information over short periods of time in WM is essential for many cognitive processes. 
WM deficits in AD have been associated with difficulties in many everyday tasks and executive control 
of WM is particularly sensitive to the disease
20 21
.  Using executive strategies to  encode  information 
is important in WM performance and learning, and there is some evidence that  use of such strategies 
is impaired at the mild stage (e.g. MMSE 18-23) but preserved at the earlier ‘minimal’ stage (e.g. 
MMSE > 24) of AD
22
.   
 
1.5 CHUNKING STRATEGIES IN WM 
It has been demonstrated that WM has a limited capacity
23
, therefore strategies are often employed to 
improve the amount of information that can be held or manipulated within WM.  A common and 
effective strategy is chunking. Chunking is a form of strategic encoding which involves the recoding of 
a set of data into a compressed, efficient form and can extend WM capacity
24-26
.  
A number of verbal and spatial WM tasks have been developed that encourage the reorganization of 
information into higher level chunks
24 26
. Both digit and spatial span sequences are presented in either 
structured or random forms.  Structured sequences of digits to be learned are presented as runs of 
ascending or descending adjacent, even or odd numbers. Therefore within, for example a 6 digit trial 
of ‘2 4 6 9 7 5’, there is a sequence of three ascending even numbers, followed by a descending 
group of three odd numbers. This intrinsic structure within the span sequence encourages the 
grouping or ‘chunking’ of the digits into two blocks of three, thus allowing more information to be held 
in WM.  In contrast, random sequences are designed to have no obvious associations between digits, 
making chunking relatively more difficult. 
In structured spatial sequences every location is either presented in the same column, row or 
diagonal as the preceding location. Therefore, the sequence follows identifiable shapes or patterns 
that can be chunked.  In contrast, unstructured sequences follow no such pattern and are designed to 
be as random as possible (Figure 1-2).  
Previous studies have demonstrated that structured stimuli significantly encourage chunking, 














Figure 1-2: Examples of structured (A) and random (B) digit and spatial span sequences 
Structured sequences encourage chunking of span items to improve recall. 
 
1.6 NEURAL BASIS OF WM: FUNCTIONAL NEUROIMAGING   
Animal 
28-31
 and human studies have demonstrated that encoding, storage and retrieval of information 
in WM is associated with activity in the prefrontal cortex (PFC) and posterior parietal cortex (PPC).  
Many of these studies utilised functional neuroimaging to investigate the neural correlates of cognitive 
function, and functional magnetic resonance imaging (fMRI) is one of the most commonly used 
methods.  
In brief, fMRI is based on the principle that the magnetic resonance of haemoglobin differs according 
to its oxygenation state.  Neuronal activity requires oxygen, and therefore there is an increase in 
blood flow and delivery of oxygenated haemoglobin, which subsequently shifts to a deoxygenated 
state with increased activity.  The difference in magnetic resonance associated with the change in 
oxygenation state can be measured, as the Blood Oxygen Level Dependent (BOLD) signal.  Several 
assumptions are made when fMRI is used to measure cognitive processes.  The main assumption is 
that the BOLD signal correlates with underlying neural activity.  The exact relationship between 
electrical activity at a neural level and BOLD signal remains unclear
32
, and there is a temporal delay 
between neural activity and the BOLD response.  Therefore during analysis the BOLD response has 
to be modelled onto the time series of the cognitive events under investigation.  Over the last 20 
years, both the quality of images due to increasing magnetic strength and improved signal–to-noise 
ratios, and the sophistication of analysis tools have allowed increasingly accurate mapping of 
cognitive processes to underlying brain activity.   
31 
 
Echo planar imaging allows the collection of data from the whole brain over a few seconds
33
.  This 
allows improved temporal resolution of functional brain imaging and combined with event-related 
experimental designs enables more sophisticated and specific analysis of cognitive processes. 
A well-established analysis tool for fMRI data is Statistical Parametric Mapping (SPM)
34
.  This 
software package provides modules for temporal and spatial pre-processing of raw data, to correct for 
movement and register all images into normalised three-dimensional space. SPM uses the general 
linear model to convolve the BOLD response with the experimental time series and produces a study 
design matrix using conditions of interest. Contrasts between conditions of interest can then be 
analysed statistically.  Random effects analysis allows examination of statistical differences between 
conditions of interest at a group level, where inferences about the neuroanatomical correlates of the 
cognitive function under investigation can be made.   
 
1.7 FUNCTIONAL NEUROIMAGING OF WORKING MEMORY 
Functional imaging studies have identified the possible neurological correlates of both the subsidiary 
systems and executive components of the WM model.  The phonological system has been linked to 
left supramarginal gyrus and speech areas
35 36
.  The visuospatial system has been associated with 
activity in a range of frontal, parietal and occipital regions
37 38
.  FMRI studies have also sought to 
identify the neurological correlates of central executive function.  Several groups have identified 
activation in dorsolateral prefrontal cortex (PFC) and left  posterior parietal cortex (PPC) during the 
executive control of information within verbal WM
39-42
, demonstrating the importance of the PFC in 
WM tasks requiring executive control 
40 43 44
. A confounding factor has been the observed increase in 
PFC activity with increasing task difficulty 
45
.  A series of fMRI studies using the verbal and spatial 
chunking tasks described above have overcome this effect of task difficulty, demonstrating activation 



























Figure 1-3 Common prefrontal and parietal activation patterns seen during chunking in verbal and visuospatial 






1.8 COGNITIVE TRAINING AND CHUNKING 
 Cognitive training involves the use of theoretically-driven strategies or exercises designed to target 
specific cognitive domains to optimise cognitive function 
46
.  
Cognitive strategies used for training have been categorised as internal
47
 (e.g. method of loci, 
association between modalities, or chunking), and external (using lists/diaries/alarms or 
pharmacological cognitive enhancers such as modafinil
48
).  Cognitive interventions for individuals with 
cognitive impairment have also been categorised according to whether the approach is restorative 
(i.e. seeking to strengthen and restore impaired function) or compensatory (i.e. seeking to work 
around impairments to improve function
49
). 
There have been inconsistent reports of the efficacy of cognitive training among healthy young 
subjects.  Throughout childhood development and as adults, we learn new skills and develop 
expertise through practice and training.  However, cognitive training appears to have limitations in 
33 
 
improving cognitive function in healthy adults.   Physical exercise may build not only expertise in the 
specific sport trained but also lead to increased general levels of fitness, however it has been 
frustratingly difficult to demonstrate a similar effect with memory or other cognitive training.  The 
evidence appears to be that cognitive training leads to improvements in the trained tasks but not an 
overall or generalised improvement in brain or cognitive ‘fitness’.  As an example, a recent large study 
demonstrated improvements in trained cognitive tasks but no transfer of benefits to untrained tasks
50
.  
Despite this, a billion-dollar brain-training industry has developed offering software and tools that 
make various promises to improve brain function 
51
.  
There are however, a growing number of reports of cognitive training leading to generalised 
improvements to non-trained tasks, and WM has emerged as the focus of many of these approaches.   
A recent review of WM training in healthy subjects concluded that WM training may generalise to non-
trained tasks that rely on WM and control of attention, consistent with training-induced plasticity in a 
common parietal-prefrontal network 
52
. These improvements have also been associated with changes 





1.9 COGNITIVE TRAINING IN HEALTHY ELDERLY SUBJECTS 
There is some evidence for the efficacy of cognitive training in healthy elderly subjects.  In a large 
study,  2802 healthy elderly subjects demonstrated training-related improvements in memory and 
problem-solving 
55
, with benefits remaining at 5 year follow up 
56
, and some residual benefits at 10 
year follow up
57
.  An earlier meta-analysis of 33 studies involving 1539 subjects also found a large 




1.10 PLASTICITY  
The underlying neurobiological processes for changes seen at a cognitive level remain poorly 
understood.  However plasticity at a cellular, synaptic and neural network level may underpin 
cognitive effects. There is growing evidence that plasticity persists throughout the age span and even 
in the context of neuro-degeneration
59-61
.  Therefore there is a theoretical basis for cognitive training 




1.11 COGNITIVE TRAINING IN EARLY AD AND MCI 
A recent systematic review of cognitive training in mild cognitive impairment (MCI)
46
 described 7 
studies of cognitive intervention. Of these, 6 reported improvement in objective measures of cognitive 
function following training. However it is still unclear as to whether cognitive training results in 
transferrable benefits or can reduce further deterioration in cognitive function in MCI. 
The literature for cognitive training in AD demonstrates variable results and is limited by the relatively 
small number of RCTs, small sample sizes, a large variability in outcome measures, and multiple 
cognitive training techniques used, making it difficult to evaluate the efficacy of a single strategy.  In 
order to identify whether there is evidence for cognitive interventions in AD a meta-analysis and meta-
regression of the literature was performed and is presented in Chapter 2. 
 
1.12 FUNCTIONAL IMAGING OF COGNITIVE TRAINING 
There are a number of possible ways in which activation might change following training. Kelly and 
Garavan (2005), in a review of practice related changes in functional activity, identify three main 
patterns in the literature.  Training may be associated with increased activation
53
,  or reduced 
activation
62
, due to increased neural efficiency.  Alternatively functional reorganisation may occur  with 
redistribution of activation within the existent neural network or function relocated to additional 
regions
63
.  Changes in functional connectivity both within and between neural networks is also 




1.13 FUNCTIONAL IMAGING IN MCI AND EARLY AD  
FMRI studies have demonstrated that when task-difficulty is controlled and only successful attempts 
at a cognitive task are examined, AD participants recruit similar brain regions to healthy controls
65
.  
However, AD participants also show evidence of reduced functional connectivity between brain 
regions, including between PFC and PPC during WM tasks
66 67
.  Scanning participants pre- and post- 
cognitive training using identical tasks matched for performance allows cognitive improvement to be 
reflected in differential cortical activation. One study has used fMRI to examine healthy elderly 
controls and patients with MCI, before and after a cognitive training program primarily targeting 
episodic memory
61
.  The MCI participants demonstrated training-related increased activation in a 
35 
 
large network of brain areas including frontal and parietal areas activated prior to training, and also 
the recruitment of alternative areas. This contrasted with the group of healthy elderly controls who 
demonstrated reduced activation after training in a similar network. An intriguing finding was that 
memory training normalized the initial brain activation deficits seen in MCI participants compared with 
controls. This study provides evidence for cognitive training-related plasticity in the early stage of 
neurodegenerative disease and supports the use of cognitive training.  However, no study has yet 
investigated the effect of cognitive training on working memory in this way in early AD.   
 
1.14 PILOT STUDY - CHUNKING IN EARLY AD 
In a pilot study, the use of chunking strategies to improve WM performance was investigated in 13 
participants with very mild AD (MMSE >23), 15 participants with mild AD (MMSE 18-23) and 15 
healthy elderly controls
68
. Verbal and spatial WM tasks were adapted from paradigms previously used 
in healthy young participants and briefly described above
24 26
. In the verbal WM task, normal elderly 
controls and AD participants performed significantly better on structured compared to random trials, 
demonstrating successful use of chunking strategies to improve WM performance. In the spatial task, 
controls and participants with very mild AD performed significantly better on structured trials, however 
mild AD participants showed no significant span difference between the conditions.  This was 
interpreted as a preserved ability to use chunking strategies to aid WM in early AD, which becomes 
lost by the mild-moderate stages of the disease (Figure 1-4). 
This is in keeping with literature on executive dysfunction and WM in early AD, which suggests that 
strategic or executive WM tasks become impaired during mild-moderate AD, but are preserved at the 






Figure 1-4: Digit and spatial span results from pilot study demonstrating improved performance with structured 




1.15 IMPLICIT MEMORY AND COGNITIVE TRAINING IN AD 
Declarative memory is assumed to be explicit and to depend on conscious awareness. Non-
declarative or implicit memory, in contrast, is assumed to operate unconsciously and refers to 
memories whose recall is expressed through performance.  Implicit memory has been demonstrated 
in complex cognitive tasks, such as learning rule structures in an artificial grammar task
69
. A key 
observation made in the pilot study was that some control and early AD participants successfully 
benefitted from chunking strategies, despite not being explicitly aware of doing so. In a subset of early 
AD participants the hypothesis that explicitly informing participants of chunking techniques would 
improve WM performance in a single session was tested.  This was indeed the case, suggesting that 
simple training in chunking techniques may lead to improvements in WM performance in early AD. 
 
1.16 SUMMARY AND NEED FOR PROPOSED TRIAL 
This current randomised controlled trial (RCT) combined theoretical insights into working memory and 
cognitive training, developments in functional neuroimaging in Alzheimer’s disease and current 
knowledge of cognitive functioning within AD. There is an urgent need to further elucidate the 
effectiveness of cognitive training in early AD using theoretically - driven cognitive training regimes
49
. 
The findings of preserved chunking ability in early AD provided a novel therapeutic target for effective 
cognitive training, and functional neuroimaging provides a powerful tool to demonstrate functional re-
organisation as a result of cognitive training.  
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This randomised controlled trial investigated the impact of chunking training on WM capacity, general 
cognitive function and functional activity within PFC and PPC in early AD.  My aim was that it would 
be novel, timely and would assess a simple intervention that may improve working memory capacity 





Chapter 2  COGNITIVE INTERVENTIONS IN DEMENTIA - META-





Cognitive interventions for dementia, such as cognitive training (CT), cognitive stimulation (CS) and 
cognitive rehabilitation (CR) are widely used and NICE guidelines recommend the use of CS
70
. 
However there is a lack of clarity over the efficacy and effectiveness of these interventions in terms of 
stabilisation or improvement in cognition, and a lack of information regarding individual cognitive 
outcomes. A Cochrane meta-analysis of CS included fifteen randomised controlled trials (RCTs) and 
concluded that CS significantly improved general cognitive outcomes such as the Mini Mental State 
Examination (MMSE
71
, mean difference = 1.74, 95% CI 1.13 to 2.36, p < 0.001) and Alzheimer’s 
Disease Assessment Scale-Cognition (ADAS-Cog
72
, mean difference = 2.27, 95% CI 0.99 to 3.55, p = 
0.0005)
73
. A Cochrane review of twelve RCTs investigating CT or CR reported no significant 
improvements on any cognitive outcome measure
74
.  Neither of these meta-analyses examined the 
effects of including active or non-active control conditions on effect size. 
By contrast, Sitzer et al (2006) reviewed 5 non RCTs and 12 RCTs of dementia cognitive 
interventions, defined by compensatory or restorative approaches. Overall effect sizes of 0.37 (SD: 
0.45) for restorative and 0.40 (SD: 0.46) for compensatory interventions on general cognitive 
outcomes were reported
49
, but studies that compared intervention to waiting list controls tended to 
produce greater effect sizes (d = 0.53, SD = 0.47) than those using attention-controlled placebo 
controls (d = 0.36, SD = 0.58, p = 0.511). 
Most recently, Kurz et al (2011) found significant standardized mean differences (SMD) on the MMSE 
(SMD: 0.21, (95% CI 0.03, 0.39), p = 0.02) and ADAS-Cog
72
 (SMD: -0.3, (95% CI -0.48, -0.13), p = 
0.0005) for CS, but not for CT and CR in a meta-analysis of RCTs in dementia and MCI.  These 
authors concluded that there was no convincing evidence that these cognitive score changes 






Consideration of these meta-analyses highlights the limitations of the evidence base. Methodological 
difficulties, such as a lack of suitable control interventions
76
 and failure to maintain complete blinding 
to allocation, can mean that factors such as increased attention, socialisation or motivation could 
contribute to observed changes or that participant and investigator placebo effects may operate. This 
would be particularly expected for CS interventions which are often less specific in nature and 
encompass more social activities. A wide range of different approaches and cognitive outcomes are 
also used, which creates difficulties in comparing studies.  The current analysis therefore had three 
aims.  
Firstly it aimed to evaluate and compare the overall efficacy of each type of intervention (i.e. CT, CS 
or CR) on commonly-used clinical outcomes of general cognitive function (MMSE and ADAS-Cog), 
with consideration of the use of both active and non-active controls.   
Secondly meta-regression analyses were conducted to examine associations between effect sizes 
and variables that may influence the efficacy of cognitive interventions.  







2.2.1 SELECTION OF STUDIES 
Online literature databases and trial registers (Web of Knowledge, Cochrane Collaborative Central 
Register of Controlled Trials, PubMed/Medline) were searched using the terms in Figure 2-1. Previous 
meta-analyses and systematic reviews of cognitive interventions in dementia
49 73-75 77
 were also 






“cognitive stimulation” OR “cognitive rehabilitation” OR “cognitive training” 
OR “cognitive therapy" OR "cognitive retraining” OR “cognitive support” 
OR “cognitive intervention” OR “cognitive exercise” OR “cognitive 
strategy" OR "cognitive aid" OR "memory function” OR “memory 
rehabilitation” OR “memory therapy” OR “memory aid” OR “memory 
group” OR “memory training” OR “memory retraining” OR “memory 
support” OR “memory stimulation” OR “memory strategy” OR “memory 
management” OR “brain training” OR “brain rehabilitation” OR “brain 
stimulation” OR “brain retraining” OR “brain exercise” OR 
“neuropsychological training” OR "neuropsychological therapy" OR 
"neuropsychological strategy" OR "neuropsychological aid" OR 
“neuropsychological stimulation” OR “neuropsychological rehabilitation” 
OR “neuropsychological exercise” OR “neuropsychological intervention” 
OR “neuropsychological retraining” OR “neuropsychological support” OR 
“psychostimulation” OR “executive training” OR “executive stimulation” 
OR “executive rehabilitation” OR “attention training” OR “attentional 








dement* OR “alzheimer’s disease” OR alz* OR AD OR DAT OR DLB OR 
FTD OR VD OR “memory impairment” OR “cognitive impairment” OR 
“memory disorder” OR “cognitive disorder” OR “memory dysfunction” OR 
“cognitive dysfunction” 
 
Figure 2-1: Search terms for systematic review 
 
 
2.2.2 INCLUSION AND EXCLUSION CRITERIA 
Studies were included in the meta-analysis if the study was a peer-reviewed RCT; participants had a 
diagnosis of dementia; mean age of participants in the study was greater than 60 years; sufficient 
data were available for calculation of effect sizes (unavailable information was requested from authors 
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and included if obtained); and the number of participants in each condition was more than 5 at any 
point,.  RCTs were included if they compared a cognitive intervention to an active or non-active 
control or with another treatment (pharmacotherapy or other non-pharmacological therapy). An issue 
in assessing efficacy of cognitive interventions has been the description and classification of the 
intervention used. A useful approach is to divide these interventions into CT, CS and CR
77
. Studies 
were screened and selected for inclusion and rated as to the best description of the intervention and 
control groups using the criteria described in Table 2-1. If it was decided that a study contained 
elements of more than one type of intervention it was classed as mixed e.g. mixed cognitive training 
and stimulation (MCTS). Active controls comprised of interventions that were designed to control for 
non-specific therapeutic effects, including time, attention and non-specific input from research or 
clinical teams (e.g. social support, psychoeducation, discussion groups, non-directed activities). Non-
active controls consisted of treatment as usual (TAU), waiting list conditions, or a minimal intervention 






Repeated guided practice 
Uses standardised tasks 
Theoretically motivated strategies 
Range of difficulties (adaptive) 
Aims for improvement in isolated cognitive domain with 






Wide range of activities 
Group format 
Significant emphasis on social interaction 
Aims for general improvement in cognitive function 
Non adaptive 









ACTIVE CONTROL GROUP 
Intervention matched for time/social interaction 
Intervention contains cognitive content not directly 
related to cognitive outcome measure. 
 
NON-ACTIVE CONTROL GROUP 
Waiting list/treatment as usual or minimal intervention 
not matched for time/social interaction/no specific 
cognitive content 
Table 2-1: Definitions of cognitive interventions and control groups 
 Adapted from Clare et al77
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2.2.3 ASSESSMENT OF TRIAL QUALITY 
A risk of bias tool
78
 was used to assess study quality in five areas known to affect clinical outcomes 
(sequence generation, allocation concealment, blinding of outcome assessors, incomplete outcome 
data and selective outcome reporting). Studies were rated as to the degree of bias in each study and 
if inadequate or unclear rates were scored in all five areas of bias the study was excluded from meta-
analyses.  
 
2.2.4 DATA EXTRACTION 
Means and standard deviations (SD) or standard errors (SE) for each outcome measure in each 
condition and time point were extracted for each study. If means and SD were not available in 
published articles, authors were contacted and obtained information was included. 
 
2.2.5 CALCULATION OF EFFECT SIZES 
The methods for calculation of effect size, meta- analysis and meta - regression were based on recent 
meta-analyses by Gould et al
76 79
.   
For continuous data, effect sizes (g) were calculated by computing the mean change scores (Mpost – 
Mpre or Mfollowup – Mpre) between the intervention and comparator conditions (control or other 
treatment groups), which allows an estimate of effectiveness even when the intervention and control 
groups are non-equivalent.  The mean change scores were divided by the pooled pre-intervention SD 
(SDpre) and corrected for upward bias (Cp) to account for bias resulting from small sample sizes and 
differences in degrees of freedom due to inclusion of pre-intervention means
80
, (Equation 2-1).  
 
g = Cp [(M post intervention – M pre intervention) - (M post comparator – M pre comparator)/ SD pre] 
 
where SD pre = square root [((Nintervention-1) SDpreintervention
2
 + (Ncomparator-1) SDprecomparator
2
/ Nintervention + 
Ncomparator -2] 
and Cp = 1 – [3/4(Nintervention + Ncomparator -2) -1] 
Equation 2-1: Calculation of effect size (g) 
 
 43 
If two or more comparisons from the same study were entered into the same meta-analysis, then the 
number of participants in the shared group was divided equally between comparisons to avoid 
double-counting participants.  
If two or more outcomes within the same cognitive domain were reported within a single study a 
composite effect size was calculated.  Composite scores were calculated by taking the mean of the 
effect sizes of the outcome measures within the same domain
81
, and calculating the variance of the 
mean of correlated outcomes (Y). (Equation 2-2). 
 





      
 
   
              
   
     
Where m is the number of outcomes, Vi is the variance for several outcomes i = 1, . . . , m,  and rij is 
the correlation between Yi and Yj
81
 
Equation 2-2: Calculation of the variance of correlated outcomes. 
 
  
Domains were coded as memory, working memory, attention, executive function or other 
(incorporating language, visuospatial, speed of processing and praxis).  All cognitive tasks are 
summarised with domain attribution in Table 2-4.   
 
2.3 STATISTICAL ANALYSIS 
 
2.3.1 META-ANALYSES 
Random-effects meta-analyses using a DerSimonian and Laird estimator based on inverse variance 
weights were employed, as heterogeneity in treatment effects was anticipated because of between-
study variations in clinical factors (e.g. content of intervention). Separate meta-analyses were 
conducted for subtype of cognitive intervention (CT, CS, CR and MCTS), in combination with subtype 
of control group (active or non-active) and outcome measure, to provide specific pooled effect sizes 
for each type of intervention and outcome.  Separate meta-analyses were also conducted for each 
outcome measure at different time points (post-intervention [defined as 0-4 weeks after the 
intervention], 3, 6 and 9-12 month follow-up) to avoid non-independence of effect sizes. 
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For each meta-analysis, the overall effect size was calculated by weighing the average effect size for 
each study according to sample size and then pooling across studies. The z statistic was employed to 
test whether the pooled effect size was significantly different from 0. The I
2
 statistic was used to 
examine variability in effect sizes between studies. The I
2
 statistic estimates the proportion of variation 
in effect sizes due to heterogeneity, whereby values of 25%-49%, 50%-74% and >75% indicate low, 
moderate and high heterogeneity respectively
82
. High levels of heterogeneity in effect sizes between 
different studies can result in potentially misleading conclusions being drawn. If there was evidence of 
low to high heterogeneity, and greater than 3 studies were included in the meta-analysis, 95% 
prediction intervals were calculated in order to provide an estimate of the range of treatment effects 
within an individual study setting
83
. Finally, publication bias was estimated using funnel plots and the 
Egger regression asymmetry test.  If publication bias was detected, a non-parametric trim and fill 
method was used to impute missing studies and re-estimate the pooled effect size
84
.  An alpha level 
of 0.05 was used for tests of the estimated average treatment effect and publication bias. Data were 
analyzed using the metan function in Stata 10 (StataCorp, College Station, TX). 
 
2.3.2 META-REGRESSION ANALYSES 
Planned meta-regression analyses were used to examine whether any between-study heterogeneity 
could be explained by format of intervention (group or individual) and measures of study quality 
(sequence generation, allocation concealment, blinding of outcome assessors), as these have been 
suggested by previous analyses to influence effect size
49
.  Other variables examined were setting of 
intervention (outpatient/community vs inpatient/care home facilities), intensity of intervention (hours 
per week), length of intervention (weeks) and severity of dementia (as determined by mean MMSE 
score). If more than 30% of data were missing, the variable was excluded from analyses. The above 
variables, together with effect sizes, were entered into separate random-effects univariate meta-
regression analyses using restricted maximum likelihood estimation. Knapp-Hartung adjustment was 
employed to control for risk of false positives with multiple covariates. Separate meta-regression 
analyses were conducted for the different general cognition outcome measures. Any factor that was 
significant in univariate analyses was entered into a random-effects multivariate meta-regression 
analysis that corrected for multiple comparisons (thus controlling for the risk of false positives). Data 
were analyzed using the metareg function in Stata 10. 
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2.3.3 CLINICAL SIGNIFICANCE AND SENSITIVITY ANALYSES 
Mean change scores were also calculated as (M post intervention – M pre intervention) - (M post comparator – M pre 
comparator) to provide estimates for comparison with minimal clinically important differences (MCID) in 
general cognition outcome measures. For the ADAS-Cog, the most commonly cited measure, there is 
general agreement that a 4 point change is clinically significant
 85
.  There is a greater range of opinion 
for the MMSE, with values of between 1.4
86 87
 and 3 being cited
88 89
.   
Sensitivity analyses were conducted by repeating random-effects meta-analyses of the main 
comparisons using SDs of mean change scores, without correction for upward bias, to calculate 
weighted mean difference scores.  These weighted mean difference scores were then compared with 




The PRISMA checklist has been used to guide reporting of results
90
. (Table 2-6). 
  Results are presented as: 
1) Comparison of different cognitive intervention approaches using general cognition outcome 
measures, and meta-regression results. 
2) Examination of specific cognitive domain outcomes in CT studies. 
 
2.4.1 IDENTIFICATION AND CHARACTERISTICS OF INCLUDED STUDIES 
Literature searches identified 2206 potential studies, 59 of which met inclusion criteria for data 








2.5 COMPARISON OF DIFFERENT COGNITIVE INTERVENTIONS 
USING GENERAL COGNITION OUTCOMES 
 
Of the 59 included studies, 33 contained general cognition outcome measures that could be included 
in meta-analyses
93-125
. Summary characteristics of these studies are presented in Table 2-7. 
Four studies were classified as CT
91-94
, 21 as CS
95-115
, and 7 as mixed cognitive training and 
stimulation (MCTS)
116-122
. One study contained separate CS and MCTS interventions
123
. There were 
no RCTs of CR with general cognitive outcomes. 
Only 8 studies used active control groups
91-93 99 100 116 117 121
. Twenty one studies used non-active 
control groups, whilst 2 studies had both active and non-active control groups
114 122
. One study 
compared the intervention to other treatments and non-active controls
108
, and 1 study compared the 
same intervention in different settings
115
.    
The most commonly - used general cognitive outcome measure was the MMSE. Seventeen studies 
used the MMSE alone
92-96 98-100 104 111 112 114 117-121
, 10 studies included both the MMSE and ADAS-
Cog
97 101 102 106 108-110 115 116 123
 and 2 studies used the ADAS-Cog alone as a general cognition outcome 
measure
103 105





Two studies used both the MMSE and one other general cognitive measure (MODA)
91 107
. 
Only 8 studies included follow-up data
91 95 101 111 114 122
 
105 119
, ranging from 6 weeks to 10 months post-
intervention, with the most common follow-up period being 6 months. 
 
2.5.1 QUALITY OF STUDIES 
Risk of bias and study quality is summarised in Table 2-8. Randomization was the least adequately 
addressed, with only 12 studies adequately or partially adequately reporting randomisation sequence 
and 10 studies adequately reporting allocation concealment. 
 
2.5.2 META-ANALYSIS  
Results of the meta-analyses conducted are presented in Table 2-2. 
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2.5.2.1 COGNITIVE STIMULATION  
Post-intervention, there was a significant pooled effect size for CS vs non-active control on the MMSE 
(g = 0.51, (95% CI= 0.35, 0.66), z = 6.23, p < 0.001, Figure 2-3). There was low heterogeneity 
between studies (I
2
 = 24.9%). The calculated 95% prediction interval (0.124 to 0.89) suggested that 
the intervention was beneficial in individual settings. 
 
 
Figure 2-3: Forest plot of CS studies vs. non active controls: MMSE outcome 
*Tadaka et al 2007 compared CS with control in two independent subgroups of Alzheimer’s disease 
(AD) and Vascular dementia (VD) patients, therefore both could be included in same meta-analysis. 
 
 
A smaller but still significant pooled effect size of 0.35 (95% CI 0.06, 0.64; z = 2.34, p = 0.019) was 
found for CS vs. active control on the MMSE (Figure 2-4), with no heterogeneity between the three 
studies (I
2 
= 0.0%).  
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Figure 2-4: Forest plot of CS studies vs active control, MMSE outcome. 
 
On the ADAS-Cog there was a significant pooled effect size favouring CS of -0.26 (95% CI -0.44, -
0.08; z = 2.82, p = 0.005, Figure 2-5). There was low heterogeneity between the nine studies (I
2
 = 
18.5), however 95% prediction intervals (-0.62 to 0.10) suggested that the intervention may not be 
beneficial in individual settings. There were no studies comparing CS to active control that used the 
ADAS-Cog as an outcome measure. 
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Figure 2-5: Forest plot of CS studies vs. non active controls, ADAS-Cog outcome. 
 
Two CS vs. non-active control studies assessing other general cognitive outcome measures (CAS 
and MODA) were included in a meta-analysis. A non-significant positive effect size of 0.25 was found 
(95% CI -0.44, 0.94; z = 0.71, p = 0.48).  
At up to 3 months follow-up, there was a pooled effect size of 0.796 in favour of CS (95% CI: 0.052, 
1.539; z = 2.10, p = 0.036), on the MMSE, however both studies included in the analysis compared 
CS to non-active controls. There was moderate heterogeneity between these studies (I
2
 = 54.5%).  By 
6 months follow-up a non-significant pooled effect size of 0.273 (95% CI: -0.10, 0.64; z = 1.45, p = 
0.15) was found on the MMSE, with no heterogeneity between the 3 studies (I
2  
= 0.0%). At 10 months 
follow-up, a significant effect of CS (g= -0.40 (95% CI: -0.723, -0.075); z = 2.41, p = 0.016) on the 
ADAS-Cog was seen.  
 
2.5.2.2 COGNITIVE TRAINING 
Only one study compared CT to a non-active control group
94
, therefore no meta-analyses could be 
conducted. On the MMSE there was a non-significant pooled effect size of 0.22 favouring CT vs 
active controls (95% CI -0.745, 1.180; z = 0.44, p = 0.658). There was significant heterogeneity 
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between the three studies (I
2 
= 76.9%) and 95% prediction intervals (-11.033 to 11.467) suggested 
that the intervention may not be beneficial in individual settings. 
 
There were no studies comparing CT to active or non-active control groups using the ADAS-Cog as 
an outcome measure. One study used the MODA as an outcome measure therefore no meta-
analyses could be conducted. 
 
2.5.2.3 MIXED COGNITIVE TRAINING AND COGNITIVE STIMULATION 
Non-significant pooled effect sizes were found with MCTS vs. non-active, 0.447 (95% CI: -0.568, 
1.462; z = 0.86, p = 0.388) and active controls, 0.253 (95% CI: -0.179, 0.686; z = 1.15, p = 0.251) on 
the MMSE.  Heterogeneity between the three MCTS vs. non-active control studies was significant (I
2 
= 
73.8%) with 95% prediction intervals (-11.333 to 12.227) suggesting the intervention may not be 
beneficial in individual settings.   
It was not possible to conduct meta-analyses on studies comparing cognitive interventions to other 
treatments (e.g. pharmacological treatment) as only a single study investigated this
108
. Similarly only a 
single study compared a cognitive intervention in different settings and therefore no meta-analysis 
was performed. 
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Analysis No. of 
studies 
N   
Tx/control  
Pooled Effect size 
g (95% CI) 
Overall effect:  




 %  (P value) 
Prediction 
interval: 95% CI 
Publication Bias 
Egger’s Test 
Bias coef (p) 
Cognitive Stimulation 
Post-Intervention-MMSE 
   CS vs NA 








0.51 (0.35, 0.66) 








0.12 to 0.89 
N/A 
 
1.09  (0.14) 
-2.67 (0.55) 
Post-Intervention- ADAS-Cog 
   CS vs NA 












-0.62 to 0.10 
 
-0.017 (0.99) 
Post-Intervention- Other general cog 
outcome 























    CS vs NA at 3 months (MMSE) 
    CS vs NA at 6 months (MMSE) 











0.80 (0.05, 1.54) 
0.27 (-0.10, 0.64) 



















    CT vs NA 
    CT vs Active 
No studies of CT vs Active or Non-
active using ADAS-Cog. 
























Mixed Cognitive Training and Stimulation 
Post–Intervention- MMSE 
CTCS vs NA 








0.45 (-0.57, 1.46) 













Table 2-2: Results of Meta-analyses of general cognitive measures 
CS= Cognitive Stimulation, CT= Cognitive training, MCTS= mixed Cognitive training and cognitive stimulation interventions. NA= non-active control group, MMSE= Mini- 
Mental State Examination, ADAS-Cog= Alzheimer’s Disease Assessment Scale-cognitive subscale, UC = unable to calculate;  
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2.5.3 META-REGRESSION ANALYSES 
The results of the meta-regression analyses are presented in Table 2-3. 
For both MMSE and ADAS-Cog outcome measures, meta-regression analyses revealed no significant 
associations between effect sizes and type of control group (active vs. non-active), setting (inpatient 
vs. outpatient), length of intervention, format of intervention (group vs. individual), intensity of 
intervention in hours per week, or mean severity of dementia of participants. In addition, there were 
no significant associations between effect sizes and measures of potential bias: randomisation 
sequence, randomisation allocation, blinding of outcome assessors, incompleteness of outcome data 
or selective outcome reporting. 
The limited number of studies precluded meta-regression analysis at any of the follow-up time points. 
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Variables Regression Coefficient (SE) 95% CI P value Q   (P) I
2
 
MMSE Outcome studies (n=30)      
Continuous Variables 
Length of intervention (weeks) 
Intensity of intervention (hours/week) 






-0.002 to 0.010 
-0.018 to 0.059 














Intervention (0= CS, 1= CT/MCTS) 
Control (0= non-active, 1= active) 
Setting (0=outpatient/community, 1= 
inpatient/care home) 








-0.461 to 0.135 
-0.484 to 0.157 
-0.177 to 0.484 
 























Blinding of outcome assessors 
Incomplete outcome data 










-0.357 to 0.217 
-0.421 to 0.111 
-0.482 to 0.114 
-0.257 to 0.356 






















ADAS-Cog Outcome studies (n=11) 
Continuous Variables 
Length of intervention (weeks) 
Intensity of intervention (hours/week) 






-0.014 to 0.0001 
-0.045 to 0.031 














Intervention (0= CS, 1= CT/ MCTS) 
Control (0=non-active, 1= active) 
Setting (0=outpatient/community, 1= 
inpatient/care home) 








-0.937 to 0.788 
-1.112 to 1.394 
-0.552 to 0.920 
 



















Quality- related  
(0=inadequate, 1= adequate) 
Sequence generation 
Allocation concealment 
Blinding of outcome assessors 
Incomplete outcome data 










-0.243 to 0.721 
-0.243 to 0.721 
-0.063 to 0.880 























Table 2-3: Results of meta-regression analyses. UC = unable to calculate; Q= fit of model without heterogeneityI2= proportion of variation due to heterogeneity  
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2.5.4 CLINICAL SIGNIFICANCE AND SENSITIVITY ANALYSES 
Repeated random-effects meta-analyses of the main CS comparisons, using SDs of mean change 
scores, produced a significant weighted mean difference score of 1.78 (95% CI 1.23, 2.33; p < 0.001) 
for CS vs non-active control on the MMSE and -1.92 (95% CI: -3.43, -0.4; p = 0.01) for CS vs. non-
active control on the ADAS-Cog.  However the weighted mean difference score for the MMSE in CS 
vs. active studies was non-significant (1.45, 95% CI: -0.11, 3.02; p = 0.07). 
Comparisons of the calculated mean change scores for each study were made with the range of 
published mean clinically important differences (MCIDs).  For the CS studies, there was only evidence 
of the majority of studies (11/17) reaching minimal clinical significance with the lowest published 
threshold for MCID (1.4 MMSE points). However with the more conservative MCID of >2 MMSE 
points, only 9/17 CS vs. non-active studies and no CS vs. active control studies reached MCID.  Of 
note, only 2/9 CS vs. non-active control studies reached MCID on the ADAS-Cog. 
For the CT studies, the one study vs. non active controls met criteria for MCID of > 1.4 MMSE 
points.  Of the CT studies vs. active controls, 2/3 did not meet criteria (i.e. mean difference < 1.4 
MMSE points) however one study met criteria for MCID with a mean difference of > 2 MMSE points. 
Out of the 6 MCTS studies with MMSE outcomes, 2/3 of the MCTS vs. active and 2/3 of the MCTS vs. 
non active controls did not meet criteria as mean difference < 1.4 MMSE points, and 1/3 of studies for 
each type of control group met criteria for mean difference > 1.4 but less than 2.   Of the 2 MCST 
studies with the ADAS cog as an outcome, neither met MCID. 
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2.6 EXAMINATION OF SPECIFIC COGNITIVE OUTCOMES IN CT 
AND MCTS STUDIES. 
 
Tasks were classed according to which cognitive function they primarily assessed.  The cognitive 
domains were divided into working memory (WM), episodic memory (MEM), attention (ATT), 
executive function (EXEC), or ‘other’ (incorporating language, visuospatial function, speed of 
processing and praxis).  Cognitive tasks that were included in the meta-analyses and their domain are 
summarised in Table 2-4. 
Out of the 59 studies, 9 CT studies
91-94 124-128
  and 6 MCTS studies
116-120 123
 had data on specific 
outcome domains that could be included in meta-analysis. All outcome measures used in each study 
with their calculated effect sizes are shown in Table 2-5. Due to the limited number of studies that 
contained comparable outcomes, studies with active and non-active controls were combined in single 
meta-analyses to examine overall effects within cognitive domains.  Composite effect size values 
were calculated for episodic memory outcomes in four CT studies
92 93 125 127
 and three MCTS 
studies
117 118 128
.  Composite effect size values were also calculated for executive function outcomes in 
four CT studies
91 93 94 126
 and four MCTS studies
116 117 119 128
.  No studies contained data on 
correlations between outcomes within cognitive domains. Therefore composite values were calculated 
using a plausible correlation between tasks of r = 0.5, based on previous studies
81 129
 .   
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TASK DOMAIN BRIEF DESCRIPTION STUDY USED 




Grid of blocks is presented and a number are tapped sequentially.  Subjects 
asked to recall the order the blocks were tapped.   (+ve scored) 




 WM Sequence of digits is read aloud.  Subjects asked to immediately recall digits in 










Two arithmetic tests of different levels of difficulty- a 2 step forward calculation, 
and a 3 step backward calculation.  Cog performance was measured as the 
number of correct calculations. Also used to measure a Dual task cost in 
percentage when combined with timed walking test.   (dual task –ve scored) 
Schwenk (2010)  






Four tests used, (+ve scored) subjects asked to learn and recall: 
1)15 item list of semantically unrelated words,  
2)paired associates task (six word pairs of low probability of being commonly 
associated) 
3)familiar pairs task (6 word pairs that are commonly associated) 







A tray with 15 categorisable everyday objects is shown for 1 minute. 
Total number of objects recalled by subject and carer together (collaborative 
recall) and individually (individual) is scored. 
A ‘clustered’ version also performed, where the objects were arranged in 







12 nouns read one at a time. Task is to remember as many words as possible 
















Subjects shown complex figure and then tested on their delayed recall of the 
figure (+ve scored)  
Jelcic (2012) 







A list of 15 words is read aloud.  Subject repeats all the words he/she can recall.  
This procedure carried out 5 times.  Another list of 15 words is then presented, 
with one attempt at recall.  
Immediately following this, subjects asked to remember as many words as 




  MEMORY 
 
 
Series of words and pictures were presented.  Subjects then asked to recall 
these and 
Scored on ‘verbal reminding’ , and Recognition (hits)  (+ve scored) 
Heiss (1994) 
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MEMORY  Subjects are shown a series of fragmented pictures in a sequence, from most to 
least fragmented, and asked to identify the image .Task administered on 2 
occasions. (+ve scored)  
 
Heiss (1994) 
Hopkins verbal learning 
test-revised
135
   
MEMORY 
 
12 nouns (4 words each from 3 semantic categories) are learned over 3 trials.  
25 min later, a delayed recall trial (free recall) and a recognition trial (12 target 
and 12 false words) are completed. (+ve scored) 
Cahn Weiner ( 2003)  







6 figures, arranged in a 2 X 3 matrix are displayed for 10s. 4 tests attempted: 
1)immediate recall  
2)additional 10s exposures, followed by recall successive trials.  
3)delay recall of figures  (25 minutes later without any further exposure)  
4)recognition trial   (all +ve scored) 
Cahn Weiner (2003)  







Asked to orally generate words beginning with F, A, S in 1-min periods.  The 
total score is the sum of the number of words generated across the 3 trials 
alternate version asks subjects to generate nouns within a category(+ve scored) 
 






  EXEC Part A subject connects 25 encircled numbers in order.  
Part B subject connects 25 encircled letters and numbers in alternating, 
ascending order. Performance is timed on both parts- less time= less impaired 









60 patterns present in order of difficulty.  Subjects asked to identify the missing 




 EXEC Written colours differ from the ink colour they are printed in.  Subjects have to 
first say the written word, and in the second trial name the ink colour instead 
(timed- -ve scored) 
Jelcic (2012) 




EXEC Battery of simple bedside tests of sequencing, behavioural inhibition (go no go), 
motor sequencing and frontal release signs  (+ve scored) 
Kawashima (2005) 
Maci (2012)  
Digit cancellation test
141
 ATT Subjects asked to cross out specific digits from a list of numbers. Score consists 
of the correctly crossed out numbers minus the incorrectly crossed out numbers 
(+ve scored).  Letter cancellation version used by Beck et al.  Attention and 
Concentration task used by Heiss- details unclear. 
 




Table 2-4: Brief description of specific cognitive tasks. reported in studies included in the meta-analyses 








SS  -0.40 VER REMIND  0.23 FLUENCY  0.64 TOKEN TEST(LANG) -0.17 
  RECOG HITS  0.37   ORIENTATION  0.29 
  RECOG FALSE POS  -0.12   ATT 0.48 
  FRAG PIC DIFF  0.10   PRAXIS -0.45 
  1ST PRES  0.19   REACTION TIME  0.08 
  






SS -0.33 WORD REP 0.14 FLUENCY (C) -0.02 MATRICES (IQ ) -0.04 
  PROSE MEM  -0.14 FLUENCY (C) 0.56 DIGIT CANC (ATT) -0.34 
      DENOMINATION -0.17 
      CONST APRAXIA -0.11 
      IDEO APRAXIA R 0.42 
      IDEO APRAXIA L 0.02 
JELCIC 2012 
Focused lexical semantic training  
AC 
DS  0.65* RECALL- IMM   0.31 FLUENCY  (L) 0.03 REY FIG COPY  0.25 
  RECALL- DEL 0.61 FLUENCY  (C) 0.06 CLOCK DRAWING  -0.08 
  RECALL- RAVL DEL 0.72* STROOP  -0.23 BNT  0.51 
  REY FIGURE  0.00 TRAIL A  -0.32 verbal NT (SM) 0.79* 
    MATRICES (IQ) -0.08   
NEELY 2009 
Taught: 
-spaced retrieval ----hierarchical cueing 
- face name recall and IADL  
-Either individual (IND) or with carer (COL) 
NAC 
 
  RECALL object 
rand- COL 1.70*  
 
  
  RECALL object 
clust- COL 0.96*  
 
  
  RECALL rand word- 
COL 0.40  
 
  
  RECALL word cat- 
COL 0.60  
 
  
  RECALL object 
rand- IND 0.24  
 
  
  RECALL object 
clust- IND 0.27  
 
  
  RECALL rand word- 
IND 0.30  
 
  
  RECALL word cat- 




Taught Association (word-image) 
NAC 
  RECALL daily task -0.43     
  RECALL unrelated 
words 1.11*  
 
  
  RECALL unfamiliar 1.15*     
 60 
words 
  RECALL familiar 
words 0.27  
 
  
  RECOG daily task -0.01     
  RECOG unrelated 
words 0.03  
 
  
  RECOG unfamiliar 









Dual task training 
AC 
DTC  2  0.11   DTC serial 3 back  0.49   
    DTC combine 3  0.82*   
  
  
DTC combine 2 (EX + 
WM) 0.25   
KAWASHIMA 2005 
Arithmetic and reading aloud 
NAC 
    SIMILARITIES  0.93*   
    FLUENCY  0.12   
    MOTOR PROG  0.68   
    CONFLICT INST  0.18   
    GO NO GO  -0.23   
    PREHENSION  N/D   
MACI 2012 
physical exercise and MDT 
NAC 
    FAB  0.78   
  
      






  HVLT TOTAL  0.27 COWA  -0.11 JLO (PERC) -0.50 
  HVLT RECALL 0.24 TRAILS A  -0.48 BNT (SM) 0.07 
  HVLT RECOG  0.26 TRAILS B  0.32   
  BVSMT TOTAL  -0.48     
  BVSMT RECALL -0.13     
  BVSMT RECOG  0.26     
        
TARRAGA 2006 
Computerised MDT+ stimulation and IADL training 
AC + NAC 
     FLUENCY (SEM) -0.43 BNT (SM) -0.03 
  SKT -0.22 FLUENCY (P) -0.09   
        
BECK 1988 
Focus on attention and reading, used object matching, concentrating 
on detail in adaptive training. adaptive.  
NAC 
  DIGIT RECALL 0.75   ATTENTION/READ -0.60 
  VERBAL RECALL 0.09   MATCH (PERCEP) -0.32 




Spaced retrieval , association (number-object) taught 
DS  -0.25 RECALL IM (LM1) 0.30 VSAT SECS (EX ATT) -0.21   
DS 0.22 RECALL DEL -0.16 VSAT ERR (EX ATT) 0   
 61 
AC BACK  
  VISUAL REP  -0.20 COWA  -0.09   
  VISUAL REP DEL  0.33 FLUENCY  0.08   
    FLUENCY  0.17   
KOLTAI 2001  
spaced retrieval Face-name recall verbal elaboration, 
 repetition,  
 external aids, 
  coping strategies 
NAC 
  WLM TOTAL  -0.45     
  WLM RECALL  0.58 
    
KURZ 2012 
 external aids establishing routines 
 reminiscence  planning 
NAC 
  WMS LM  0.01 TRAILS A  0.14   
    RWT  -0.12 
  
BUSCHERT 2011 
 visual imagery 
 face-name association  
 external memory aids reminiscence 
 Multisensory 
Stimulation 
errorless learning approach  
AC 
  RBANS RECALL  0.43 TRAILS A  0.01   
    TRAILS B (EX) -0.88 
  
Table 2-5: All cognitive outcomes and calculated effect sizes (Hedges g) for CT and MCTS studies 
 *Significant effect sizes are in red. AC= active control.  NAC= non active control. WM = working memory, EM= episodic memory, EXEC = executive function, LANG = 
language, PERC= perception, ATT= attention.  MDT= Multi domain training (i.e. several tasks training different cognitive domains), SS = spatial span, DS = digit span.  See 
Table 2-4 for description of tasks. 
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2.6.1 COGNITIVE TRAINING STUDIES- EPISODIC MEMORY OUTCOMES 
Meta-analysis of all CT studies with episodic memory outcomes revealed a significant pooled effect 






Figure 2-6: Forest Plot of CT studies with memory outcome measures.   
Blue= active controls, Red = NA controls.  *Neely (2009): number of controls corrected for inclusion of 2 
independent experimental groups in same meta-analysis  
 
    
  
   Effect size 
 -2.0440  0  2.04400 
 Study 
 Effect size 
 (95% CI)  % Weight 
 Heiss (1994)   0.23 (-0.43, 0.90)  24.5  
 Jelcic (2012)   0.44 (-0.19, 1.07)  27.5  
 Neely collab (2009)*   0.91 (-0.22, 2.04)   8.5  
 Neely indiv (2009)*   0.27 (-0.81, 1.35)   9.3  
 Zarit (1982)   0.31 (-0.51, 1.12)  16.2  
 Beck (1988)   0.09 (-0.79, 0.96)  14.1  
 Overall   0.34 (0.01, 0.67)  100.0  
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2.6.2 COGNITIVE TRAINING STUDIES – EXECUTIVE FUNCTION OUTCOMES 
Meta-analysis of CT studies with executive function outcomes produced a significant pooled effect 
size of 0.40 ((95% CI: 0.11, 0.70), z =   2.66 p = 0.008), with no heterogeneity between studies (I
2
 =   
0.0%).  (Figure 2-7). 
 
 
Figure 2-7: Forest plot of CT studies with executive function outcomes.  




   Effect size 
 -1.4232  0  1.42320 
 Study 
 Effect size 
 (95% CI)  % Weight 
 Schwenk (2010)   0.52 ( 0.00, 1.03)  33.2  
 Galante (2007)   0.27 (-0.88, 1.42)   6.6  
 Heiss (1994)   0.64 (-0.04, 1.32)  19.1  
 Jelcic (2012)   0.14 (-0.48, 0.76)  23.0  
 Kawashima (2005)   0.34 (-0.36, 1.03)  18.1  
 Overall   0.40 ( 0.11, 0.70)  100.0  
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2.6.3 COGNITIVE TRAINING STUDIES- WORKING MEMORY OUTCOMES 
Figure 2-8 shows the forest plot of 5 CT studies with working memory outcomes.  4 used active 
controls and 1 used NA controls.  The pooled effect size was non significant (0.17 (95% CI: -0.27, 




Figure 2-8: Forest plot of CT studies with working memory outcomes.  
Blue= active and Red= non active control groups. 
 
  
   Effect size 
 -1.6596  0  1.65963 
 Study 
 Effect size 
 (95% CI)  % Weight 
 Jelcic (2012)   0.65 ( 0.02, 1.29)  23.2  
 Schwenk (2010)   0.10 (-0.40, 0.61)  28.3  
 Galante (2007)  -0.33 (-1.49, 0.83)  11.0  
 Heiss (1994)  -0.40 (-1.07, 0.27)  22.1  
 Beck (1988)   0.75 (-0.16, 1.66)  15.4  
 Overall   0.17 (-0.27, 0.61)  100.0  
 65 
2.6.4 COGNITIVE TRAINING AND ATTENTION OUTCOME MEASURES 
4 studies included outcome measures of attention.  The pooled ES was non significant (-0.05 (95% CI 
: -0.51,0.41) z = 0.22, p = 0.829), with low heterogeneity between studies (I
2






Figure 2-9: Forest plot of cognitive training studies and attention outcome measures 
Blue= active controls, red = non active controls. 
 
There were not enough comparable outcome measures of other cognitive domains to enter into a 
meta-analysis.  Effect sizes for individual outcome measures are listed in Table 2-5. 
 
  
   Effect size 
 -1.5024  0  1.50243 
 Study 
 Effect size 
 (95% CI)  % Weight 
 Heiss (1994)   0.48 (-0.20, 1.15)  31.2  
 Galante (2007)  -0.34 (-1.50, 0.81)  13.5  
 Beck (1988)  -0.60 (-1.50, 0.29)  20.5  
 Jelcic (2012)  -0.08 (-0.70, 0.54)  34.7  
 Overall  -0.05 (-0.51, 0.41)  100.0  
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2.6.5 MCTS STUDIES- EPISODIC MEMORY OUTCOMES 
Three studies used active controls and 3 studies used non active controls.   Combining all studies in 
one meta-analysis revealed an overall non-significant pooled ES of 0.02 ((95% CI -0.19, 0.24), z = 
0.20 p = 0.838), with no heterogeneity between studies (Figure 2-10). 
 
 
 Figure 2-10: Forest Plot of MCTS studies with memory outcome measures. 
 Blue= active control groups and Red = non active controls 
 
  
   Effect size 
 -1.4588  0  1.45880 
 Study 
 Effect size 
 (95% CI)  % Weight 
 Cahn-Weiner (2003)   0.07 (-0.60, 0.74)  10.1  
 Buschert (2011)   0.43 (-0.60, 1.46)   4.3  
 Davis (2001)   0.07 (-0.57, 0.72)  11.0  
 Koltai (2001)   0.06 (-0.78, 0.91)   6.3  
Kurz (2012)   0.01 (-0.27, 0.28)  59.7  
 Tarraga (2006)  -0.22 (-0.95, 0.51)   8.5  
 Overall   0.02 (-0.19, 0.24)  100.0  
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2.6.6 MCTS STUDIES WITH EXECUTIVE FUNCTION OUTCOMES 
Three studies with active control groups and two studies with non active control groups included 
executive function measures.  Combining all studies, the ES was non-significant (g=-0.03 (95% CI: -
0.25, 0.20), z =  0.23, p = 0.815) with no heterogeneity between studies (Figure 2-11). 
.  
 
Figure 2-11: Forest Plot of MCTS studies with executive function outcomes. 




   Effect size 
 -1.8759  0  1.87594 
 Study 
 Effect size 
 (95% CI)  % Weight 
Maci (2012)   0.78 (-0.31, 1.88)   4.3  
 Cahn-Weiner (2003)   0.01 (-0.66, 0.69)  11.4  
 Davis (2001)  -0.01 (-0.66, 0.63)  12.4  
 Kurz (2012)  -0.12 (-0.40, 0.15)  67.1  
 Buschert (2011)   0.44 (-0.59, 1.47)   4.9  




2.7.1 GENERAL COGNITIVE FUNCTION 
There was evidence of statistically significant efficacy of CS when MMSE was used as the outcome 
measure, although effect sizes were small to moderate in magnitude (0.35 for active and 0.51 for non-
active controls). ADAS-Cog score also showed significant improvement in comparisons with only non-
active controls, again with a small effect size of -0.26. Where there was heterogeneity between the 
trials reviewed, prediction intervals indicated that CS was beneficial in individual settings as measured 
by the MMSE but not the ADAS-Cog. The meta-analyses results are consistent with recent Cochrane 
reviews in finding little evidence for significant efficacy of CT in dementia, however there were fewer 
CT trials that included general cognitive outcome measures.  Interventions using a mixture of CT and 
CS approaches also did not significantly improve general cognition. 
Examination of between-group mean MMSE difference scores revealed that only when the lowest 
threshold for the MCID are used did the majority of CS studies (13/20 studies) reach minimal clinical 
improvement. The weighted mean difference for CS studies compared to adequate active controls of 
1.45 (95% CI -0.11, 3.02; p = 0.07) only just reached the lowest MCID threshold of 1.4 points, and 
was not statistically significant in the sensitivity analysis.  When the ADAS-Cog was used as an 
outcome measure, only 2 out of 9 studies versus non-active controls (and no studies versus active 
controls) demonstrated mean differences of greater than 4 points, and the weighted mean difference 
for all studies of -1.92 (-3.43 to -0.4) lies well below the MCID of 4.  Due to this limited evidence of 
clinically important differences in MMSE or ADAS-Cog scores when interventions are compared to an 
adequate placebo control, although statistically significant improvements in MMSE or ADAS-Cog 
scores are seen with CS, this analysis is consistent with that of Kurz et al
75
 in finding that there is 
currently only limited evidence that any cognitive intervention leads to clinically significant general 
cognitive improvement in dementia. 
A significant issue here is the inadequacy of blinding and placebo controls in psychosocial RCTs such 
as those of CS.  Psychosocial interventions may appear more effective than they truly are due to the 
overestimation of effect sizes resulting from inadequate placebo controls (a fact that has been 
demonstrated in this meta-analysis where larger effect sizes were found when CS was compared with 
non-active controls than when compared with active controls). Studies examining the true efficacy of 
 69 
psychosocial interventions should aim to at least to be single-blinded (i.e. blinding of participants), 
with active placebo controls.  It is, of course, difficult to blind participants in psychosocial interventions, 
and such blinding raises ethical issues, but it is not impossible, as demonstrated in a recent CBT 
trial
142
.  Ultimately, it is clear from our meta-analyses that more randomised, single-blinded, active 
placebo controlled studies are required to properly assess the efficacy of cognitive interventions in 
dementia.   
 
2.7.2 SPECIFIC COGNITIVE OUTCOMES IN CT AND MCTS STUDIES 
Examination and meta-analyses of specific cognitive functions revealed that the most commonly 
assessed domains were episodic memory and executive function. Studies that taught mnemonic 
strategies usually taught visualisation of words to be learnt, or association between objects and 
names.   This is consistent with the primary training strategies of many of the studies, which sought to 
specifically target episodic memory or teach executive strategies.  Cognitive training RCTs 
demonstrated significant training related improvements in executive function and episodic memory 
(although only when all studies were included in the meta-analysis).  Notably no MCTS study 
demonstrated any significant improvements in the specific outcomes assessed.  
An interpretation of these results is that training effects are more likely when the outcomes reflect the 
focus of the training intervention.  Many MCTS trials contained a wide range of activities, compared to 
the focused approach of CT.  Perhaps unsurprisingly, the most efficacious studies were those that 
concentrated on the most specific training approaches
93 125 126
. 
The criticism of this approach is reflected in the general cognitive outcome data, that there is little 
evidence of transfer to general outcomes, however in this analysis, only 4 CT studies included 
general cognitive outcomes. 
Of relevance to the current study, there was no evidence of overall improvement in general WM tasks. 
However of the two studies assessing verbal WM, rather than spatial WM, one reported a moderate- 
large significant effect of training (g = 0.65 (95% CI: 0.02, 1.29)
93
, and the other a moderate-large  but 
insignificant effect (g = 0.74  (95% CI: -0.16, 1.659)
124
. And in neither of these studies was the 
intervention primarily targeting WM.  The one study that targeted executive WM using a dual task 
training paradigm  demonstrated  significant improvements in divided attention (g = 0.816  (95% CI: 
0.288, 1.344). 
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Overall these results remain consistent with other recent reviews that call for further studies, where 
specific cognitive domains are targeted using theoretically driven training paradigms in AD
49 75
.   A 
focus on WM appears to be one of the most promising avenues for cognitive training in healthy 
adults
52
, and chunking is a strategy that may underlie efficacy
53
.  The evidence from the current meta-
analysis that targeted training may improve episodic memory and executive function provides further 
impetus for the current study, which used chunking, an executive WM strategy, and assessed 
outcomes in WM, episodic memory and executive function.  This randomised, placebo- controlled trial 













Title Identify the report as a systematic review, meta-analysis, or both. 1 
Abstract  
Structured summary Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number. 
2 
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Objectives Provide an explicit statement of questions being addressed with reference to participants, interventions, 
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Search  Present full electronic search strategy for at least one database, including any limits used, such that it could be 
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Study selection  State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
5 
Data collection process  Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
5 
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Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
5 
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Synthesis of results  Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I
2
) for each meta-analysis.  
6,7 
Risk of bias across 
studies  
Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
6 
Additional analyses  Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 




Study selection  Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions 
at each stage, ideally with a flow diagram.  
7,8, Figure 
2-2 
Study characteristics  For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
8, Table 2-7 
Risk of bias within 
studies  
Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  8, Table 2-8 
Results of individual 
studies  
For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
8,9  
Figs 2,3,4  
Synthesis of results  Present results of each meta-analysis done, including confidence intervals and measures of consistency.  8,9, Table 2-2 
Risk of bias across 
studies  
Present results of any assessment of risk of bias across studies (see Item 15).  8,9  
Additional analysis  Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  10,Table 2-3,  
Discussion  
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11,12 
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2 GPs as 
OP, 
1 GP at 
home 
1) 20 (4),  
2) 20.8 (5), 
3) 18.4 (5.1) 
GP  60 min 
1 x wk,  
 
IND 40 min 
1 x wk  
22  1) GP vs 
IND 
2) GP vs 
home 
3) IND vs 
home 
0 , 22  GP 5 
IND 6 
Home 5 
 73.8 82.4 GP vs. IND: 
ADAS-Cog=  -2.16 
MMSE= -0.84 
 




IND vs. HOME: 
ADAS-Cog=-5.84 
MMSE=4.04 










GP 1 hour 
3 x wk  
 
12  NA 0, 12 
(post) 
24 (f/u) 
13 10 84.5 100 MMSE= 7.4 
 







IP 20.77 GP  hr/day 
5 x wk  
4  NA 0, 16 71 16 80 70.1 MMSE= 2.46 CS 
  




IP and care 
home 
15 -20 IND, 30-40 
min 
3 x wk 
 














90 min 1 x 
wk  
 
20  NA 0 and 20 
(post)
 
6 7 73.7 69.2 MMSE= 2.26 
ADAS-Cog= -2.6 
CS  







2 x week  
5  NA 0 and 6 
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1 hr  
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2 x  wk   
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(post) 
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S 12:  


























1 x wk  
8  NA 
(TAU) 
0 and 8 
(post) 
51 51 79.34 51 MMSE= 1.88 CS 
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Community Unclear GP 1.5hr 
2 x wk 
3.5  1  14 10 74.08 No info N/A CT 
Table 2-7: Characteristics of studies included in the meta-analyses.   
IP= inpatient, OP= outpatient, IG= Intervention Group, CG= Control Group, GP= Group sessions, IND = Individual sessions, NA- non-active control, TAU= Treatment as usual, 
post= post-intervention, f/u= follow-up, MMSE- Mini mental state examination, ADAS-Cog- Alzheimer’s Disease Assessment Scale_ cognitive subscale, CS= cognitive 
stimulation, CT= cognitive training, MCTS= mixed cognitive stimulation and training, AD= Alzheimer’s Disease, VD= vascular dementia, MODA= Milan Overall Dementia 
Assessment , MATTIS DRS= Mattis dementia rating scale 
a
MMSE/CAS/MODA/MATTIS- positive score favours intervention. ADAS-Cog- negative score favours intervention.
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of IN/ UN 
ratings 
Reasons for quality ratings 
Avila et al 
(2007) 
AQ AQ AQ AQ AQ 0  
Baldelli et al 
(2002) 
IN/UN IN/UN IN/UN AQ AQ 3 No information about A, B.States that subjects were divided 
into groups, however correspondence by email to Cochrane 
group confirmed that studies were randomised. 
No information about C 
Baldelli et al 
(1993) 
IN/ UN IN/UN IN/ UN AQ  AQ 3 No information about A, B. States that subjects were divided 
into groups, however correspondence by email to Cochrane 
group confirmed that studies were randomised. 
No information about C 
Bottino et al 
(2005) 
AQ AQ AQ AQ AQ 0  
Breuil et al 
(1994) 
IN/UN IN/UN PAQ PAQ IN/ UN 3 No information about A or B; E- some tasks were discarded 
and others grouped. 
Buettner et 
al (2011) 
IN/UN IN/UN AQ IN/UN AQ 3 No information about A, B. D- sig difference in dropouts 
between groups and not included in analysis. 
Burgener et 
al (2008) 
IN/UN IN/UN IN/UN IN/UN AQ 4 No information about A, B or C.  Patients could self refer. 
No mention of method of randomisation 
D: reason for 3 of 5 drop out in control group- 'increased 




AQ AQ AQ AQ AQ 0  
Cahn-
Weiner et al 
(2003) 
AQ AQ PAQ PAQ AQ   
Chapman et 
al (2004) 
AQ AQ AQ PAQ AQ 0 D: uneven number of dropouts in each group (8 in exp 
group, 5 in donepezil only group) 
Coen et al 
(2011) 
IN/UN IN/ UN AQ AQ  AQ 2 No information about A or B  
Davis et al 
(2001) 
IN/UN IN/UN PAQ PAQ AQ 2 No information about A or B; 4 patients did not crossover 
from the placebo group due to lack of interest in continuing 
the study 
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Ferrario et al 
1991 
IN/UN IN/UN IN/UN AQ AQ 3 No information for A,B or C 
Galante et al 
(2007) 
PAQ PAQ AQ IN/ UN AQ 1 A and B states ‘randomly assigned to one of two groups in 
order of recruiting’ 
D: 1 drop out in control group, leaving groups mismatched 
(7 vs 4), dropouts not included in analysis 
Graessel et 
al (2011) 
AQ AQ AQ AQ AQ 0  
Haight et al 
(2006) 
IN/UN IN/UN IN/UN IN/UN AQ 4 No information about A, B – states 'were assigned randomly 
by the researchers' no information about C or D 
Heiss et al 
(1993) 
IN/UN IN/UN IN/UN IN/UN  AQ 4 No information about A,B, C or D 
Jelcic et al  
(2012) 
AQ IN/UN AQ AQ AQ 1 Unclear info about B 
Kawashima 
et al (2005) 
IN/UN IN/UN IN/UN AQ AQ 3 No information about A, B or C 
Koltai et al 
(2001) 
IN/UN IN/UN IN/UN PAQ PAQ 3 No info about A, B or C. D: some missing data but probably 
unrelated to study. E: reports results stated in methods, 
however adds subsequent subjective 'anosognosia rating' 
and re analyses some results using this 
Kurz et al 
(2012) 
AQ AQ AQ AQ AQ 0  
Lai et al 
(2004) 
IN/UN IN/UN AQ PAQ AQ 2 No information about A and B- just states that 'were 
randomly assigned to groups' 
Luttenberger 
et al (2012) 
AQ AQ AQ PAQ AQ   
Maci et al 
(2012) 
AQ PAQ AQ AQ AQ   
Neely et al 
(2009) 
IN/UN IN/UN IN/UN AQ AQ 3 No information given about A, B or C states that 'first 30 
couples who agreed to participate were randomly assigned' 
Niu et al 
(2010) 
AQ AQ AQ AQ AQ   
Onder et al 
(2005) 
AQ AQ AQ AQ AQ   
Onor et al 
(2007) 
IN/UN IN/UN IN/UN AQ AQ 3 No information about A,B just states that 'simple 
randomisation was used' No information about C 
Quayhagen 
et al (1995) 






IN/UN IN/UN IN/UN IN/UN AQ 4 A and B 'subjects were randomly distributed in groups at the 






AQ AQ AQ PAQ AQ   
Spector et al 
(2003) 
AQ AQ AQ IN/UN AQ 1 No information about D 
Spector et al 
(2001) 
AQ AQ IN/UN PAQ AQ 1 C: outcome measures not blinded 
Tadaka et al 
(2007) 
AQ PAQ AQ IN/UN AQ 1 Unclear information for D 
Tarraga et al 
(2006) 
IN/UN IN/UN IN/UN PAQ PAQ 3 Unclear/no information about A,B and C 
Wang et al 
(2007) 
PAQ IN/UN PAQ PAQ AQ 1 B-  Unclear information 
Zarit et al 
(1982) 
IN/UN IN/UN IN/UN AQ AQ 3 No information about A, B or C 
Table 2-8: Quality ratings for studies included in the meta-analyses 
AQ= adequate, PAQ= partially adequate, IN/UN= inadequate/ unclear 
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Chapter 3 METHODS – RCT  
 
 
3.1 SUMMARY OF TRIAL 
The study followed a parallel single-blinded, randomised controlled trial design.  Participants were 
randomly allocated to a cognitive training or active control condition.  Both groups were assessed with 
a battery of neuropsychological assessments and performed a digit span task whilst undergoing fMRI.  
The neuropsychological assessments and fMRI were performed pre- and post- interventions, which 
consisted of 18 sessions delivered over approximately 6 weeks.  
 
3.2 RECRUITMENT 
Participants were recruited from Mental Health for Older Adults (MHOA) services of the South London 
and Maudsley NHS Mental Health Foundation Trust (SLAM).  Memory clinics and community mental 
health teams (CMHTs) were contacted and provided with an information sheet describing the study.  
Potential participants were also identified from monthly SLAM dementia neuroimaging meetings and 
from the Institute of Psychiatry (IOP) Dementia Case Register.  The Case Register is a database of 
individuals with dementia collated by specialist dementia research nurses in the Department of Old 
Age Psychiatry at the IOP.  Individuals in this database have previously consented to being involved 
in research and most have been receiving annual contact with researchers for assessment of 
cognitive function as part of a longitudinal study.  Some participants had been involved in other 
research studies over the preceding 2 years; however no participant approached to take part in the 
study was currently involved in any other interventional study.  Potential participants were initially 
approached by members of their clinical care teams or by the specialist nurses to ascertain whether 
they would be interested in taking part in the study. If verbal consent was given, their contact details 
were passed to the researcher.  No patients self-referred to the study.   
(See Appendix 1 for examples of all patient information sheets and consent forms). 
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3.3 INCLUSION CRITERIA 
Inclusion criteria were: 
1) Diagnosis of possible or probable Alzheimer’s disease.  The diagnosis was made by a 
multidisciplinary team assessment/clinical services, based on ICD criteria and NINCDS-
ADRDA criteria for diagnosis of AD
7
.  A diagnosis of mixed dementia was permitted.  If a 
participant was, in the opinion of the clinical team, at the point of transition from a diagnosis of 
MCI to AD due to evidence of cognitive and functional decline, they were also considered for 
inclusion. 
2) Age 65 or above 
 
3.4 EXCLUSION CRITERIA 
Exclusion criteria were: 
1) Diagnosis of significant co-morbid neurological or psychiatric illness 
2) Significant visual or auditory impairment that would make it difficult for the participant to 
perform the tasks. 
3) Primary diagnosis of fronto-temporal dementia, Lewy body dementia, vascular dementia or 
other non AD dementia. 
4) Past medical or surgical history that would contra-indicate undergoing an MRI scan at 3T.  As 
any previous surgery could potentially have resulted in the retention of iron-containing clips, 
all participants who had a history of surgery required evidence that there were no metallic 
implants still present.  This was either from surgical notes or plain x-ray imaging that could 
clearly demonstrate the absence of metal.  As many participants had had surgical procedures 
several decades ago, it was not always possible for contemporaneous surgical notes to be 
accessed, and if this was the case participants were excluded from the study.  Any cases 
where there was a query over safety were discussed with radiographers in the MRI 
department in advance of the scan booking. 
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3.5 INFORMED CONSENT PROCEDURE 
Potential participants who were identified by research nurses or members of clinical teams were 
asked for verbal consent to be contacted by the study researcher (JH).  The researcher then 
contacted the participant by telephone, to briefly describe the study and ask if they would like to 
receive further information.  If they agreed, an information sheet was then sent to the participant and a 
follow up phone call was made after 2-3 weeks.  If the participant remained interested in taking part in 
the study, an initial home visit was arranged.  At this initial visit the study was described, and potential 
participants and their carers were encouraged to ask any questions.  If they remained interested in 
taking part in the study, they were asked to consent to provide details about their medical history and 
for the researcher to contact their GP or access relevant hospital medical records to ensure their 
safety to undergo MRI.  A follow-up visit was arranged after approximately a further 2-3 weeks, and if 
a review of medical records had confirmed that the participant was safe to undergo MRI, a date was 
given for the initial MRI scan.  The reasons for the study, including the design and randomisation, 
were discussed, and participants were again given the opportunity to ask any questions about the 
study.  All participants were assessed for capacity to make a decision regarding their participation in 
the trial.  If any participant lacked capacity to make an informed decision regarding participation they 
were excluded.  Participants were then asked to complete the consent form.  A mobile telephone 
number was left with the information sheet and participants and carers were encouraged to contact 
the researcher at any time with questions or concerns they may have had about the study. 
 
3.6 RANDOMISATION 
An internet based block randomisation program
143
 was used to randomise participants in blocks of 10, 
with 5 participants randomised to each of the cognitive training and control groups.  Participants were 
randomised following the baseline fMRI scan. The randomization was performed online by an 
individual not involved in the study, who had no information about, or contact with, the participants.  
The researcher was then informed of group allocation on a participant by participant basis.  This 
meant the researcher was unable to refer participants for randomisation in a way that could 








3.7.1 OF PARTICIPANTS 
During discussion of the study, both arms of the study (cognitive training and active control) were 
presented to participants and their carers as providing a significant amount of cognitive stimulation 
and potentially leading to benefits. However, it was stressed that there were no guarantees that 
participants would experience any personal benefit or improvement in cognition as a result of training.  
It was clearly stated in the information sheet that participants were randomly allocated to the two 
different groups, however once training was commenced none of the participants asked to which of 
the groups they had been allocated, and all participants considered they were engaging in cognitive 
training.  In this way participants were effectively blinded as to their allocation for the duration of the 
study. 
 
3.7.2 OF RESEARCHER 
Due to a single researcher being responsible for all aspects of the study (recruitment, assessment, 
intervention and analysis), it was not possible to blind the researcher to allocation post randomisation. 
 
3.8 BASELINE ASSESSMENTS 
 
The following assessments were performed at baseline to ensure participants met inclusion criteria 
and to provide demographic and baseline information for the study. 
1) Age 
2) Gender 
3) Years of education 
4) National Adult Reading Test (NART)
144
, as a test of pre-morbid IQ. 
The NART requires participants to read aloud a list of 50 irregular words.  The word list is 
presented to the participant, who is asked to read each word out loud.  A point is scored for 
the correct pronunciation of each word.  The total score can be used to estimate a pre-morbid 
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IQ score.  The NART is widely used to estimate pre-morbid intellectual ability, including in 
dementia patients
145
. Pre-morbid IQ was estimated using the equation: 
 IQ = 127.8 - 0.78 x (NARTerrors)
146
.  
5) Geriatric Depression Scale (GDS)
147
, to exclude significant depressive illness.  The 30 point 
GDS was used to assess current depressive symptoms.  It has been extensively validated in 
older adults
148
.  Each question is scored with either one point for ‘yes’ or zero for ‘no’.  A 
score of 11-20 indicates mild depression and a score of 21-30 indicates severe depression. 
6) Hachinski Ischaemic Score
149
; Thirteen questions regarding significant cerebro-vascular risk 
factors or factors considered important in vascular aetiology are asked with a maximum score 
of 18. A score of 4 or less suggests no evidence for vascular aetiology, whilst a score above 7 
is suggestive of vascular dementia. 
7) Neuropsychiatric Inventory (NPI)
150
, to exclude behavioural and psychological symptoms that 
may affect performance in the study.  Twelve areas are assessed in the NPI (delusions, 
hallucinations, agitation, depression, anxiety, euphoria, apathy, disinhibition, irritability, 
aberrant motor behaviour, sleep and appetite/eating disorders).  Each of these areas is 
scored on a 4 point scale of frequency and a 3 point scale of severity.  A caregiver distress 
score is also produced from a 6 point scale of (0= none, 6= extreme). NPI score is calculated 
by multiplying frequency x severity score.  
8) Sensory screening - for handedness and to exclude significant visual or auditory impairment 
that could influence performance or participation in the study. 
9) Webster rating scale
151
- to exclude evidence of significant extrapyramidal or parkinsonian 
symptoms and signs. 
 
3.9 PRIMARY OUTCOME MEASURES - WORKING MEMORY 
 
The following measures were performed at both baseline and post intervention. 
 
3.9.1 DIGIT SPAN (Figure 3-1)
15 26
 
This is a well established task of verbal working memory
23
.  Twenty trials of a laddered digit span task 
were performed
26 68
.  Participants were initially shown a 3 digit sequence and asked to remember the 
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sequence for a few seconds and then to verbally recall the sequence in order.  If they correctly 
recalled the sequence, then the number of digits to be recalled (span) would increase by 1 for the 
subsequent trial.  Conversely, if the sequence was incorrectly recalled, the next trial would have one 
less digit.  In this way participants would tend to reach and then oscillate around their maximum span.   
Two versions of this task were performed.  A ‘structured’ version, whereby digits were presented in 
runs of consecutive numbers or increasing or decreasing in 2s (e.g. 2,4,6,8 or 9,7,5,1,2,3).  These 
structured sequences encouraged chunking. A second ‘random’ version of this task was also 
performed.  Here a random number generator was used to ensure the digits were presented in as 
random a sequence as possible.  Previous studies have demonstrated that structured sequences 




The task was performed on a laptop computer.  Digits were presented for 1000ms with a 500ms delay 
between digits.  After the final digit was presented there was a further delay of 500ms, before the 
word ‘RESPOND’ appeared on the screen.  At this prompt the participant verbally recalled the digits in 
order, and the researcher typed them into the computer.  If the digits had been correctly recalled the 
word ‘CORRECT’ was presented on the screen, if incorrect the words ‘TRY AGAIN’ were presented.  
There was then a delay of 500ms before the next trial commenced.  All trials started with the words 
‘NEXT TRIAL’ together with a number to inform the participant how many digits would be presented in 
the subsequent span.   
The timings of the presentation of the digits and length of trials were based on pilot data
68
, which 
ensured that participants with AD were given enough time to attend and respond to the stimuli.  The 
length of the starting span (3 digits) was also chosen following the results of a pilot study 
demonstrating that the majority of participants with AD could perform this successfully
68








3.9.2 SPATIAL SPAN 
This is a task of spatial working memory, based on Corsi’s block tapping task
152
, which has been used 
extensively in participants with AD
17 153
.  In this task, a 4 x 4 grid of red squares was presented on a 
computer screen.  Initially 3 blocks sequentially flashed blue for 1000ms before returning to red.  
Participants had to remember which blocks had changed and the sequence.  After a 500ms delay, an 
audible tone sounded and using a touch-screen, participants had to directly press on the blocks that 
had changed colour, in the correct sequence. If the participant correctly recalled the sequence, the 
following sequence increased by one, incorrect recall resulted in one less block being highlighted in 
the next sequence. In this way participants would reach their maximum span and oscillate around 
this.  Again, two versions of this task were performed.  A ‘structured’ version, whereby blocks tended 
to be presented in the same row or column, or in recognisable shapes.  Secondly, a ‘random’ version 
was performed, where blocks were presented in random combinations.  The structured version has 
been shown to encourage the use of chunking both in young participants
24
, elderly controls and 
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participants with early AD
68
 .  Figure 3-2 shows an example of the spatial span task and Figure 3-3 
shows examples of structured and random trials for both digit and spatial span tasks. 
 




Figure 3-3: Examples of A) STRUCTURED and B) RANDOM trials for both digit and spatial span tasks 
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3.10 SECONDARY OUTCOME MEASURES 
The following measures were performed at both baseline and post intervention. 
 
3.10.1 GENERAL COGNITIVE FUNCTION 
3.10.1.1 MINI MENTAL STATE EXAMINATION (MMSE)
71
  
This is a widely used 30-point pen-and-paper assessment incorporating assessments of orientation 
(10 points), immediate and delayed recall (6 points), reading, repetition, writing and copying of a 
shape (4 points), object recognition (2 points), following a three-stage instruction (3 points) and 
attention (5 points).  Points are scored for each correct response, with a maximum score of 30. 
 




This is a widely used 70 point pen-and-paper assessment involving eleven subsections that evaluate 
word recall, word finding and naming, following commands, orientation, copying shapes, performing a 
5 stage task, recall of test instructions, word recognition, spoken language ability and language 
comprehension.  It is reverse scored, therefore higher scores represent greater cognitive impairment.  
 
3.10.2 EPISODIC MEMORY 
3.10.2.1 LOGICAL MEMORY I AND II 
This is a task of verbal episodic memory taken from the Wechsler Memory Scale
131
.  Participants are 
read a short story and asked to remember it.  As soon as the examiner has finished reading it, they 
are asked to recall as much of the story as possible (LM I).  They are then distracted by performing 
other tasks, and 25 minutes later asked to recall the story again (LM II). Each part is scored for 25 
specific and 7 thematic components, with a total score of 32 points. 
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3.10.2.2 PAIRED ASSOCIATE LEARNING TASK (PAL)
154
  
This is a task of visuo-spatial episodic memory that is sensitive to episodic memory deficits in early 
AD
155 156
 (Figure 3-4).  A number of boxes are presented at different locations on a computer screen.  
Each box covers a picture.  The boxes are initially shown, followed by the pictures under each box.  
Each picture is then presented in the middle of the screen and the participant has to recall which 
picture appeared under which box, therefore testing both object and location recall.  If a participant 
correctly recalls all the pictures, the next set of boxes has one more box/picture combination.  If an 
error is made a new set of boxes are presented, with one fewer box/picture.  If 3 errors are made, the 
task ends. The task was performed by the participant verbally stating which box they wished to select 




Figure 3-4: Screenshot of the Paired Associates Learning Task.   




3.10.3 EXECUTIVE FUNCTION 
3.10.3.1 GRAMMATICAL REASONING TASK (GR)
157
.  
This is a test of executive functioning/verbal reasoning
158
 (Figure 3-5). In this task a picture of a 
square and circle are presented on a computer screen.  A sentence describing the relationship 
between the circle and square is presented above the picture and the participant has to choose 
whether the sentence describing the picture is true or false.  The participant has 90 seconds to 
answer as many true/false questions as they can. This was done by the participant verbally 




Figure 3-5: Screenshot of the Grammatical Reasoning Task.   




3.10.3.2 ODD ONE OUT TASK (OOO)
157 159
  
This is a test of executive functioning/reasoning (Figure 3-6).  In this task a 3 x 3 grid of objects are 
presented on a computer screen. Each object may be made of up of one or multiple shapes or 
colours.  One object differs from all of the others, owing to it being a different shape, combination of 
parts or colour. The participant has to choose verbally which object they think is the ‘odd one out’.  




Figure 3-6: Screenshot from the Odd One Out Task.  
The participant is required to select which of the 9 objects is the odd one out. 
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3.10.3.3 SELF ORDERED SEARCH (SOS)  
This is a test of executive functioning/planning
159
 (Figure 3-7).  In this task a series of boxes are 
presented on a screen. The aim is to search through the boxes in order to find a gold coin hidden in 
one of the boxes.  Gold coins appear sequentially in the boxes, with a new coin appearing in one of 
the remaining boxes after each coin has been found.  There are two rules to the task.  Firstly, a coin 
will never be hidden in the same box twice, therefore if a coin has already been found in a box, and 
the participant looks in that box again, they will lose a “life”.  Secondly, if a participant looks in the 
same empty box twice whilst looking for a coin, they will lose a “life”.  The task proceeds with the 
participant deciding which boxes to look in, and continues until a gold coin has been found in each 
box.  If an error is made, the participant loses a “life” and a new trial is started with one less box.  If 
the participant successfully finds all the gold coins, a new trial begins with one additional box.  The 
task therefore tests the participant’s ability to plan and execute a strategy and also recall the spatial 




Figure 3-7: Screenshot from the Self Ordered Search task.   
A gold coin has just been found in the top right box. The participant must now continue to search 
through the boxes until the three remaining coins are located. However they must not revisit the top 




3.10.3.4 VERBAL FLUENCY 
This is a well established task of executive function
137
 , and a version taken from the Addenbrookes 
Cognitive Examination-Revised (ACE-R) was used
160
.  Participants are asked to generate as many 
words as they can beginning with the letter P in one minute, not including place or person names.  
They are then asked to generate as many types of animal they can in one minute, whose name 
begins with any letter of the alphabet. The total number of words generated for each category is 




3.10.3.5 TRAIL MAKING TASKS A & B
138
  
This is a task of executive functioning.  In Task A, participants are asked to connect a series of 
numbered circles on a piece of paper as quickly as possible.  In Task B, participants are again asked 
to connect a series of circles containing ascending numbers or letters of the alphabet.  On this 
occasion they are asked to alternate between numbers and letters (e.g. 1-A-2-B-3-C etc) and connect 
up all of the circles as quickly as possible.  Prior to doing the task, participants are given short 
practice examples to complete.  If an error is made, the examiner is allowed to point this out to the 
participant for them to correct.  Each part is timed, and a time to completion for each part of the task is 






3.10.4.1 SUSTAINED ATTENTION RESPONSE INHIBITION TASK (SART)
162
 
This is a test of sustained attention and response inhibition, originally designed for use with brain 
injured individuals.  In this task single digit numbers are individually presented for 500ms on a 
computer screen.  The font size and boldness of the digits varies, and a small cross is presented for 
1000ms between digits.  The participant has to press the space bar on the keyboard in response to 
every number presented on the screen, with one exception - they are told not to press the bar if the 
number 3 is presented.  If they make an error and accidentally press the bar when a 3 is presented 
they are instructed to continue with the task as before.  Fifty practice trials were completed followed 
by 270 test trials, lasting 405s in total.  The number of commission errors (pressing bar when ‘3’ 
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presented), omission errors (not pressing bar for all other numbers) and total errors was recorded for 
analysis. 
 
3.10.5 FUNCTIONAL AND QUALITY OF LIFE ASSESSMENTS 
3.10.5.1 INSTRUMENTAL ACTIVITIES OF DAILY LIVING (IADL)
163
   
This is a questionnaire covering instrumental activities of daily living.  A 15 point version was used 
that included 8 categories of instrumental ADLs and 7 basic ADLs. It is completed by the participant 
and carer to provide a score of functional impairment.   
 
3.10.5.2 DEMENTIA QUALITY OF LIFE (DEMQOL)
164
  
This is a questionnaire covering how the participant has been feeling, how concerned they have been 
about aspects of their memory and about activities of daily living.  It is scored out of 28 and used to 
give an overall score for perceived quality of life.  
 
3.10.6 METACOGNITION 
3.10.6.1 THE META-MEMORY IN ADULTHOOD QUESTIONNAIRE (MIA) 
165
   
This is a questionnaire of 108 questions scored on a Likert scale.  The questions are divided into 7 
domains to give a measure of the participants’ beliefs about their own memory function.  The sub 
categories are strategy use, memory capacity, change in memory, tasks, locus, achievement, and 
anxiety.  Total scores and scores broken down by sub category were analysed. 
 
3.10.6.2 SUBJECTIVE REPORTS OF STRATEGY USE AND PERFORMANCE DURING 
SPAN TESTING 
During the pre- and post-testing sessions, the span tasks were presented in two blocks, and 
participants were not informed which block consisted of structured or random trials. Immediately 
following each block of either structured or random trials, participants were asked: 
1) Did you use any strategy to help you remember the numbers? 
Based on their answer, participants were either coded to have explicitly used chunking strategies 
(score = 1), or not (score = 0). 
After both blocks were administered participants were asked: 
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2) Did you find one of the blocks easier than the other and why, or did you find them the same? 
Response to this question was coded 1-4 as follows: 
1) participant found structured trials easier   
2) participant found random trials easier  
3) participant found no difference between blocks  
4) no data available for participant (as these questions were administered following a revision to the 
study protocol to collect meta-cognitive data). 
A ‘match’ score was also defined by whether the participant had a greater score on the trial type they 





3.11.1 COGNITIVE TRAINING 
Participants in the cognitive training group underwent 18 sessions of training on a structured digit 
span task.  The quantity and intensity of training sessions was based on previous studies of 
successful cognitive training
53
.  Each session consisted of 30 trials of structured digit spans, divided 
into 2 blocks of 15 trials.  Initially span length was 3 digits and the span length increased or decreased 
by one digit following a correct or incorrect response, as described in 3.9.1.  At the beginning of the 
session participants were reminded that they may find it useful to group some digits together in 
‘chunks’ according to the relationships between the numbers (e.g. 1-2-3 or 2-4-6) and that there 
would be deliberate structure within the spans to enable this.  However, participants performed all the 
training trials independently and were not helped to identify chunks by the researcher during the trials.    
Three training lists of digit spans were used for the training sessions in a pseudo-random fashion.  
Each list consisted of 20 different combinations for each span length, and the span presented 
depended on how the participant had performed on the previous trial.  Participants therefore were 
exposed to a range of structured stimuli during training, however most of the structure within the 
spans was a combination of digits consecutively increasing (1,2,3), decreasing (9,8,7), or 
increasing/decreasing by  two (e.g. 2,4,6 or 9,7,5,3,1) or three (e.g. 9,6,3).  The stimuli lists used in 
the testing sessions at pre- and post- were not used during training.  Each training session took 
approximately 30 minutes.  The digit spans were presented on a laptop computer at the participant’s 

















Figure 3-8: Schematic of the training intervention.  
Example demonstrates three structured digits, if the participant correctly recalls these digits in order; the 




3.11.2 CONTROL GROUP 
Participants in the control group underwent 18 sessions of an attention control intervention.  The 
same digit span program was used as in the training group, however participants performed 30 trials 
of a random 3 digit span, in two blocks of 15.  At the end of each trial participants were informed if 
they had recalled the 3 digits correctly, however span length did not adjust according to 
correct/incorrect response, and remained fixed at 3 digits (Figure 3-9).  A random number generator 
was used to produce the spans.  Although the control intervention took slightly less time than the 




Figure 3-9: Schematic of the control intervention.  
Example demonstrates three random digits, All trials presented during control intervention consisted of three 
random digits, irrespective of whether they were correctly recalled. 
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3.12 SUMMARY OF PARTICIPANT’S INVOLVEMENT 
































There were therefore a total of approximately 22 home visits, and 2 fMRI scans at the Centre for 
Neuroimaging studies, IOP, per participant, over approximately 12 weeks.  
 
 
3.13 STATISTICAL ANALYSES 
For the primary outcome measures, mean span accuracy scores were analysed using a mixed 




For the secondary outcome measures, maximum scores on the MMSE, ADAS Cog, Grammatical 
reasoning, Odd One Out, Paired Associate learning, Self Ordered Search, Logical memory I and II, 
Initial screening interview 
 
Baseline assessments 
fMRI scan   
(in Cambridge 
Intervention 
18 sessions in total 






Follow up fMRI scan   
Follow up assessments 
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IADL, DEMQoL, verbal fluency score, time to completion for Trail making task A&B, sub scores and 
total scores on the MIA and commission errors, omission errors and overall errors in the SART were 
all analysed using mixed repeated measures ANOVAs in SPSS v 22.0.  Where appropriate, all tasks 
within the same cognitive domain were included in an initial repeated measure ANOVA to examine for 
overall effects, with subsequent ANOVAs examining each task independently.  Assumptions of 
parametric data were assessed for all data.  The assumption of normality was assessed by plotting 
histograms and Q-Q plots of the raw data or residuals.  Values of skewness, kurtosis and the 
Kolmogorov-Smirnov test were also used to test for normal distribution of the data.  Homogeneity of 
variance was assessed using the Levene statistic.  If the assumptions of parametric data were 
violated, Mann- Whitney and Wilcoxon signed-rank non parametric tests were conducted.  
For all analyses the α significance level was set at 0.05.  Correction for multiple testing due to the 
number of neuropsychological tasks was not performed, as power calculations were based on an α 
value of 0.05.  The issue of multiple testing is addressed in the discussion, (section 7.11.5). 
 
3.14 SAMPLE SIZE 
As the study was based on an fMRI paradigm, the sample size was calculated from previous studies 
using a similar paradigm, yielding significant results in healthy controls with group sizes of n = 14, 
producing effect sizes of 0.9 and 1.7 
24 26
. Recent cognitive training studies have yielded significant 
results in controls with group sizes of n = 8  producing an effect size of 1.75
53
.  Based on these 
studies, power calculations give 80% power to detect a significant difference (p<0.05) with group 
sizes of > 12.  
 
 
3.15 ETHICAL APPROVAL AND TRIAL REGISTRATION 
The study was reviewed and approved by the NRES Committee East of England-Cambridge East 
(REC reference number 10/H0304/68). 
Prior to commencing the study, the trial was registered and issued with the International Standard 




Chapter 4 METHODS - NEUROIMAGING 
 
 
4.1 BEHAVIOURAL FMRI TASK 
Participants underwent two structural and fMRI examinations, at baseline and then post intervention. 
The fMRI cognitive activation protocol was based on a digit span paradigm performed by healthy 
young individuals
26
 and adapted for use in patients with AD.  
The same digit span task was presented during each FMRI session (Figure 4-1). This task was a 
variation of the digit span task administered during both the training and control interventions. Five 
digits were successively presented on a screen. Participants were instructed to remember the digits in 
order, and when the word ‘recall’ appeared on the screen, to say the numbers back out loud, in the 
correct order. The words ‘confident’ and ‘not confident were then presented on the screen, and 
participants were asked to state if they were confident or not that they had recalled the numbers 
correctly. Twenty trials were presented per run, with structured and random sequences presented 









4.1.1 FMRI TASK TIMING  
The order and duration of events during the fMRI task is shown in Table 4-1. 
EVENT DURATION (ms) 
PRE-TRIAL FIXATION CROSS 500 
FIRST DIGIT DISPLAY 1000 
INTERDIGIT INTERVAL 500 
SECOND DIGIT DISPLAY 1000 
INTERDIGIT INTERVAL 500 
THIRD DIGIT DISPLAY 1000 
INTERDIGIT INTERVAL 500 
FOURTH DIGIT DISPLAY 1000 
INTERDIGIT INTERVAL 500 
FIFTH DIGIT DISPLAY 1000 
INTERDIGIT DISPLAY 500 
PRE- RECALL DELAY VARIABLE (2000- 5000ms) 
RECALL PROMPT 7000 
CONFIDENCE PROMPT 3000 
POST- FIXATION CROSS 500ms 
POST- TRIAL DELAY VARIABLE (4000-10000ms) 
Table 4-1: Order and duration of events during fMRI task. 
 
 
The pre-recall delay and post-trial delay varied between trials, however the durations were fixed for 
each trial, and therefore all participants had identical timings for each functional run. The first 
functional run was 584.05s, the second, 594.035s and the third, 588.022s in duration. 
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4.1.2 PRACTICE AND PARTICIPANT MONITORING DURING FMRI 
All participants had a training session prior to the FMRI scan to ensure they could understand and 
perform the task. Participants also practiced the task using a mock MRI scanner, in order to 
familiarise themselves with the environment and experience of MRI prior to the scan session. 
Participants were informed that they would be able to communicate with the radiographers and 
researcher via a microphone and headphones at any time during the scan. They also held a buzzer 
button and it was stressed that if they were uncomfortable, or wished to terminate the scan they could 
communicate this either by pressing the buzzer or speaking directly to the researcher via the 
microphone. The scan session was divided into a series of structural and functional scans, and the 
participant was asked about their comfort and willingness to continue between each of the scans to 




4.2 FMRI PROTOCOL. 
 
4.2.1 FUNCTIONAL PARAMETERS AND DATA ACQUISITION 
Both pre- and post- intervention fMRI scans were performed on the same Siemens 3T scanner at the 
Centre for Neuroimaging Sciences, Institute of Psychiatry. An 8 channel head coil was used. 
The order of scans is shown in Table 4-2: 
 Scan Duration (mins) 
1) 3 plane localiser < 1:00 
2) Axial scan 36 slices < 1:00 
3) Sagittal MP-RAGE structural scan 10:04 
4) Axial high resolution GE- 43 slices 2:00 
5) First functional run- Digit span 1 10:09 
6) Axial T2 Propeller- 26 slices angled along AC/PC line 2:45  
7) Second functional run- Digit span 2 10:09  
8) Axial T2 Propeller Flair 3:20  
9) Third functional run- Digit span 3 10:09  
Table 4-2: Order of scans during each session. 
 
 
For all functional runs, an echo planar imaging (EPI), event related design was used. 37 slices 
covering the whole head were taken per repetition time (TR), with a slice thickness of 3mm and gap of 
0.3mm. The field of volume was 21.1, such that voxel size was an isotropic 3.3mm
3
. The TR was 2 
seconds and the echo time (TE) was 30ms. The flip angle was 75 degrees. 4 dummy scans were 
acquired and discarded and 300 images were taken per location with a total of 11100 images taken 
per functional run. 
The participants’ verbal responses were documented in real time by the researcher and also 
automatically recorded in both filtered and unfiltered audio files. The onset times of each event and 
volume times were also automatically recorded. Pulse oximetry data (pulse and respiratory rate) was 
collected for all participants. 
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4.3 FMRI ANALYSIS- PRE-PROCESSING  




4.3.1 RESETTING THE ORIGIN 
During data acquisition the origin was set as the centre of the scanner, however to improve the quality 
of registration the origin was reset to the location of the anterior commissure (AC). Each participant’s 
MPRAGE structural image and first functional image were manually reset to the AC, and all other 
functional images were re-oriented to this image for all 3 playlists per scanning session, using the 
display function within SPM8. This increases the likelihood of the optimal global solution being found 
when the images are warped to template space, and therefore improves the quality of co-registration. 
 
4.3.2 CREATING A DARTEL TEMPLATE 





 was used to create a group average structural template for normalisation. During the 
normalisation process images are transformed and warped into a standardised brain in MNI space. 
However as all the participants were elderly AD patients, it is likely that their brains would be 
structurally different from the standardised healthy brain templates. Therefore by using DARTEL, a 
study-specific average template was produced to improve inter-participant alignment and more 
accurate localization for analysis. DARTEL registers images by computing a single flow-field that 
stores deformation information for each participant. New tissue class images were generated and 
iteratively matched to a template generated from their own mean. ‘Smoothed’ spatially normalised 
images were then generated aligned to MNI space. 
This procedure was conducted separately for both pre- and post-MPRAGE structural images for each 
participant. 
 
4.3.3 QUALITY ASSESSMENT 
The time series difference analysis (TSDiffAna) program was used to review the variance between 
the images in each fMRI scanning session
169
. The aim was to check the images for quality and 
highlight any images where there was a peak in variance due to movement or scanner artefact. 
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Output graphs were produced displaying the variance between images, slices, max/min/mean slice 
variance and mean voxel intensity. 
These graphs were used to assess the amount of variance in the time series and specifically to 
identify any spikes of increased variance. Any peaks or spikes in variance may represent artefact, due 
to technical issues with the scanner or significant movement artefact.  
It was anticipated that there may be considerable movement artefact in an AD patient group. A priori, 
it was decided that variance would be acceptable if the scaled and slice by slice variance was <300, 
and the mean voxel intensity was between 0.9 - 1.1. 
Where there were spikes of increased variance outside these limits, the associated images were 
cross-referenced with the movement parameter graphic outputs from SPM and checked by viewing 
the images using the CheckReg function in SPM8
167
. Artefact was reviewed with the lead MRI 
physicist for the study and it was agreed that movement rather than scanner error was the most likely 
cause of the artefacts seen. Excessive movement was managed during first-level analysis (see 
section 4.4.1). See Appendix 2 for examples of TSDiffAna output graphs. 
 
4.3.4 PRE-PROCESSING 
A batch script was used for pre-processing containing the following steps: 
 
4.3.5 SLICE TIMING 
All images were corrected for slice timing as data had been collected as 37 interleaved slices, with an 
interscan interval (TR) of 2 seconds. Slice 2 (the mid-slice) was used as the reference slice.  
 
4.3.6  REALIGNMENT 
All functional images were realigned and corrected for motion using a series of rigid translations on, 
and rotations around, x-, y- and z-axes. All slice timing corrected images from each functional run 
were realigned and the mean image was resliced. The default settings in SPM8 for realignment 
estimation were used (Quality: 0.9, Separation: 4, Smoothing (FWHM): 5, Num Passes: Register to 
mean, Interpolation 2nd Degree B-Spline, Wrapping: No wrap, Weighting: 0 files)
34
. Plots of motion 
parameters in each direction (x, y, z) and rotation (pitch, yaw, roll) were produced for each participant. 
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The functional images were then co-registered to the structural reference image. The reference image 
was the participant’s structural MPRAGE image. The mean image produced by the realignment step 
was used as the source image (i.e. moved to best match the reference image), and all other slice-
corrected images from all three functional runs were selected to remain in alignment with the source 
image. 
Estimation options were kept as the default settings in SPM8 (Objective Function Mutual information, 




4.3.8 NORMALISATION TO MNI SPACE 
The co-registered images were then normalised to MNI space using the group specific DARTEL 
template and participant-specific flow-field parameters. A 2 x 3 double bounding box was used and 
images were smoothed using an 8 x 8 x 8 Gaussian kernel
34
. 
All pre-processed functional images were then compared to the EPI template in SPM8 to check the 




4.4 FMRI ANALYSIS- FIRST LEVEL ANALYSES 
Within-participant analysis was conducted for two levels of events.  
1) Basic analysis of all trials 
2) Main analysis of only correct trials and confidence reports 
  
4.4.1 BASIC MODEL 
The basic analysis extracted the onset and durations from all trials and examined four conditions: 
1) Random trials- encoding event (RE) 
2) Random trials- recall event (RR) 
3) Structured trials- encoding event (SE) 
4) Structured trials- recall event (SR) 
All trials were used in this analysis, irrespective of whether the participant gave the correct response. 
Therefore, as all participants received identical stimulus lists during the pre- and post- trial fMRI 
session, the onsets and durations of these events were identical for all participants. 
The exception was for participants who had scanning sessions terminated early for various reasons 
(such as requesting early termination of the session). In these cases, only the onsets and durations of 
trials actually performed were analysed, with the onset and duration lists corrected to reflect this for 
these participants. 
The design matrix was formed from the 4 specified event regressors of interest (random encoding, 
random recall, structured encoding, structured recall) and six movement regressors, each 
corresponding to 3 transformations (x, y, z) and 3 rotations (pitch, roll, yaw) produced from the 
realignment stage of pre-processing. If there was excessive movement between subsequent images, 
resulting in significant movement artefact on the images, these were excluded from analysis by 
defining them as additional regressors of no interest. This was done by calculating the difference 
between the translation and rotation values between all adjacent images and producing a value for 
movement between images. If this value was greater than 4mm in any direction of translation, or 0.1 




Figure 4-2: Design matrix for basic analysis. 
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The haemodynamic response was convolved with the specified time series of events at each voxel 
using the General Linear model, and low-frequency noise was removed using a high pass filter. The 
relative contribution (β) of each variable (X) in the design matrix to the observed data (Y) at each 




Once the design matrices had been defined and estimated, the following contrasts for the first-level 
analysis were specified: 
contrast 1= structured trials during encoding  
contrast 2= random trials during encoding 
contrast 3= all trials (structured and random) during encoding 
contrast 4= structured trials encoding > random trials during encoding 
contrast 5= random trials encoding > structured trials during encoding 
contrast 6= all trials during recall  
If extra regressors were created for participants in the first-level specification, these were accounted 
for by adjusting the contrasts so they contained the correct number of parameters. This was also the 
case for participants who had only one or two functional runs. 
The β values for each contrast were then entered into T-tests to examine for significant effects at an 




4.5 MAIN ANALYSIS MODEL 
In this model, only correct trials were examined, and encoding, delay and recall events were included 
in the model. Incorrect and ‘not confident’ responses were also modelled as regressors of no interest.  
 
4.5.1 EXTRACTING ONSET AND DURATIONS  
Behavioural data during each participant’s scanning session was examined, and participant specific 
onset and duration timings were extracted for the following events: 
1. Correct random trials 
2. Correct structured trials 
3. Incorrect random trials 
4. Incorrect structured trials 
5. Correct trials with confident response 
6. Incorrect trials with confident response 
7. Correct trials with not confident response 
8. Incorrect trials with not confident response 
For each of these conditions, the following data was extracted in separate text files: 
Text file 1 = Encoding onset (fixed duration 7.5s for all trials) 
Text file 2 = Delay (pre- recall delay) onset  
Text file 3 = Delay durations (variable duration) 
Text file 4 = Recall onset (fixed duration 7s for all trials) 
Text file 5 = Confidence response onset (fixed duration 3s for all trials) 
Text file 6 = Post- trial delay onset  
Text file 7 = Post- trial delay duration (variable duration) 
 
Therefore there were 8 x 7 = 56 text files produced per functional digit span run. As three runs were 
conducted per scanning session, a total of 3 x 56 = 168 text files containing individual onset or 
duration data were produced per participant per scanning session. These text files were produced 
using a Visual Basic macro in Microsoft Excel.  
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4.5.2 DEFINING REGRESSORS 
In order to capture the regressors of interest - namely correct random trials, correct structured trials 
and confident correct trials, at the encoding, delay and recall time points, the events were 
parameterized to ensure events modelled were independent (orthogonal). 
Four parameters were modelled for each of the encoding, delay and recall phases, with 12 
parameters overall in each functional run. 
1) All random trials (correct and incorrect trials) 
2) All structured trials (correct and incorrect trials) 
3) All not confident trials (correct and incorrect trials) 
4) All incorrect trials (structured and random trials) 
In this way, the random and structured parameters modelled only correct and confident trials, as 
parameters 7-12 modelled out all incorrect and non confident trials. 
In addition, the 6 movement parameters from realignment were included as regressors of no interest. 
As for the basic model, extra movement regressors were created if a translation between successive 
images was > 4mm or rotation between successive images was > 0.1 radians.  
If no conditions were present (e.g. there were no incorrect trials) a value of ‘1’ with zero duration at 
time point zero was placed in the initial image for that regressor, and that participant would be 
excluded from analysis for contrasts where parameters were not unique. 
 
Using the general linear model (GLM), β values were estimated for each of the defined variables, and 
by including separate incorrect and non confident regressors, the effect of incorrect and not confident 
trials were modelled out of the combined correct and incorrect structured and random regressors. The 
design matrix is shown in Figure 4-3. A batch script was used to conduct the first-level analysis (see 





Figure 4-3: Design matrix for main analysis 
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4.5.3  DEFINING CONTRASTS 
To analyse the different trial types and confidence responses, twenty-one contrasts were then defined 
for all participants. These were seven contrasts defined for each of the encoding, delay and recall 
phases of the task: 
1) Random trials 
2) Structured trials 
3) All trials (structured and random) 
4) Structured trials > random trials 
5) Random trials > structured trials 
6) Not confident trials 
7) Incorrect trials 
If additional movement regressors or reduced number of runs were present, then the contrasts were 
adapted accordingly. See Appendix 3 for code and details of the defined contrasts. 
 
4.6 FIRST-LEVEL RESULTS 
At the individual participant level the following contrasts were examined; 
1) Effect of encoding (all trials) vs baseline 
2) Effect of delay (all trials) vs baseline 
3) Effect of recall (all trials) vs baseline. 
4) Effect of chunking (str>rand and rand>str contrasts) 
 
T- tests were used to examine activations and deactivations with the first three contrasts. These were 
performed to identify whether the working memory task produced the expected areas of brain 
activation, and therefore to demonstrate that the digit span paradigm was successfully reflecting task 




4.7 SECOND-LEVEL ANALYSIS 
 
4.7.1 DESIGN MATRIX 
Group statistical analyses were conducted using random effects analysis to examine the consistency 
of effect sizes across the group. 
The individual estimated β values from the first-level analysis for structured trials vs baseline and 
random trials vs baseline were taken to the second-level analysis and a factorial design was 
employed for the group analysis. 
The factorial design had two dependent within participants factors: TIME (pre- vs post-), and TRIAL 
TYPE (structured vs random), and one independent between participants factor: GROUP (control vs 
training).  A 2 X 2 X 2 Factorial design was therefore produced with the following eight factors: 
 
1 1 1 = STRUCTURED TRIALS IN CONTROL PARTICIPANTS AT BASELINE (PRE) 
1 1 2 = RANDOM TRIALS IN CONTROL PARTICIPANTS AT BASELINE (PRE)  
1 2 1 = STRUCTURED TRIALS IN TRAINING PARTICIPANTS AT BASELINE (PRE) 
1 2 2 = RANDOM TRIALS IN TRAINING PARTICIPANTS AT BASELINE (PRE) 
 
2 1 1 = STRUCTURED TRIALS IN CONTROL PARTICIPANTS AT FOLLOW-UP (POST) 
2 1 2 = RANDOM TRIALS IN CONTROL PARTICIPANTS AT FOLLOW-UP (POST) 
2 2 1 = STRUCTURED TRIALS IN TRAINING PARTICIPANTS AT FOLLOW-UP (POST) 
2 2 2 = RANDOM TRIALS IN CONTROL PARTICIPANTS AT FOLLOW-UP (POST) 
 
The full factorial design matrix is shown in Figure 4-4.  
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Figure 4-4: Full factorial design for second-level analysis 
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4.7.2  REGION OF INTEREST (ROI) ANALYSIS 
In previous fMRI studies of verbal digit span performance on structured and random spans, 
differences in activation were found primarily in the dorsolateral prefrontal cortices (DLPFC) and 
posterior parietal cortices (PPC)
24 26
. 
The a priori hypothesis, as stated when the trial was registered (ISRCTN43007027) was therefore 
that chunking training would result in changes of activation in bilateral DLPFC and PPC. Due to 
differences in anatomy between young healthy participants and an AD population, the positive effect 
of task contrast generated by the study group was used to find orthogonal regions of interest. 
The MarsBar toolbox in SPM8
170
 was used to define a 10mm sphere around the ROI coordinates. 
The β values were then extracted and repeated measures analyses of variance (ANOVAs) were 
conducted in SPSS vs 22.0
166
 to examine for main effects and interactions. Assumptions of 
parametric data were assessed for all data extracted from MarsBar using histograms and Q-Q plots of 
the residuals, the Kolmogorov-Smirnov test and Levene’s test.  If the assumptions of normality or 
homogeneity of variance were violated, the data was examined and winsorized, replacing any value 
greater or less than the mean +/- 2.5 x SD, with the exact values of the mean +/- 2.5 x SD.  The tests 
for normality and homogeneity of variance were then repeated.  Non winsorized data was also 
analysed as part of the sensitivity analysis.  
The main analyses of interest were: 
1) Positive effect of task – to examine overall activation due to the performance of the task 
2) Main effect of time (pre- vs post-) (F contrast): to examine overall effects due to the time 
interval between scans  
3) Main effect of structured vs random trial type (F contrast): to examine overall effects of 
chunking 
4) Interaction of time x group (F contrast): to examine any overall effects of the training 
intervention. 
5) Interaction of time, trial type and group, to examine any differential effects of training when 
performing structured or random trials 
The above analyses were conducted for encoding and delay events. 
Whole brain analysis was then conducted to examine for significant areas of activation or deactivation 
other than in the defined ROIs. 
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4.8 VOXEL BASED MORPHOLOGY 
Voxel based morphology (VBM) was conducted to examine for significant structural differences 
between the groups, and whether training resulted in any structural differences. 
 
4.8.1 PRE-PROCESSING 
24 participants had MPRAGE images at both pre- and post- time points. 3 participants had only 
MPRAGE images at baseline, two had only MPRAGE images at follow-up and one participant had no 
suitable structural images for analysis. 
Pre- and post-intervention MP-RAGE images were pre-processed separately using the DARTEL 
toolbox in SPM8. As described above in 4.3.1, the origin of each structural image was reset to the AC. 
One participant was excluded at this stage due to excessive movement artefact on the follow-up 
image. Therefore 12 control and 11 training participants were included in the VBM analysis. 
 
4.8.2 CREATING A DARTEL TEMPLATE 
The DARTEL (Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra) toolbox 
within SPM8
168
 was used to create a group average structural template for the normalisation step. As 
described above, the DARTEL toolbox was used to compute a single flow-field storing deformation 
information for each participant. New tissue class images were generated and iteratively matched to a 
template generated from their own mean. ‘Smoothed’ spatially normalised images were then 
generated aligned to MNI space. This procedure was completed for both the pre- and post- MP-
RAGE structural images for each participant. 
 
4.8.3 VBM ANALYSIS 
Analysis of the main volumes of interest (VOI) defined for functional analysis along with whole brain 
analysis was performed. A factorial design was used with time (pre- vs post-training) as a dependent 
factor and group (control vs training) as an independent factor. Threshold masking was done using 
the default in SPM8 of 0.2 and no global normalisation was conducted
171
. The design matrix is shown 
in Figure 4-5. Analysis was then conducted at a whole brain level to identify significant time x group 




Figure 4-5: VBM factorial design. 
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4.9 PSYCHO-PHYSIOLOGICAL INTERACTIONS 
 
Psycho-physiological interactions (PPI) allow examination of functional connectivity between brain 
regions
172
. As previous studies had implicated bilateral DLPFC and PPC regions during chunking
26
, 
PPI analysis was used to assess for evidence of functional connectivity between the RDLPFC and 
LDLPFC, LPC and RPC regions. PPI estimates the correlation in activity between two regions over 
time and examines if these interactions between regions differ with a psychological variable. Evidence 
of functional connectivity between two regions is provided if the time course correlations change in 
synchrony with the psychological variable. Interaction regressors are estimated from the task and 
blood oxygen level dependent (BOLD) time courses using the GLM and can then be analysed for 




4.9.1 PPI DESIGN  
For the PPI analysis, data from the basic model (all trials opposed to only correct trials) was 
examined. The seed region was taken from the RDLPFC ROI. The other ROIs were then included as 
ROIs to examine PPIs between the RDLPFC and LDLPFC, LPC and RPC. 
Regressors for physiological response (BOLD response) and psychological task were used to 
produce an interaction regressor (PPI) between the seed region and each ROI (Figure 4-6). 
The design matrix is shown in Figure 4-7. 
Contrasts were then produced to examine 
1) Structured trials during encoding 
2) Random trials during encoding 
As in the functional analysis, if participants had less than three functional runs, or additional 
movement regressors, these were accounted for in the contrasts. 
The interaction regressors were then extracted into SPSS for structured and random trials at each 
time point (pre- and post-) and a repeated measures ANOVA was conducted for each ROI to examine 
















127 potential participants were screened.  Of these, 31 had a diagnosis other than AD (MCI or 
dementia of another type), 24 declined to take part, 18 were deemed unable to undergo an MRI scan 
at 3T following review of their medical records, 12 were too cognitively impaired, 5 were unsuitable 
due to behavioural and psychiatric symptoms, 4 were concurrently involved in another research study 
and 2 were due to move out of area.  Therefore 94 potential participants were excluded and 33 
participants met inclusion criteria and were recruited.  Two of these participants were unable to 
tolerate the baseline MRI scan and withdrew consent prior to randomisation, and one subject became 
physically unwell during time between recruitment and baseline assessment.  Therefore 30 
participants were randomised into 2 equal groups of 15. 
All 30 participants completed all training or control sessions and both fMRI scans. The study was well 
tolerated and there was no drop out post randomisation.  Behavioural results are therefore reported 
on all participants (training group n = 15 and control group n = 15).  A flow chart of recruitment and 





Figure 5-1: Flow chart of recruitment 
 
 
5.2 DEMOGRAPHIC AND SCREENING ASSESSMENTS 
 
5.2.1 SCREENING TASKS 
The results of the screening assessments and demographic variables are shown in Table 5-1.  There 
were no significant differences between the groups in age, gender, years of education, premorbid IQ 
(as measured using the NART
144
), or baseline MMSE
71
 score.  All participants were right handed.  
Scores on the screening assessments for mood (GDS
147





) and cerebrovascular risk factors (Hachinski
149
) were all below the 
respective cut-offs, with no significant differences between the groups.  The majority of participants 
were on stable doses of antidementia medication (cholinesterase inhibitors or memantine).  The 








(n = 15) 
Mean (SD) 
TRAINING 






AGE 80.13 (5.19) 79.40 (6.19) 65 - 88 0.124 0.728 
MMSE 25.93 (2.09) 26.00 (2.30) 22 - 30 0.007 0.934 
YRS ED 12.57 (2.82)
# 




IQ 115.63 (6.78) 117.14 (6.80) 100 - 126 0.370 0.548 






 1.40 (1.24) 0 - 5 -0.515* 0.606*
 
NPI  3.20 (5.43) 0.93 (2.84) 0 - 18 -1.381* 0.167*
 
WEBSTER 1.33 (1.40) 0.93 (1.67) 0 - 6 0.507 0.482 
GENDER 6 F 9 M 6 F 9 M  0.000 1.000 
MEDS 12 11  0.175 0.679 
Table 5-1:  Demographic and screening variables 
MMSE= Mini mental state examination, YRS ED= years of education, GDS = Geriatric Depression scale, NPI= 
neuropsychiatric inventory, F=female, M=male, MEDS= subject taking prescribed antidementia medication 




z values and significance are from Mann-Whitney U and 




5.3 PRIMARY OUTCOME MEASURES 
 
5.3.1 DIGIT SPAN 
5.3.1.1 DIFFERENCE BETWEEN STRUCTURED AND RANDOM TRIALS AT BASELINE 
At baseline, participants scored significantly higher on structured compared to random trials.  
Repeated measures analysis of variance (ANOVA) with trial type as the within participants factor and 
group as a between participants factor, revealed a significant main effect of trial type (F (1, 28) = 
20.388, p < 0.001), and no significant interaction between trial type and group (F (1, 28) = 2.504, p = 






 CONTROL TRAINING BOTH 
 MEAN (SD) MEAN (SD) MEAN (SD) 
STR 5.53 (0.90) 5.49 (0.92) 5.51 (0.89) 
RAND 5.01 (0.88) 5.23 (0.84) 5.12 (0.85) 
Table 5-2:  Mean digit span score and standard deviation (SD) at baseline.   
 
 
Figure 5-2:  Mean digit span score for both groups combined.   















































Table 5-2:  Mean digit span score and standard deviation (SD) at baseline. displays mean scores for 
each group and trial type.  T statistics and significance values are shown.  Figure 5-2 shows the mean 
span scores for both groups combined, and Figure 5-3 shows mean span scores separately for each 
group. 
 
5.3.1.2 DIFFERENCE IN DIGIT SPAN SCORES PRE AND POST INTERVENTION 
To examine overall differences in span scores following the control and training interventions, the 
change in scores for both random and structured trials was calculated (mean score post – mean 
score pre).  Examining both trial types together revealed an increase in span score of mean = 0.29 
(Standard deviation (SD) 0.52) in the control group and mean = 0.61 (SD 0.43) in the training group.   
An independent one tailed T test revealed a significant difference between the groups (T (28) = -1.82, 
p = 0.040). (Two-tailed independent T test p = 0.079) (Figure 5-4). 
 
Figure 5-4:  Mean change in digit span score averaged across both structured and random trials. 
Group difference p = 0.04 (1- tailed) 
 
In order to further examine whether the change in span scores following the intervention differed 
according to trial type (structured or random), a repeated measures ANOVA was performed 
examining mean span scores for structured and random trials at each time point.  Time and trial type 
were within participants factors and group was the between participants factor.  This revealed a main 
effect of time (p < 0.001) and a non significant interaction between time and group (p = 0.079), 

































0.053).  Therefore separate repeated measures ANOVA were performed for each trial type, with time 
as the within participants factor and group as the between participants factor. 
 
Figure 5-5: Mean change in structured digit span score due to intervention 
Error bars are SEM. There is a significant difference between groups (p=0.017). 
 
Analysis of the structured trials revealed a significant main effect of time (F (1, 28) = 24.07, p < 0.001) 
and a significant time x group interaction (F (1, 28) = 6.40, p = 0.017).  There was no significant 
between participants effect of group (F (1, 28) = 0.59, p = 0.447). The significant interaction is shown 
as a difference in change score for structured trials in Figure 5-5.  Paired T tests were subsequently 
conducted as post-hoc analyses to investigate the time x group interaction.  The control group 
demonstrated a non significant increase in span score (p = 0.115), however the training group had a 
highly significant improvement in structured span score following training (p < 0.001). The mean span 
and paired T test results are shown in Table 5-3 and Figure 5-6.  
Analysis of random trials revealed a significant main effect of time (F (1, 28) = 13.025, p = 0.001) but 
no significant interaction between time and group (F (1, 28) = 0.185, p= 0.670).  There was no main 
effect of group (F (1, 28) = 0.920, p = 0.346).  Mean scores and paired T test results are shown in 






































PAIRED T TEST 


















p < 0.001 p = 0.008 
Table 5-3 : Mean and (standard deviations) for structured and random digit span trials pre and post intervention.  




Figure 5-6:  Mean digit span score on structured trials at pre and post intervention. 



























Figure 5-7: Mean digit span scores on random trials at pre and post intervention. 
Error bars are SEM.   
 
5.3.1.3 EFFECT OF TRAINING ON CHUNKING  
A value for chunking was calculated by (mean structured score – mean random score) for each 
subject.  This was calculated at both pre and post time points.  A repeated measures ANOVA was 
then performed.  This revealed non significant main effects of time (F (1, 28) = 2.24, p = 0.145) and 
group (F (1, 28) = 0.103, p = 0.750) however the interaction between time and group was borderline 
significant (F (1, 28) = 4.067, p = 0.053).   As the time x group interaction approached significance, 
paired tests were conducted to examine the effects within each group separately.  The control group 
had no significant change in chunking (t (14) = 0.436, p = 0.436), however the training group 
significantly improved in their ability to chunk (t (14) = -2.186, p = 0.046).  Means, SDs and paired T- 
test results are shown in Table 5-4 and Figure 5-8. 
 
 CONTROL TRAINING 
PRE CHUNKING 0.53 (0.39) 0.25 (0.54) 
POST CHUNKING 0.47 (0.49) 0.66 (0.43) 
T statistic 0.436  -2.186 
p value 0.669 0.046 

























Figure 5-8: Mean chunking scores pre and post intervention on digit span task.  Error bars are SEM. 
 
 
5.3.2 SPATIAL SPAN 
 
5.3.2.1 DIFFERENCE BETWEEN STRUCTURED AND RANDOM TRIALS AT BASELINE 
At baseline, all participants scored significantly higher on structured compared to random trials (Table 
5-5).  Repeated measures analysis of variance (ANOVA), with trial type as the within participants 
factor and group as the between participants factor, revealed a significant main effect of trial type (F 
(1, 28) = 14.628, p = 0.001), and no significant interaction between trial type and group (F (1, 28) = 
0.870, p = 0.359).  The between participants effect of group was non significant (F (1, 28) < 0.001, p = 
0.991) (Figure 5-9 and Figure 5-10). 
 
 CONTROL TRAINING BOTH 
 MEAN (SD) MEAN (SD) MEAN (SD) 
STR 3.90 (0.70) 3.83 (1.05) 3.86 (0.88) 
RAND 3.56 (0.75) 3.62 (0.91) 3.59 (0.82) 

































Figure 5-9: Mean spatial span score by trial type 
Error bars are SEM. 
 
 
Figure 5-10: Mean spatial span score at baseline by group and trial type 
Error bars are SEM. 
 
 
5.3.2.2 EFFECT OF TRAINING 
To examine overall differences in span scores following the control and training interventions, the 
change in scores for both random and structured trials was calculated (mean score post – mean 
score pre).  Examining both trial types together revealed a mean increase in span score of 0.16 (SD 



















































tailed T test revealed no significant difference between the groups (t (28) = 0.144, p = 0.886).  Means 
and SD for group, trial type and time are shown in Table 5-6. 
 
Figure 5-11: Mean change on spatial scan score post – pre 
Error bars are SEM. 
 
 
 PRE POST POST- PRE FOR ALL 
TRIALS 
 STR RAND STR RAND  
CONT 3.90 (0.70) 3.56 (0.75) 4.04 (0.82) 3.74 (0.85) 0.16 (0.36) 
TRAIN 3.83 (1.05) 3.62 (0.91) 3.98 (0.66) 3.74 (0.59) 0.14 (0.57) 
Table 5-6: Means and (SD) for spatial span  
 
Repeated measures ANOVA, with time and trial type as within participants factors and group as the 
between participants factor demonstrated no significant main effects of time (F (1, 28) = 2.960, p = 
0.096) or group (F (1, 28) = 0.003, p = 0.954).  However the main effect of trial type was significant (F 
(1, 28) = 24.044, p < 0.001). There were no significant interactions between time and group (F (1, 28) 
= 0.021, p = 0.886), or time x trial type x group (F (1, 28) = 0.119, p = 0.733).   
 
5.3.2.3 EFFECT OF TRAINING ON CHUNKING 
A value for chunking was derived by calculating (mean structured score – mean random score) for 

























was then performed with time as a within participants factor and group as the between participants 
factor.   This revealed no significant main effects of time (F (1, 28) < 0.001, p = 0.987), or group (F (1, 
28) = 0.783, p = 0.384) and as already noted, a non significant interaction between time and group (F 
(1, 28) = 0.119, p = 0.733).  The mean chunking scores for each group are shown in Figure 5-12. 
 
 
Figure 5-12: Chunking scores for each group at each time point on spatial span task.   





































5.4 SECONDARY OUTCOME MEASURES 
 
5.4.1 GENERAL COGNITIVE FUNCTION OUTCOME MEASURES 
5.4.1.1 MMSE 
Repeated measures ANOVA revealed a significant main effect of time (F (1, 28) = 5.467, p = 0.027) 
and a significant interaction between time and group (F (1, 28) = 7.383, p = 0.011).  The between 
participants effect of group was non significant (F (1, 28) = 1.231, p = 0.277). As there was a 
significant group x time interaction, paired T tests were performed to examine each group.  The 
control group significantly declined in MMSE score (T (14) = 3.84, p = 0.002), whilst the training group 
demonstrated a non significant increase in score (T (14) = -0.252, p = 0.805).  Results are shown in 






MMSE PRE 25.93 (2.09) 26.00 (2.30) 
MMSE POST 24.60 (1.84) 26.10 (2.00) 
MMSE T TEST p = 0.002  p = 0.805 
Table 5-7: Mean scores, SD and results of paired T tests for MMSE. 
 
 
Figure 5-13: Mean MMSE scores pre and post interventions 



























Results are shown in Table 5-8 and Figure 5-14. As the ADAS-Cog data was not normally distributed, 
post – pre change in ADAS-Cog scores were calculated and Wilcoxon’s rank and Mann-Whitney tests 
were conducted. Independent samples testing, with post - pre score as the test variable revealed a 
significant difference between the groups, (U = 36, z =-3.175, p = 0.001 (2-tailed)).  As there was a 
significant group difference, related sample non parametric tests were performed to examine each 
group.  The control group demonstrated a non significant increase in ADAS-Cog score (z = -1.412, p 
= 0.158), whilst the training group significantly decreased in score (Z = -2.670, p = 0.008), 






ADAS-Cog PRE 13.86 / 13.00 (5.72)  14.15 / 11.00 (6.80) 
ADAS-Cog POST 14.15 / 14.66 (4.68) 11.55 / 8.67 (6.33) 
ADAS-Cog related Wilcoxon 
ranks test 
p = 0.158 p = 0.008 




Figure 5-14: Mean ADAS-Cog scores pre and post interventions 





























5.4.2 EPISODIC MEMORY OUTCOME MEASURES 
Means and SDs for all three tasks assessing episodic memory are shown in Table 5-9.  
The paired associate learning (PAL) data was not normally distributed, therefore post – pre change in 
PAL scores were calculated and Wilcoxon’s rank and Mann-Whitney tests were conducted.  






LOG MEM 1 PRE 11.33 (6.00) 10.67 (6.14) 
LOG MEM 1 POST 11.87 (4.03) 13.80 (6.87) 
   
LOG MEM 2 PRE 7.93 (7.05) 7.20 (8.20) 
LOG MEM 2 POST 7.73 (8.06) 12.47 (8.27) 
   
PAL PRE 3.07 (0.59) 3.47 (0.74) 
PAL POST 3.20 (0.94) 3.00 (0.65) 
Table 5-9: Means and SDs for episodic memory outcomes 
 
5.4.2.1 LOG MEMORY 1 AND 2
174
 
Results are shown in Table 5-9, Figure 5-15 and Figure 5-16.  A repeated measures ANOVA with 
time and task (log mem 1 vs log mem 2) as within participants factors and group as the between 
participants factor was performed.  There were significant main effects of time (F (1, 28) = 8.029, p = 
0.008) and task (F (1, 28) = 7.848, p = 0.009).  The between participants main effect of group was 
non significant (F (1, 28) = 0.402, p = 0.531). There was a significant interaction between time and 
group (F (1, 28) = 6.850, p = 0.014), but no significant interaction between time x task x group (F (1, 
28) = 1.50, p=0.231).  Therefore there was a significant improvement in verbal episodic memory 










Figure 5-16: Mean Log memory 2 scores 

















































5.4.2.2 PAIRED ASSOCIATES LEARNING
157
  
Results are shown in Table 5-9 and Figure 5-17.  Independent samples testing, with post-pre score as 
the test variable revealed no significant difference between the groups, (U = 71.5, z =-1.783, p = 
0.075 (2-tailed)).    
 
 
Figure 5-17: Mean Paired Associate Learning (PAL) score 
Error bars are SEM.  Group difference is non significant (p = 0.075). 
 
 
5.4.3 EXECUTIVE FUNCTION OUTCOME MEASURES 
Six tasks were used to assess varying aspects of executive function.  These were verbal fluency
175
, 
Trail making test parts A and B
138
, Grammatical reasoning (GR)
157
, odd one out (OOO)
157




The Trail making test part B was not included in the analysis as 7 out of 14 control participants and 11 
out of 15 training participants at baseline, and 50% of each group at follow up failed to complete the 
task.  Therefore significant floor effects were seen with this task, preventing reliable analysis of 
results. 
Data from the Trail making test part A and Self Ordered Search (SOS) tasks were not normally 
distributed, therefore post – pre change in Trails A and SOS scores were calculated and individual  























Individual repeated measures ANOVAs, with time as the within participants variable and group as the 
between participants variable were conducted on the fluency, GR and OOO tasks. The repeated 
measures ANOVAs revealed that there were no significant main effects of time or group and no 
significant time x group interactions on any of the executive function tasks.  Similarly, non parametric 
independent samples testing, with post-pre score as the test variable revealed no significant 
differences between the groups on either the Trails A or SOS tasks (see Table 5-10).  Figure 5-18, 
Figure 5-19, Figure 5-20, Figure 5-21 and Figure 5-22 show mean scores on each executive function 
task included in the analysis. 
 
 
 CONT TRAIN TIME X GROUP F (p) 
FLUENCY PRE 8.21 (2.52)
1 
8.64 (2.73) 0.32 (0.577) 
FLUENCY POST 8.27 (2.43) 8.00 (2.59)  
    
GRAM REASON PRE 4.73 (4.59) 6.00 (5.28) 3.44 (0.074) 
GRAM REASON 
POST 
6.80 (5.72) 5.40 (4.40)  
    
ODD ONE OUT PRE 
7.60 (2.29) 10.20 (3.10) 2.07 (0.162) 
ODD ONE OUT POST 8.53 (3.02) 
9.40 (3.42)  
    
 CONT TRAIN MANN WHITNEY U (p) 
TRAILS A PRE 77.70 (39.43)
1 
91.34 (81.62) 91.5  (0.556) 
TRAILS A POST 78.36 (47.18) 84.63 (59.47)  
SELF ORD SEARCH 
PRE 
4.00 (0.93) 4.87 (1.06) 76.5  (0.121) 
SELF ORD SEARCH 
POST 
4.67 (1.05) 4.93 (1.39)  
Table 5-10:  Means, SDs and results of individual repeated measures ANOVAs  
Results of group x time interactions, and non parametric independent samples tests are shown. 
1
n=14, as one 
























































































































Figure 5-22: Mean score on self ordered search task.  Error bars are SEM. 
 
 
5.4.3.1 SUSTAINED ATTENTION 
Sustained attention was measured using the SART
162
.  The errors were categorised as either 
omission errors (not responding to the appropriate number) and commission errors (responding to a 
number 3).  An overall error score was calculated by adding the omission and commission errors. 
A repeated measures ANOVA, examining overall errors, with time as the within participants factor and 
group as the between participants factor found no significant main effects of time (F (1, 23) = 0.239, p 
= 0.630) or group (F (1, 23) = 0.093, p = 0.763), and no significant time x group interaction (F (1, 23) = 
2.273, p = 0.145).   Individual repeated measures ANOVA for omission errors and commission errors 
























 Time x group p 
SART ERROR PRE 29.17 (25.92) 26.62 (31.63) 0.145 
SART ERROR POST 21.33 (17.39) 30.62 (37.17)  
OMISSION PRE 22.42 (22.35) 18.46 (27.74) 0.127 
OMISSION POST 15.58 (13.34) 23.62 (33.30)  
COMMISSION PRE 6.75 (4.62) 8.15 (8.42) 0.939 
COMMISSION POST 5.75 (4.92) 7.00 (6.67)  
Table 5-11: Mean and SD for error types in SART task 
Significance values for time x group interactions from repeated measures ANOVA are also shown. 
1
Data only 






































5.4.4 NON COGNITIVE OUTCOME MEASURES 




 outcome measures are shown in Table 5-12, Figure 5-24 and 
Figure 5-25. 
 
 CONT TRAIN Time x group (p) 
IADL PRE 11.79 (2.01)1 12.40 (1.64) 0.620 
IADL POST 11.71 (1.98)1 12.53 (1.64)  
DEMQOL PRE 98.07 (10.37)
1
 102.13 (6.81) 0.585 
DEMQOL POST 98.73 (8.58)
1
 102.60 (5.60)  





5.4.4.1 INSTRUMENTAL ACTIVITIES OF DAILY LIVING 
Repeated measures ANOVA revealed no significant main effects of time (F (1, 27) = 0.023, p = 0.881) 






























Repeated measures ANOVA revealed no significant main effect of time (F (1, 27) = 0.890, p = 0.354) 
or group (F (1, 27) = 1.680, p = 0.206) and no time x group interaction (F (1, 27) = 0.305, p = 0.585). 
 
 





5.4.5.1 META-MEMORY IN ADULTHOOD QUESTIONNAIRE (MIA) 
A repeated measures ANOVA of all sub-category scores and overall score revealed no significant 
main effects of time (F (1, 22) = 0.371, p = 0.549) or group (F (1, 22) = 0.008, p = 0.928).  There was 
a non significant interaction between time and group (F (1, 22) = 1.153, p = 0.295), however there 
was a significant time x category x group interaction (F (1, 22) = 2.575, p = 0.048).  Therefore 
separate repeated measures ANOVAs were conducted for each category.  The results are shown in 
Table 5-13.  For strategy there was a borderline significant main effect of time (F (1, 22) = 4.071, p = 
0.056) and a significant time x group interaction (F (1, 22) = 7.854, p=0.010), (Figure 5-27). For task, 
there was a significant main effect of time (F (1, 22) = 4.866, p=0.038), however the time x group 
interaction was non significant (F (1, 22) = 3.401, p=0.079) (Figure 5-28).  All other domains revealed 


























CATEGORY CONTROL n=10 TRAIN n=14 
Time x 
group 
 PRE POST PRE POST p 
STRATEGY 63.00 (9.65) 59.57 (7.96) 57.36  (6.26) 63.00 (8.16) 0.010 
TASK 54.91 (4.97) 58.71 (3.83) 56.43  (6.24 57.07 (3.95) 0.079 
CAPACITY 46.91 (7.11) 48.79 (7.89) 48.43  (8.72)    48.00 (8.90) 0.149 
CHANGE 38.82 (6.10) 37.71 (9.82) 39.64  (8.67) 41.53 (9.66) 0.116 
ANXIETY 47.64 (7.19) 47.21  (9.23) 47.29  (8.48) 44.4  (8.97) 0.289 
ACHIEVEMENT 59.73 (7.58) 56.00  (4.79) 58.50  (7.12)     58.67  6.75)    0.090 
LOCUS 29.45 (3.64) 28.50  (4.01) 29.36  (3.73) 29.07 (3.39) 0.628 
TOTAL 340.45 (11.07) 336.50 (20.70) 337.00 (0.10) 341.73(20.66) 0.295 































Figure 5-27: Mean strategy score on the MIA 

























































5.4.5.2 CHUNKING SUBJECTIVE REPORTS DURING DIGIT SPAN 
5.4.5.2.1 Question 1: Did you use any strategy to help you remember? 
As can be seen in Table 5-14 and Figure 5-30 , the majority of participants did not report explicitly 
using chunking strategies at either time point. The percentage of participants using chunking in the 
training group increased following training, however there were no significant between group 
differences at either time point, and no paired differences between pre and post responses for either 
group.  
 
 % CHUNKING % NOT CHUNKING 
 PRE POST PRE POST 
CONT 33.33 26.67 40 53.33 
TRAIN 33.33 40 53.33 46.67 
Table 5-14: Percentage of participants who explicitly used chunking strategies during digit span tasks 
Of note the percentages do not add up to 100%, as table does not show percentages for participants whom it 




5.4.5.2.2 Question 2: Did you find one of the blocks easier? 
As shown in Table 5-15 and Figure 5-29, the majority of participants reported noticing no difference 
between structured and random trial types at either time point.  However the percentage in the 
training group reporting that structured trials were easier doubled from pre (20%) to post (40%), whilst 
the percentage of control participants reporting that structured trials were easier reduced from 20% 
(pre) to 6.67% (post).  There were no significant group differences at baseline, however at post 
intervention the group difference on the ‘easier’ report approached significance (p = 0.066). Wilcoxon 
signed ranks test for paired (pre and post) within group differences was also non significant (Table 




















CONT 20 6.67 40 6.67 20 46.67 
TRAIN 20 0 66.67 40 6.67 46.67 
Table 5-15: Percentages of participants by report of which block of trials they found easier to perform 
STR easier= structured trials easier, RAND easier = random trials easier, NO DIFF= found no difference between 




Matching actual performance with perceived easier trial type revealed that at both time points the 
majority of participants did not correctly match the preferred trial type block with performance at either 
time point (Table 5-16), however there were no significant group differences or within participants 
effect of time (Table 5-17, Table 5-18,and Figure 5-31).  
 
 CONT TRAIN 
 PRE POST PRE POST 
MATCH 13.33 20 20 40 
NO MATCH 53.33 53.33 66.67 53.33 
Table 5-16: Percentages of match between which trial type participants reported as easier and actual 
performance 











EASIER 99.500 -0.592 0.554 
CHUNK 92.500 -0.898 0.369 
MATCH 105.000 -0.482 0.630 




EASIER 71.000 -1.835 0.066 
CHUNK 110.000 -0.114 0.910 
MATCH 90.000 -1.175 0.240 





CHUNK EASIER MATCH 
CONTROL 
Z -0.750 <0.001 -1.000 
Asymp. Sig. 
(2-tailed) 
0.453 1.000 0.317 
TRAIN 
Z -1.510 -0.577 -1.342 
Asymp. Sig. 
(2-tailed) 
0.131 0.564 0.180 
































Figure 5-31:  Count of numbers of matches between participants’ report of which trial type they thought was 















































Chapter 6 NEUROIMAGING RESULTS 
 
 
6.1 BEHAVIOURAL RESULTS DURING FMRI 
 
6.1.1 SUMMARY OF PERFORMANCE 
As shown in Table 6-1, there were a total of 1714 completed digit span trials in the pre training fMRI 
session, and 1715 completed trials in the post training fMRI session.   
 
















TOTAL (n= 1715) 76.3% 71.6% 
Table 6-1: Percentages of correct trials during fMRI 
 
In the pre training fMRI session, control participants performed better on structured (70.2% correct) 
than random trials (65.1% correct), and trained participants also performed better on structured 
(73.9% correct) than random trials (72% correct). 
At follow up, control participants performed better on structured trials (74.1%) than random trials 
(71.3% correct).  Trained participants also performed better on structured (78.6% correct) than 
random trials (71.9% correct). 
A repeated measures ANOVA was performed with time point (pre vs. post), trial type (structured vs. random) and 
correct performance (correct vs. incorrect) as within participants factors, and group as a between participants 
factor. All significant effects are shown in Table 6-2,  
156 
 
Figure 6-1 and Figure 6-2.  There were no other significant main effects or interactions. 
 
SIGNIFICANT RESULTS F Sig. 
CORRECT (CORRECT vs. INCORRECT) 34.961 <0.001 
TRIAL TYPE x CORRECT 6.871 0.014 
Table 6-2: Results of repeated measures ANOVA of span performance during fMRI  
 
 
Figure 6-1: Correct trials across both groups and time point 
Error bars are SEM.  The difference between trial types is significant (p = 0.014) 
 
 











































6.1.2 CONFIDENCE REPORTS DURING FMRI 
During fMRI sessions, participants reported on a trial by trial basis whether they were confident that 
they had correctly recalled the span.  These confidence reports were analysed on a trial by trial basis, 
with a ‘match’ scored for correct trials with a confident response, or incorrect trials with a not confident 
report. A ‘miss’ was scored for correct trials with a not confident report, or incorrect trials with a 
confident report.  Each participant’s match and miss scores were calculated for each trial type at each 
fMRI session.   
 
CONT (%) TRAIN (%) 
PRE POST PRE POST 
MATCH 
STR 83.4 83.0 81.3 85.8 
RAND 78.1 81.5 80.1 78.3 
TOTAL 80.7 82.3 80.7 82.0 
Table 6-3: Percentage of correct matches by trial type and time point 
Match = correct trial with confident response or incorrect trial with not confident response.   
 
Table 6-3 and Figure 6-3 show the percentages of matches for each trial type at each time point.  A 
repeated measures ANOVA revealed no main effects of time (F (1, 27) = 0.479, p = 0.495) or group 
(F (1, 27) = 0.001, p = 0.976), however the main effect of trial type was significant (F (1, 27) = 7.893, p 
= 0.009).  There was a non significant time x group interaction (F (1, 27) = 0.002, p = 0.963), however 
the time x trial type x group interaction was significant (F (1, 27) = 5.326, p = 0.029).  Individual 
repeated measures ANOVA of each trail type revealed no significant main effects or interactions. 
 
Figure 6-3: Percentage of correct matches by trial type and time point 


























6.2 FIRST LEVEL – INDIVIDUAL PARTICIPANT ANALYSIS 
 
An example of the individual participant level results is presented for participant CH09 at baseline.  
 
6.2.1 OVERALL EFFECTS OF ENCODING vs. BASELINE (ALL TRIALS) 
At a conservative significance threshold, correcting for family wise error (FWE) PFWE < 0.05 and extent 
threshold k = 50 voxels, examination of the statistical parametric map (SPM) demonstrated significant 
activations in fronto-parietal areas previously identified as active during encoding in similar digit span 
tasks
26
 (Figure 6-4). 
 
6.2.2 CHUNKING EFFECTS  
In contrast to previous work examining chunking in young participants
24 26
, there were no fronto-
parietal regions demonstrating increased activation for the structured > random trials contrast, with a 
liberal significance threshold of p < 0.01 uncorrected (Figure 6-5).  However the opposite contrast 
(random > structured) revealed a cluster of voxels demonstrating increased activation (x = -46, y = -
30, z = 61; x= -58 y = -19, z = 43, and x = -16, y = -40, z = 73) significant at the cluster level (pFWE = 






















6.3 SECOND LEVEL - GROUP ANALYSIS 
 
Second level analyses followed an a priori hypothesis-driven approach based on previous studies 
demonstrating significant effects of chunking within dorso-lateral prefrontal cortex (DLPFC) and 
posterior parietal cortex (PPC).   Results are presented as follows. 
1) ROI (Region Of Interest) definition 
2) Overall effects across all ROIs 
3) Effects in individual ROI areas if significant overall effects seen. 
4) Whole brain analysis at a liberal significance threshold to examine for further areas of interest 
 
6.3.1  REGION OF INTEREST (ROI) DEFINITION 
Bilateral DLPFC and PPC ROIs were defined from the study group data set.  This was to allow for the 
anticipated task related functional differences between AD participants used in the current study and 
healthy young populations examined in previous studies
24 26 27
. 
ROI were defined by averaging across all groups and conditions and examining the SPM of the 
overall positive effect of task.  As shown in Figure 6-7 and Figure 6-8, several voxels were significant 









Figure 6-8: SPM of positive effect of condition contrast 
Significance threshold of p<0.001 (uncorrected). Results for voxels reaching significance with pFWE < 0.05 are 
shown. 
 
The contrasts of interest (time x group interactions) are orthogonal to the positive effect of task data 
used to identify ROIs, so should be free from bias.  However, as a secondary sensitivity analysis, 
ROIs from a recently published iteration of the multiple demands network were also examined
176
 for 
comparison with the study-defined ROIs.  These were chosen rather than the original Bor et al ROIs
26
 
as they represent a more up to date iteration of networks of regions involved in similar strategy 
performance, and were taken from data from older participants, and therefore may be more 
appropriate to the current study population (see sensitivity analyses 6.4.1.1).   
165 
 
 The coordinates of the defined ROI from the current study data are shown in Table 6-4 and Figure 
6-9. 
 
REGION COORDINATES (x y z) 
ROI defined as 10mm
3 
sphere around this 
central point 
RIGHT DLPFC                39,   43,  33 
LEFT DLPFC               -39,  36,   36 
RIGHT PARIETAL CORTEX 46 , -40,  42 
LEFT PARIETAL CORTEX  -37,  -45,  37 
Table 6-4: Defined ROIs from group F contrast of positive effects of condition. 
 
 
Figure 6-9: Locations of the 4 defined ROI, crosshairs are on the RDLPFC ROI. 
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6.3.2 OVERALL EFFECTS ACROSS ALL ROIs 
The β values produced from each of the factors in the model were estimated for each ROI using the 
MarsBar toolbox in SPM8
170
.  These β values were exported into Microsoft excel and SPSS and 
assessed for normality and homogeneity of variance.  As the data was not normally distributed, due to 
an outlier in each group, the data was winsorized, replacing the outliers with exact values of the mean 
– 2.5 SD, which effectively normalised the data.  Analyses of the non-winsorized data are reported as 
part of the sensitivity analyses in 6.4.  A mean β value across all 4 ROIs was calculated for each 
participant.  These individual values were then averaged across each group.  Change in β value by 
time was calculated as (post – pre) for each group and trial type.  Overall change was calculated by 
averaging across both trial types.  This gave a single mean and SD for change in β value for each 
group, averaged across ROI and trial type (Table 6-5 and Figure 6-10).  The β values estimated by 
SPM8 don’t strictly represent BOLD signal or functional activation, as they are estimates of the 
contribution of the conditions of interest to the observed effects calculating using the GLM.  However 
in the interests of clarity, β values will be classified in charts and tables as ‘fMRI response’. 
 
 
Mean change in fMRI 
response 
(post- pre intervention) 
SD 
CONTROL 1.03 2.20 
TRAIN -0.58 2.17 
Table 6-5: Means (SD) of change in β value (fMRI response) across all 4ROI and trial type. 
 
An independent T test revealed a near-significant difference in activation change between groups 




Figure 6-10:  Overall mean change in fMRI response 
This is the fMRI response averaged across all 4 ROIs for each participant for all trials.  Error bars are SEM.  The 
group difference approaches significance (p = 0.059). 
 
As the behavioural results demonstrated that chunking training affected performance on structured 
trials more than random trials, the change in activation during performance on structured trials alone 
was examined. An independent T test demonstrated a significant difference between groups (t (27) = 
2.32, p = 0.028 (2-tailed)), (Table 6-6 and Figure 6-11). 
 
 
Mean change in fMRI 
response 
(post- pre intervention) 
SD 
CONTROL 1.16 2.32 
TRAIN -0.78 2.17 
Table 6-6: Mean change in fMRI response for structured trials 



































Figure 6-11: mean change in fMRI response across ROIs with structured trials 
Error bars are SEM.  The group difference is significant (p = 0.028). 
 
As the overall effects were approaching significance, repeated measures analyses were conducted to 
examine for significant main effects and interactions between group and time, trial type, and ROI. 
 
6.3.3 ANALYSES OF INDIVIDUAL ROIs 
Mean β values and event types were entered into a repeated measures ANOVA.  Within participant 
factors were time (pre vs. post), trial type (structured vs. random), ROI (DLPFC vs. PC) and 
hemisphere (right vs. left), with group as the between participants factor.  Significant and near 
significant main effects and interactions are shown in Table 6-7.  No other main effects or interactions 
were significant.  
INTERACTION F Sig.(p) 
TIME x GROUP 3.899 0.059 
ROI x HEMISPHERE 4.211 0.050 
TIME x TRIAL x HEMISPHERE 5.422 0.028 
TIME x ROI x HEMISPHERE x GROUP 4.232 0.049 
TRIAL x ROI x HEMISPHERE x GROUP 3.775 0.063 
TIME x TRIAL x ROI x HEMISPHERE 6.989 0.013 
Table 6-7: Significant and borderline significant main effects and interactions.  
 
To further examine these significant complex interactions, separate repeated measures ANOVAs 
were conducted for each ROI and trial type.  For structured trials there was a significant interaction 

































interaction (F (1, 27) = 5.030, p = 0.033), and no other significant main effects or interactions.  For 
random trials there was a significant ROI x hemisphere interaction (F (1, 27) = 4.562, p = 0.042), and 
no other significant main effects or interactions.  Therefore further ANOVAs were conducted with each 
ROI individually examining each trial type separately. 
 
6.3.3.1 RIGHT DORSOLATERAL PREFRONTAL CORTEX 
A repeated measures ANOVA, with time and trial type as within participants factors and group as the 
between participants factor, revealed a time x group interaction approaching significance (F (1, 27) = 
3.854, p = 0.060).  There were no other significant main effects or interactions. (Table 6-8, Figure 
6-12 and Figure 6-13) 
 
MAIN EFFECTS  F Sig.(p) 
TIME 0.373 0.546 
TRIAL 1.228 0.278 
GROUP 0.091 0.766 
INTERACTIONS:   
TIME x GROUP 3.854 0.060 
TRIAL x GROUP 0.007 0.934 
TIME x TRIAL 2.164 0.153 
TIME x TRIAL x GROUP 0.385 0.540 








Figure 6-12: RDLPFC:  Mean fMRI response from all trials at each time point for the control and training groups. 
Error bars are SEM.  
 
 
Figure 6-13: RDLPFC: Mean fMRI response by trial type and group.  Error bars are SEM 
 
Therefore the effect of training on mean fMRI response approached significance, with training 
resulting in reduced activation in the RDLPFC, compared to increased activation seen in the control 
group. 
Examining each trial type separately; for structured trials only, there was a significant time x group 
interaction (F (1, 27) = 4.422, p = 0.045), but no main effects of time or group. 
For random trials only, the time x group interaction was non significant (F (1, 27) = 3.133, p = 0.088), 





















































6.3.3.2 LEFT DORSOLATERAL PREFRONTAL CORTEX 
A repeated measures ANOVA was conducted on LDLPFC data with time (pre vs. post) and trial type 
(str vs. rand) as the within participants factors and group as the between participants factor. 
There were no significant main effects of time (F (1, 27) = 0.534, p = 0.471), trial type (F (1, 27) = 
2.458, p = 0.129) or group (F (1, 27) = 0.024, p = 0.879).  There were also no significant group x time, 
or group x trial x time interactions (Table 6-9). 
 
MAIN EFFECTS F Sig.(p) 
 TIME 0.534 0.471 
TRIAL 2.160 0.153 
GROUP 0.024 0.879 
   
INTERACTIONS   
TIME x GROUP 2.160 0.153 
TRIAL x GROUP 0.418 0.523 
TIME x TRIAL 0.440 0.513 
TIME x TRIAL x GROUP 0.361 0.553 
Table 6-9: ANOVA results for LDLPFC. 
 
 
Figure 6-14: LDLPFC:  Mean fMRI response from all trials at each time point for the control and training groups. 




























Figure 6-15: LDLPFC: Mean fMRI response by trial types, groups and time. Error bars are SEM. 
 
Examining each trial type separately, revealed that there were no significant main effects or 
interactions with either trial type.  
Although the differences were non-significant, training resulted in reduced activation in the LDLPFC, 
compared to increased activation seen in the control group, a similar pattern to the RDLPFC. 
 
6.3.3.3  LEFT PARIETAL CORTEX 
A repeated measures ANOVA was conducted on LPC data with time (pre vs. post), and trial type (str 
vs. rand) as within participants factors and group as the between participants factor. As shown in 
Table 6-10, there were no significant main effects of time or trial type, or between participants effect of 
group.  There was no significant interaction between time and group, however the interaction between 
time x trial type x group was significant (F (1, 27) = 4.647, p = 0.040). 
 
 
MAIN EFFECTS F Sig.(p) 
 TIME < 0.001 0.987 
TRIAL 2.170 0.152 
GROUP 0.139 0.713 
   
INTERACTIONS   
TIME x GROUP 2.521 0.124 



























TIME x TRIAL 0.032 0.859 
TIME x TRIAL x GROUP 4.647 0.040 
Table 6-10: LPC ANOVA results 
 
 
Figure 6-16 and Figure 6-17, show the same pattern of training effects on activation seen in the 
DLPFC, with training resulting in a decrease in activation compared to an increase in the control 
group. Additionally, in the LPC there was a significant differential effect of training on activation 
between structured and random trials. 
 
Figure 6-16: LPC:  Mean fMRI response from all trials at each time point for the control and training groups. Error 
bars are SEM. 
 
 


















































Examining structured trials only revealed a significant time x group interaction (F (1, 27) = 4.604, p = 
0.041) and no significant main effects of time or group.  No significant main effects or interactions 
were found with only random trials. 
  
6.3.3.4 RIGHT PARIETAL CORTEX 
A repeated measures ANOVA was conducted on RPC data with time (pre vs. post), and trial type (str 
vs. rand) as within participants factors and group as the between participants factor. There were no 
significant main effects of time, trial type or group, and no significant interactions (Table 6-11, Figure 
6-18 and. Figure 6-19). 
 
MAIN EFFECTS F Sig.(p) 
 TIME 0.171 0.683 
TRIAL 0.818 0.374 
BETWEEN PARTICIPANTS-GROUP 0.069 0.795 
   
INTERACTIONS   
TIME x GROUP 2.429 0.131 
TRIAL x GROUP 0.475 0.497 
TIME  x TRIAL 0.042 0.840 
TIME x  TRIAL x  GROUP 2.010 0.168 
Table 6-11: RPC ANOVA results 
 
 
Figure 6-18: RPC:  Mean fMRI response from all trials at each time point for the control and training groups.  



























. Figure 6-19: RPC: Mean fMRI response by trial types, group and time.  Error bars are SEM  
 
Examination of structured trials revealed a near significant time x group interaction (F (1, 27) = 4.072, 
p = 0.054) and no main effects of time or group.  There were no significant main effects or interactions 
when random trials were examined. 
These results demonstrate a similar pattern of training - related reduced activation in all four regions 
of interest as a result of training compared with activation in all four regions in the control group.  




























6.4  SENSITIVITY ANALYSIS 
6.4.1 SENSITIVITY ANALYSIS- ANALYSIS OF ALL TRIALS 
The basic model described in the methods chapter (section 4.4.1), examined all correct and incorrect 
trials together as a single event of interest.  The same 4 ROIs were examined from the β values 
estimated from this model. 
As described in 6.3.2, the data was winsorized and a mean β value across all 4 ROI was calculated 
for each participant.  These individual values were then averaged across each group.  Change in β 
value by time was calculated as (post – pre) for each group and trial type.  Overall change was 
calculated by averaging across both trial types.  This gave a single mean and SD for change in β 
value for each group, averaged across ROI and trial type. 
An independent T test revealed a mean difference in fMRI response across this network of 0.94 (SD = 
1.80) in the control group and -0.35 (SD = 1.80) in the training group (t (27) = 1.930, p = 0.064 (2-
tailed)).  Therefore when all trials are examined irrespective of correct or incorrect response, the 
overall effect of training on the defined ROIs approached significance (Figure 6-20). 
 
 
Figure 6-20: Mean change across all 4 ROI and trial types for basic model 
































Examination of each ROI independently with repeated measures ANOVAs also produced similar 
results to the main analysis, with a significant training effect (time x group) interaction seen in the 
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Table 6-12: ANOVA results for all 4 ROI for analysis of all (correct and incorrect) trials. 
 
 
Figure 6-21: Mean fMRI response for RDLPFC for basic model 
Both correct and incorrect trials examined, (time x group p = 0.034).Error bars are SEM. 
 
Therefore, analysis of all trials irrespective of correct response produced similar results to the main 






























6.4.1.1 SENSITIVITY ANALYSIS- COMPARISON WITH MD ROIs 
The contrasts of interest (time x group interactions) were orthogonal to the contrast used to define the 
ROI from our own participant group.  However in order to provide further evidence for choice of these 
regions being valid and free from bias, the analysis was repeated using a network of regions recently 
identified as an important multiple demands (MD) network
176
.  These results are the latest iteration of 
previous work by Bor et al
27
, and therefore supersede previous chunking – associated ROIs
26
.  
These MD ROIs were bilateral: 
1) anterior frontal region (centre x = +/- 21, y = 44, z = -9) 
2) anterior inferior frontal region (centre x = +/- 35.1, y = 18.7, z = 2.64) 
3) inferior frontal region (centre x = +/- 38.1, y = 26.3, z = 23.9)   
4)  ACC/SMA (centre x = +/- 5.65, y = 22.6, z = 38.7) 
5) inferior parietal cortex (centre x = +/- 35.3, y = -58.3, z = 40.5) 
No data was available for right or left anterior frontal regions at the group level, therefore β values 
were estimated for the remaining four bilateral regions using MarsBar.  (Figure 6-22). 
 




As the purpose of this analysis was to provide confirmation of the results derived from the study 
defined ROI, rather than investigate overall significance, these β values were winsorized and entered 
into separate repeated analyses ANOVAs for each ROI.  Trial type and time were within participants 
factors with group as the between participants factor.  As shown in Table 6-13, there were no 
significant main effects of time, and no significant time x group interactions for any of the ROI.  
However there was a significant time x trial type x group interaction in the right anterior inferior region 
(RAIFR) (F (1, 27) = 5.565, p = 0.026) and a time x trial x group interaction that neared significance in 
the left inferior parietal cortex (LIPC) (F (1, 27) = 3.505, p = 0.072).  These represent areas in the 
RDLPFC and LPC, and are therefore similar to the defined ROIs from the present study that provided 
significant or near significant time x group, or time x trial x group interactions.  In all regions a similar 
pattern was seen, with training resulting in a decrease in activation with time, compared to an 
increase in activation in the control group.  These interactions are shown in Table 6-13, Figure 6-23, 










































































Table 6-13: MD ROI:  repeated measures ANOVA results of MD ROIs. 
Within participants main effect of time and time x group interaction, and between participants effect of group are 










Figure 6-24: Mean fMRI response by group and time point in the RAIFO 


























































Figure 6-25: Mean fMRI response by group and time point in the LIPC.   
 
6.4.1.2 ANALYSIS WITH NON - WINSORIZED DATA 
As discussed in 6.3.2, the β values estimated in SPM8 for the ROIs were assessed for normality.  As 
some of the ROI data was not normally distributed the data was winsorized to adjust outliers.  Out of 
the 464 data points, only 8 were adjusted by this process, and all from one control and one training 
participant.  The training participant’s β values demonstrated a large reduction post training in the 
DLPFC ROIs, therefore they were consistent with the group data but of a greater magnitude that 
skewed the data.  
Analysis of the overall change in fMRI response was conducted in the same manner as with the 
winsorized data.  The mean β value across all 4 ROI was calculated for each participant    These 
individual values were then averaged across each group.  Change in β value by time was calculated 
as post – pre for each group and trial type, and overall change was calculated by averaging across 
both trial types.  This gave a single mean and SD for change in β value for each group, averaged 
across ROI and trial type (Table 6-14 and Figure 6-26).  A Mann Whitney test revealed a significant 

































 Mean change in fMRI 
response 
(post- pre intervention) 
SD 
CONTROL 1.03 2.20  
TRAIN -0.68 2.38  
Table 6-14: Mean change in fMRI response across all 4 ROIs using non-winsorized data. 
 
 
Figure 6-26: Mean change in fMRI response across all 4 ROI using non-winsorized data 
Error bars are SEM. There is a significant group difference (Mann Whitney test, p = 0.05). 
 
Repeated measures ANOVAs were conducted for each ROI individually.  Trial type and time were 
within participants factors with group as the between participants factor.  The results from the original 
data, including the outliers, revealed a similar pattern of results, with significant or near significant 
interactions in the RDLPFC (time x group p = 0.049) and LPC (time x trial x group p = 0.065. (Table 
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Table 6-15: Repeated measures ANOVA results for all ROIs, using non-winsorized data. 
 
 
Figure 6-27: RDLPFC: Mean fMRI response across both trial types using non-winsorized data 




Figure 6-28: LPC: mean fMRI response for each trial type using non–winsorized data 























































Therefore all three sensitivity analyses produce a consistent pattern of results.  There was a decrease 
in fMRI response following training, compared with an increase in fMRI response in control 
participants.  This training-related difference was consistently most significant in RDLPFC and LPC, 
with structured trials. 
 
 
6.5 EFFECTS OF CHUNKING AT BASELINE 
 
The contrast between structured and random trials was examined at baseline to identify whether the 




β values were averaged across the 4 ROIs for each individual, for each trial type separately.   
A paired T test revealed no significant difference in activation between structured and random trials, 
when both groups were included in the analysis (t (28) = -0.661, p = 0.514 (2-tailed), Figure 6-29). 
 
 
Figure 6-29: Mean fMRI response across all 4 ROI, for both groups combined at baseline. 
Error bars are SEM 
In keeping with this, repeated measures analysis with trial type as a within participants factor and 
group as a between participants factor revealed no significant main effect of trial type (F (1, 27) = 
0.491, p = 0.490), no significant main effect of group (F (1, 27) = 0.493, p = 0.489) and no significant 



























Therefore, although there was a significant difference between performance on structured and 
random trials, this was not reflected in any underlying significant differences in activation in the ROIs. 
 
Figure 6-30: Mean fMRI response by trial type and group at baseline 
Error bars are SEM.   
 
6.5.1 EFFECT OF TRAINING ON CHUNKING 
A value for chunking was calculated by (mean β value during structured trials – mean β value during 
random trials) in each ROI for each participant.  The values were then averaged across all 4 ROIs to 
produce an overall chunking score.  This was calculated at both pre- and post-intervention time 
points.  A repeated measures ANOVA was then performed.  There were no significant main effects of 
time (F (1, 27) = 0.115, p = 0.738), or group (F (1, 27) = 0.107, p = 0.747), and no significant 
interaction between time and group (F (1, 27) = 2.249, p = 0.145).  As found in ANOVAs of individual 
ROIs, there was a significant change in fMRI response with chunking following training in the LPC (F 
(1, 27) = 4.635, p = 0.040) (Figure 6-31), and no other significant main effects or interactions for any 
of the other ROIs.  Although mostly non-significant, the change in fMRI response with the chunking 
contrast is consistent with all training group results, which demonstrated that structured trials 




























   
Figure 6-31: Mean fMRI response in LPC for chunking contrast 
(β value for structured – β value for random trials) at both time points and for both groups.  The time x group 






































6.6 WHOLE BRAIN ANALYSIS 
 
Results of whole brain analysis were also examined to identify any additional voxels or voxel clusters 
that significantly changed in level of activation, other than the defined ROIs. 
 
6.7  EFFECTS OF TRAINING- TIME X GROUP CONTRASTS 
The time by group contrast was examined for the whole brain, with a liberal threshold of p = 0.01 
uncorrected, and an extent threshold of 5 voxels.  
 
Figure 6-32: T contrast of time x group at p< 0.01 uncorrected, rendered on single participant template from 
SPM8. 
 
Several predominantly frontal regions reached this liberal significance level. (Table 6-16, Figure 6-32 




 value P (uncorr) 
COORDINATES 
x,  y,  z 
AREA 
10.14 0.002 40, 39, 28 RDLPFC 
8.96 0.003 14, 33,  0 
RIGHT CORPUS 
CALLOSUM 
8.1 0.005 -8, 32, 3 LEFT FRONTAL 
7.19 0.008 -15, 36, 3 LEFT FRONTAL 
7.93 0.006 21, 8, 21 
RIGHT SUB 
CORTICAL 
7.89 0.006 -38, -3, 34 LEFT INF FRONTAL 
7.36 0.008 21, -9, 42 
RIGHT FRONTAL 
SUB GYRAL 
Table 6-16: Whole brain analysis of time x group F contrast 
Coordinates of voxel clusters k>20, with a significance level of < 0.01 uncorrected are shown.  
 
T contrasts revealed that the direction of the significant effects was in the same as in the defined 






Figure 6-33: SPM for Time x group interaction (F contrast) 
Clusters of > 20 voxels at p < 0.01 (uncorrected) are shown. 
 
 





Figure 6-35 SPM of whole brain analysis (negative time x group T contrast, p<0.01 (uncorrected) 
 
 
6.7.1  EFFECTS OF TRAINING - TIME X TRIAL TYPE X GROUP CONTRASTS 
 
Whole brain analysis examining the F contrast for time x trial type x group revealed a number of 
frontal, parietal and subcortical areas that reached significance at the liberal uncorrected threshold of 
p < 0.01.  At the cluster level, a right subcortical area at x = 21, y = -7, z = 3, reached significance at 
pFWE < 0.05.  T contrasts revealed that the coordinates reaching significance were for the negative 









x, y, z 
AREA 
13.54 2732 21, -7, 3 
Thalamus / globus 
pallidus 
Table 6-17:  Whole brain analysis of time x trial x group contrast 


























6.8 EXPLORATORY SUBCORTICAL ANALYSIS 
 
As the T contrast had revealed a sub cortical area that reached significance at the cluster level, 
further exploratory analysis was conducted.  Previous studies have demonstrated that successful 
cognitive training is associated with increased activation in striatal areas 
177
.   Dahlin et al 
demonstrated that in older healthy participants, successful WM training was associated with 
increased activation in a left striatal area, with peak activation at  x = –24, y = 10, and z = –2)177. 
Exploratory analysis was therefore conducted at 10mm spheres around the central coordinates of the 
significant cluster identified from the current study and from the Dahlin et al study to examine whether 
there was evidence for a training related increase in subcortical activation. (Figure 6-40). 
 




MarsBar was used to estimate β values for the subcortical ROI as above, and the values were then 




The training group showed increased activation for random trials, but reduced activation for structured 
trials, whilst the control group demonstrated increased activation for both trial types (Table 6-18, 
Figure 6-41, Figure 6-42). 
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Figure 6-41: L STRIATUM: Mean fMRI response for both groups and time points 




























Figure 6-42: Mean fMRI response for Right Striatal ROI 



























6.9 WHOLE BRAIN ANALYSIS - EFFECT OF CHUNKING 
The whole brain main effect of chunking was also examined with the F and T contrasts of the main 
effect of trial type. As shown in Figure 6-44, Figure 6-45, and Figure 6-46, a number of predominantly 
parietal and occipital voxels reached significance at the liberal threshold of p < 0.01 uncorrected.  
Table 6-19 shows voxel clusters that reached significance at pFWE < 0.05.  These were in the parietal 
lobe (BA40) and occipital lobe.  Of note, the significant contrast was the random > structured; 
participants demonstrating increased activation during random compared to structured trials. 
 
 
Figure 6-43: Main effect of trial type F contrast at p < 0.01 rendered on single participant template in SPM8 
 
kE F value 
Coordinates 
x,  y,  z 
AREA 
1048 17.86 62, -42, 25 BA40- PARIETAL 
33357 16.46 21, -48,  -2 OCCIPITAL 
Table 6-19:  Whole brain analysis of Main effect of trial type 




Figure 6-44: SPM of main effect of trial type F contrast during encoding 









Figure 6-46: SPM of Random > structured T contrast across both groups and time points during encoding 
The significant cluster pFWE < 0.001 is shown 
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6.10  DELAY ANALYSIS 
 
6.10.1 EFFECT OF TRAINING ON ROIs  
The delay period of interest is the variable time point during which participants were asked to hold the 
5 digits they had just seen in working memory, prior to the cue to recall the digit span.  The same 4 
main ROIs were examined as had been during the encoding phase. 
A repeated measures ANOVA with time, trial type, ROI and hemisphere as within participants factors 
and group as the between participants factor revealed a near significant main effect of trial type (F 
(1,27) = 3.950, p = 0.057) and a significant main effect of ROI (F (1,27) = 9.395, p = 0.005). 
There were no other significant main effects or interactions (see Table 6-20). 
 
MAIN EFFECTS F Sig.(p) 
TIME 0.094 0.761 
TRIAL 3.950 0.057 
ROI 9.395 0.005 
   
INTERACTIONS   
TIME x GROUP 1.245 0.274 
TRIAL x GROUP 0.584 0.451 
ROI x GROUP 0.123 0.729 
TIME x TRIAL x GROUP 0.584 0.451 
TIME x TRIAL x ROI x GROUP 0.199 0.659 
Table 6-20: ANOVA results for the delay event. 
 
Therefore, although there were no significant effects of training, it is notable that the pattern of 
activation change from the encoding phase persisted during the delay phase - with training leading to 
a reduction in activation (mean = -0.60 (SD = 2.82)) compared to an increase in controls (mean = 1.06 
(SD = 4.96)).  However due to the large variance this group difference was not significant (t (28) = 




Figure 6-47: Mean change in fMRI response across all 4 ROIs and trial types.  Error bars are SEM. 
 
6.10.2 EFFECT OF CHUNKING 
The main effect of trial type approached significance (p = 0.057).  There was a positive effect of 
chunking at both time points and for both groups with increased activation across all 4 ROIs for 
structured compared to random trials.  Of note, this reduced in the training group but increased in the 
control group following intervention; however these interactions were not significant (Figure 6-48). 
 
 
Figure 6-48: Mean fMRI response with chunking contrast 


























































6.10.3  DELAY ANALYSIS - WHOLE BRAIN 
Results of whole brain analysis were also examined to identify any additional significant regions, other 
than the defined ROIs. 
 
6.10.3.1 EFFECTS OF TRAINING ON WHOLE BRAIN DURING DELAY 
The time by group F and T contrasts was examined for the whole brain, with a liberal threshold of p = 
0.01 uncorrected.  As shown in Figure 6-50, Figure 6-51 and Figure 6-52, there were occipital, 
parietal and temporal voxels that were significant at p < 0.01 uncorrected.  One occipital cluster (at x 
= 6, y = -84, z = 19) reached significance at pFWE <0.05.  
As shown in Figure 6-53, the time x trial type x group F contrast revealed only a small number of 
widely distributed voxels that reached significance at p < 0.01 uncorrected. 
 
 
Figure 6-49: T contrast of Structured > Random trials 





Figure 6-50: SPM of time x group F contrast for delay 
p < 0.01 (uncorrected).  Coordinates of largest clusters of significant voxels are shown. 
 
 
Figure 6-51: SPM of positive group x time interaction T contrast during delay 




Figure 6-52: SPM of negative time x group T contrast during delay 




Figure 6-53: SPM of time x trial type x group F contrast for delay 






6.10.3.2 EFFECT OF CHUNKING ON WHOLE BRAIN DURING DELAY 
The effects of chunking were examined with the F and T contrasts for main effect of trial. 
 
 
Figure 6-54: SPM of main effect of trial type (F contrast) during delay 






Figure 6-55: SPM of structured > random T contrast across both groups and time points during delay 
Voxels significant at the cluster level pFWE < 0.05 are shown. 
 
 
Figure 6-56: SPM of random > structured contrast across both groups and time points for delay 
There are no significant voxels at p < 0.01 (uncorrected). 
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As can be seen in Figure 6-49, Figure 6-54, Figure 6-55 and Figure 6-56, a range of frontal, temporal 
and parietal voxels reached significance at p<0.01 uncorrected.   For the structured > random T 
contrasts across all groups and time points, there was a significant frontal cluster (cluster level pFWE 




x, y, z 
REGION 
25438 3.93 -39, 6, 45 FRONTAL LOBE 
Table 6-21:  Whole brain analysis of structured > random t contrast during delay phase 
Coordinates of largest clusters of significant voxels shown.  (cluster significant at pFWE < 0.001). 
 
Therefore, the effect of trial type appeared to differ between the encoding and delay phases, with 
random trials producing greater activation than structured trials during encoding, but the reverse 
pattern emerging during the delay phase. 
 
 
6.11 ANALYSIS OF RECALL PHASE 
As verbal responses were given during the recall phase, movement artefact due to speech prevented 
meaningful analysis of this event.  Therefore the recall events were modelled as regressors of no 




6.12 VOXEL BASED MORPHOLOGY 
Voxel based morphology (VBM) was performed to examine for any significant structural differences 
between the groups that may have developed as a result of training.  
Initially the 4 defined ROIs were examined using repeated measures ANOVA.  As can be seen in 
Table 6-22, there were no significant main effects of group or time.  However there were significant 
main effects of hemisphere and ROI and a significant hemisphere x ROI interaction.   
There were no significant interactions between time x group or time, group, hemisphere and ROI, 
suggesting that training did not result in any significant structural changes in the 4 ROIs.  (Figure 
6-57, Figure 6-58, Figure 6-59 and Figure 6-60).  
 
 
MAIN EFFECTS F Sig. 
TIME 1.303 0.267 
HEMISPHERE 38.616 <0.001 
ROI 6.670 0.017 
GROUP 1.339 0.260 
   
INTERACTIONS   
TIME x GROUP 0.073 0.790 
TIME x HEMISPHERE x GROUP 0.061 0.807 
TIME x ROI x GROUP 0.278 0.604 
HEMISPHERE x ROI 88.424 <0.001 
TIME x HEMISPHERE x ROI 4.751 0.041 
TIME x HEMISPHERE x ROI x GROUP 0.217 0.646 





Figure 6-57: RDLPFC- no sig change in structure between groups 






























































Figure 6-59: Mean β value in the LPC.  Error bars are SEM.  
 
 
Figure 6-60: Mean β value in the RPC.  Error bars are SEM. 
 
 
6.12.1 WHOLE BRAIN ANALYSIS 
Whole brain analysis was examined with F and T contrasts for the main effect of time, and time x 
group interactions.  There was a significant main effect of time (pFWE < 0.05) in multiple areas, 
however no significant time x group interactions. (Figure 6-61, Figure 6-62, Figure 6-63, Figure 6-64, 
Figure 6-65). Therefore it can be concluded that there was a significant overall effect of time in 
multiple brain regions, as would be expected in an AD population, however no significant effect of 



































































Figure 6-64: SPM of time x group t contrast for VBM, demonstrating no significant voxels.  
 
 






6.13 PSYCHOPHYSIOLOGICAL INTERACTIONS - CONNECTIVITY 
ANALYSIS 
 
For the PPI analysis, the seed region was defined as the RDLPFC, with the other defined ROI as the 
regions of interest (ROI 1 = LDLPFC, ROI 2 = LPC, RO1 3 = RPC). 
The estimated PPI values were entered into a repeated measures ANOVA, examining connectivity 
between the seed region and each of the other ROI separately: 
 
6.13.1 RDLPFC- LDLPFC 
MAIN EFFECT F value Sig. (p) 
TIME 1.273 0.269 
TRIAL TYPE 2.383 0.134 
GROUP 0.159 0.694 
   
INTERACTIONS   
TIME x  GROUP 0.101 0.753 
TRIAL TYPE x GROUP 3.915 0.058 
TIME x TRIAL  1.625 0.213 
TIME x TRIAL x GROUP 0.291 0.594 
Table 6-23: PPI results for RDLPFC- LDLPFC 
 
6.13.2 RDLPFC-LPC 
MAIN EFFECT F value Sig.(p) 
TIME 0.067 0.798 
TRIAL TYPE 1.538 0.226 
GROUP 0.029 0.865 
   
INTERACTIONS   
TIME x  GROUP 0.108 0.745 
TRIAL TYPE x GROUP 0.221 0.642 
TIME x TRIAL  1.155 0.292 
TIME x TRIAL x GROUP 4.087 0.053 




Figure 6-66: PPI results for RDLPFC- LPC by trial type, time and group. 
 
Therefore the PPI between the RDLPFC and LPC shows a near significant group x trial type x time 
interaction p = 0.053. 
 
6.13.3 RDLPFC- RPC 
MAIN EFFECT F value Sig.(p) 
TIME 0.274 0.605 
TRIAL TYPE 0.888 0.354 
GROUP 0.250 0.621 
   
INTERACTIONS   
TIME x  GROUP 0.143 0.709 
TRIAL TYPE x GROUP 1.913 0.178 
TIME x TRIAL  0.423 0.521 
TIME x TRIAL x GROUP 1.135 0.296 



























Chapter 7 DISCUSSION 
 
 
7.1 CHUNKING IN WORKING MEMORY 
 
As described in Chapter 1, the Baddeley and Hitch model of working memory (WM) describes two 
limited capacity subsidiary systems, the phonological loop and visuo-spatial sketchpad.  Above these 
subsidiary systems are the central executive and episodic buffer.  These higher-level components 
provide attentional and executive control and resources to the more passive lower-level systems
16 19
.  
As WM capacity appears to be limited to only a few items of information
23
, humans use executive 
strategies to enable these items held in WM to be complex mental representations.   Chunking, 
despite its conceptual simplicity, is a major strategy behind our ability to form such complex mental 
representations. By recognising or enforcing patterns on information, and compressing it into a more 
efficient state, chunking enables us to create, assess and manipulate these complex chunks within 
the limited workspace of WM.  
Seen in this light, our use of chunking is almost limitless.  Language is an example of the chunking of 
individual letters to form words. A more complex example is the chunking and binding of sensory 
inputs with semantic and episodic memories that forms many of our subjective conscious 
experiences, such as recognising a friend..  
Chunking therefore has a profoundly powerful and ubiquitous role in how we experience and interact 
with the world.  In the words of Bor  ‘Chunking can vastly increase the practical limits of WM; it is the 
secret master of this online store, and the main purpose of consciousness
178
.  To Bor, and other 
theorists like Bernard Baars, WM and consciousness are largely synonymous, as ‘consciousness 
boils down to the information sitting right now in our WM
178 179
.  
In the current study, participants were trained in chunking using a very simple task: structured digit 
spans.  Although an extremely simple training paradigm was used, the concept behind its 
hypothesised and observed efficacy lies not in teaching a new compensatory technique, but in 
harnessing and directing this pre-existing and powerful strategy to increase the practical limits of WM. 
The evidence from the cognitive training literature in healthy adults, and from the meta-analysis of AD 
trials in Chapter 2, suggests that training effects appear limited to trained tasks. ‘Far transfer’, i.e. the 
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transfer of training-related benefit to unrelated non-trained tasks, is the exception rather than the 
norm
50 180
.  Even some of the apparent exceptions may actually be due to underlying similarities 
between outcomes, particularly in WM training
180
.  This is because WM clearly overlaps and 
enhances many other cognitive processes.  For example, information to be encoded in episodic 
memory will first be held in WM, and recalled episodic memories will also be subjectively experienced 
and manipulated using WM resources. There is also overlap at a neural network level, as the brain 
regions most consistently associated with WM, namely the pre-frontal cortex (PFC) and posterior 
parietal cortex (PPC) network,  are also associated with a range of ‘higher level’ executive 
processes
45 176
 and have been implicated as neural correlates of consciousness
181
. 
In this study, improvements in a range of tasks were hypothesised, as chunking is an executive 
strategy that can be applied to different types of information..  The study found an improvement in the 
training task, where stimuli were designed to be easy to chunk.  However, the study also 
demonstrated that other verbal material, such as word recall lists in the ADAS-Cog or short story 
segments in the verbal episodic memory tests were also improved by training in chunking.   
There were no improvements in the performance of tasks assessing executive function, suggesting 
that rather than leading to overall executive improvements per se, training led to a specific 
enhancement of the executive strategy of chunking itself.   Furthermore, the specificity of the verbal 
effects, compared to the lack of training effects on spatial WM and spatial episodic memory tasks 
suggests that the chunking training effect was limited to the verbal modality.  In other words, although 
this study demonstrated that specific cognitive training can ‘work’ in early AD, and that training 
generalised to untrained tasks, the observed benefits were most likely due to an increase in efficiency 
of the inherent ability to chunk verbal information, rather than any increase in non-verbally measured 
cognitive ability or intelligence. 
At a neurobiological level, the PFC- PPC network is associated with the use of chunking strategies, 
with evidence for increased activation during the explicit search and formation of new chunks or 
patterns
24 27
. There is also evidence that activity in this network decreases when such chunks have 
formed, patterns or rules have been established, and behaviour becomes more implicit
182
.  The fMRI 
data from the current study demonstrated that training in chunking is associated with changes in 
BOLD activity, suggesting training-related functional plasticity in early AD.  As is discussed in more 
detail below, the observed post- training decrease in activation is consistent with a cognitive shift from 
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explicit to implicit processing and an improvement in efficiency at a neurobiological level.  Importantly, 
this study demonstrated these effects in the context of behavioural change in participants with AD.   
 
7.2 SPECIFIC AIMS OF THE STUDY 
 
The specific aims of the study and the interpretation and implications of the results are now discussed 
in more detail.  The a priori hypotheses of the study were that: 
1) Training individuals with early AD in the use of chunking strategies would improve their WM 
capacity. 
2) Following training in chunking, improvement in WM capacity would generalise across different 
modalities of WM tasks and measures of general cognitive functioning. 
3) Improvement in WM capacity following cognitive training would be associated with re-
organisation of functional activity in the prefrontal cortex and posterior parietal cortex. 
 
7.3 DID CHUNKING TRAINING IMPROVE WM CAPACITY IN 
INDIVIDUALS WITH EARLY AD? 
 
The first hypothesis was based on pilot results suggesting that participants with early AD could use 
chunking to improve their WM
68
.  Therefore, before examining the results of training it is important to 
establish whether there was evidence of a chunking effect at baseline. 
At baseline, participants performed significantly better on structured compared to random trials on 
both verbal and spatial span tasks.  Therefore, performance at baseline is consistent with previous 
results in healthy young and older people, and participants with early AD
24 26 68
.  This suggests that 
participants did use chunking strategies, and that the tasks were sufficiently sensitive to detect 
differences between the structured and random trial types. 
It is an assumption that the performance benefits seen with structured trials were due to participants 
using the intrinsic numerical ‘chunks’ or spatial shapes inherent in the structured sequences.  This 
assumption is based on previous work in young adults, where it was verified that structured 
sequences encourage chunking
24 26 27
.  It is entirely possible, however, that the strategy used by 
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participants in the current study was chunking based not on the inherent structures provided, but on 
chunking the information differently (e.g. chunking the first pair of numbers and second trio of 
numbers irrespective of any structure) or using an alternative chunking strategy such as associating 
numbers with personal memories or facts
183
.  Prior to baseline testing, there was no discussion with 
the participant about trial type or strategy; therefore they were not led in any way to use a specific 
strategy.  Previous studies have examined potential strategies used during structured and random 
digit span performance and have shown that a range of chunking strategies can lead to improved digit 
span performance
27
.  It is therefore reasonable to hypothesise that chunking was the main effective 
strategy used with structured trials in the current study.  
 
7.3.1 IMPROVEMENT IN VERBAL WM PERFORMANCE 
WM training led to a significantly greater increase in digit span score compared with the control 
intervention, both when averaged across all trial types (p = 0.040 (1 tailed)) and in structured trials 
only (p = 0.017). Structured trials improved significantly more in the training group than the control 
group.  Random trials also improved more in the training than the control group, but not significantly. 
Therefore the primary hypothesis was confirmed: training led to a significant improvement in WM 
score. This effect was more significant with the structured trials, which encouraged chunking and 
were the focus of the training intervention, than in random trials. 
As discussed above, a cognitive interpretation of this increase in score is that by using chunking, 
participants were able to increase their verbal working memory capacity.  In terms of the Baddeley 
model of WM
15 16 19
, this may be explained by the more implicit systems of the visuospatial sketchpad 
or phonological loop increasing their intrinsic storage capacity.  However a more likely explanation is 
that chunking allowed more items of relevant information to be held in WM, without an underlying 
increase in capacity per se.  To facilitate this, attentional and executive resources of the central 
executive system and episodic buffer were recruited to bind the relevant bits of information into 
‘chunks’, by recognising intrinsic patterns in the digit sequences or interfacing with episodic and 
semantic memory processes that access additional relevant information
19
. For example an important 
date that can be linked with the digit sequence presented, or a rhyme like ‘2-4-6-8 who do we 
appreciate’
19 184
.   This may initially involve an explicit process, requiring the participant to be 
consciously aware of these links. 
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As the more executive components of the working memory model (e.g. central executive and episodic 
buffer) appear to be impaired earlier in AD than the passive systems (e.g. visuospatial sketchpad and 
phonological loop)
17 21
, it is noteworthy that the AD participants in this study were able to benefit from 
WM training that focused on the use of an executive strategy.  This suggests that the use and training 
of executive strategies can still be effective in early AD.  
 
 
7.4 DID CHUNKING TRAINING LEAD TO IMPROVEMENTS IN NON-
TRAINED WM TASKS AND GENERAL COGNITIVE 
FUNCTIONING? 
 
There was no significant effect of training on performance of the spatial span tasks, either on overall 
score or ability to chunk.  Both groups increased their span scores but there were no significant 
differences between the groups or trial types.  
This suggests that the WM improvement was limited to the verbal domain.  This may be interpreted 
as evidence for a selective training effect on the phonological system within working memory, rather 
than on a more general central executive component.  There is evidence for neuroanatomical 
dissociation of verbal and visuospatial processing within WM
37 185 186
 and it may be that the underlying 
functional neural networks that were strengthened by training were specific to verbal processing.  
However the evidence that there were also generalised improvements in non-trained tasks, suggest 
that the effects are not specific to verbal WM alone. 
  
7.4.1 DID TRAINING EFFECTS GENERALISE TO GENERAL COGNITIVE MEASURES?  
Importantly, both the MMSE and ADAS-Cog showed a significant improvement following training, 
compared to controls.  Therefore there was evidence of generalised improvement in cognitive function 
following training. 
This is an important finding due to the limited evidence that cognitive training produces generalised 
improvements on non-trained tasks
187
.  It also suggests that the underlying cognitive processes learnt 
during training (chunking) and/or the functional plasticity resulting from training, supported 
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performance of cognitive tasks apparently unrelated to the training regime.  Within the ADAS-Cog, 
there is the potential to explicitly use chunking strategies to improve performance, particularly on the 
word recall section of the test, where participants have to encode and then recall a list of 10 words
72
.  
Although the words are superficially unrelated, it may be possible to use chunking to link the words 
and improve recall.  Examination of the ADAS-Cog data in the training group revealed that 
participants improved in their word recall sub-score, which may be evidence for this explanation.  
 
7.4.2 DID TRAINING EFFECTS GENERALISE TO IMPROVEMENTS IN EPISODIC 
MEMORY?   
There was a significant improvement in verbal episodic memory in training participants compared to 
controls, but no significant changes were seen in visuospatial episodic memory following training. 
This mirrored the WM results, where verbal but not spatial WM significantly improved with training.  
Chunking may have been used to improve episodic memory, by chunking aspects of the story to be 
remembered in the logical memory tasks. It would be more difficult to apply chunking strategies to the 
Paired Associates Learning task, which may be why there was no improvement seen on this task.  
There is some evidence of the overlap between WM and episodic memory processes both cognitively 
and neuro-anatomically
188 189
 and therefore it may be that the improvement in WM encoding with 
chunking training facilitated improved episodic memory encoding and recall, resulting in the observed 
training-related verbal episodic memory benefits.    
 
7.4.3 DID TRAINING EFFECTS GENERALISE TO IMPROVEMENT IN EXECUTIVE 
FUNCTION? 
There were no significant effects of training on performance of any of the executive function tasks, 
which encompassed a range of planning, reasoning, response inhibition and set shifting functions. 
Although the MD network and a PFC-PPC network have been implicated in executive function, and 
also in tasks putatively assessing fluid intelligence
190 191
, it is notable that despite evidence of training-
related plasticity in this network in the current study, there were no behavioural improvements on 
executive function tasks.  A number of factors underpin fluid intelligence
192
, and there is considerable 
overlap between the cognitive processes and the functional neuro-anatomy involved in a variety of 
attentional, working memory and executive functions
45
.  Therefore, the lack of generalised executive 
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function improvement suggests that chunking training did not improve ‘executive function’, but rather 
affected more limited and specific WM processes.  Alternatively it may be that any executive 
improvement was either too small or too specific to be picked up by the range of executive tasks used 
in this study.  The most likely explanation, however, is that training resulted in an improved ability to 
specifically use chunking strategies, and it may have been more difficult to apply these strategies to 
tasks of executive function, with the exception of the verbal fluency task.   
There were also no significant training effects on sustained attention.  This suggests that the 
improvements seen in verbal WM, episodic memory and general cognitive function were not simply 
due to an underlying improvement in sustained attention.  However this result differs from other 
studies which have demonstrated that WM training can lead to improvements in sustained 
attention
193
.    
 
7.4.4 DID TRAINING HAVE ANY IMPACT ON ACTIVITIES OF DAILY LIVING OR QUALITY 
OF LIFE?  
There were no significant effects of training on performance of Instrumental Activities of Daily Living 
(IADLs) or on the Dementia Quality of Life scale (DEMQOL).  Although not reaching significance 
levels, both groups did demonstrate an increase in score on the DEMQOL. This supports the finding 
in the literature that cognitive training is acceptable and improves quality of life rather than causing 
frustration or anxiety
110 194
.   
The IADL may have been too insensitive a measure of functional ability to capture any improvements 
following training.  Functional decline at the very early stages of AD may be subtle
195 196
, and 
combined with the fact that the IADL measure in this study was used to reflect perceived rather than 
clear objective functional ability, it is unsurprising that no functional change was detected over 8-12 
weeks.  However there was a non-significant increase amongst the training group on the IADL score. 
Therefore it may be that participants did experience improvements in everyday functioning that were 
not picked up by the measure (anecdotally one training participant reported significant improvement in 





7.5 INTERPRETATION OF BEHAVIOURAL RESULTS 
 
At the behavioural level, an important basic issue is identifying whether improved performance on a 
cognitive task actually reflects genuine improvement in the underlying cognitive function.  Even 
though the current study used an active control group to mitigate against non-specific practice effects, 
a further confounding issue is discerning what is actually being tested during an individual task.  For 
example, even the simplest digit span task requires resources of sustained attention, understanding 
of the instructions given, planning of responses, inhibition of irrelevant distractions and monitoring of 
behaviour.  A highly complex executive task will similarly require lower level resources of sensory 
processing, sustained attention, and potentially verbal or motor responses. The cognitive tests used in 
the current study are well established and have been validated to assess specific cognitive domains, 
however there are no ‘pure’ cognitive tests.  As stated above, even tasks that are superficially 
dissimilar and indicate ‘far transfer’ may not be demonstrating this at all, rather a non-specific 
improvement in a participant’s willingness to cooperate or ability to sustain attention for long enough 
to complete the tasks
180
.  This may be especially true in an AD population, whose performance on 
neuropsychological tasks may fluctuate and be more susceptible to non-specific effects of fatigue or 
anxiety than healthy young participants.  However the consistent pattern of results found within tasks 
attributed to the same domains, and use of repeated measures analysis provides evidence for the 
validity of the behavioural findings in this study.  
 
 
7.6 WAS CHUNKING TRAINING ASSOCIATED WITH CHANGES IN 
FUNCTIONAL ACTIVITY IN THE PFC AND PPC?    
 
Overall there was a significant effect of training on functional activity in bilateral prefrontal and parietal 
regions.  The control group increased in activation, whilst the training group reduced in activation.  
This overall training effect was more significant for structured trials (p = 0.028) than when averaged 
across both trial types (p = 0.059). 
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When examined by region of interest, there was a significant effect of training in the right dorsolateral 
prefrontal cortex (RDLPFC) when structured trials were examined (p = 0.045) and near-significant 
effects across both trial types (p = 0.06).  The left parietal cortex (LPC) demonstrated significant 
training-related changes, and the right parietal cortex (RPC) near significant training-related changes 
with structured trials (p = 0.04 in LPC and p = 0.054 in RPC).   
There was therefore a consistent pattern of training-related deactivation in all four regions of interest, 
contrasting with increased activation in all four regions in the control group.   
 
Sensitivity analysis examining all trials (basic model) and multiple demand (MD) regions
197
 
 demonstrated further evidence of a consistent training-related pattern of functional plasticity - with 
training resulting in a decrease in activation with time, compared to an increase in activation in the 
control group.  The significant training effects in the RDLPFC were also replicated in the analysis of all 
trials, and with structured trials in the right anterior inferior frontal area of the MD network. 
Whole-brain analysis of the effects of training showed several predominantly frontal regions reaching 
an uncorrected significance level (p < 0.01), with a reduction in activation as a result of training.  An 
exploratory sub-cortical ROI analysis demonstrated an increase in activation for both trial types in the 
control group, but in the training group activation was increased for random trials and decreased for 
structured trials.  
There were no significant effects of training on functional activity during the delay phase of the task; 
however the pattern of activation change from the encoding phase persisted - with training leading to 
a reduction in activation compared to an increase in activation in the control group. Examining effects 
across the whole brain, one occipital cluster reached significance (pFWE < 0.05), again demonstrating 
reduced activation following training.  
 
Therefore the consistent pattern of training-related plasticity was of a decrease in functional activity in 
all cortical areas and a trial-dependent training effect in subcortical regions with structured trials 
demonstrating a decrease and random trials an increase in activation.  
This was in contrast to increased activation in all examined cortical and subcortical areas in control 




This pattern of results is consistent with the growing literature reporting that cognitive training leads to 
a decrease in cortical functional activity
63
.  A useful analogy for this has been provided by Petersen et 
al (1998)
198
.  They suggest that there is a scaffolding-storage framework that is built up during 
cognitive training.  Initially a task requires large attentional and executive resources in order to be 
successfully performed, and is a predominantly explicit process. This executive resource is 
underpinned by a ‘scaffold’ of cortical regions, including the prefrontal cortex (PFC), anterior cingulate 
cortex (ACC) and posterior parietal cortex (PPC)
63 198
.  As described in a review by Kelly and 
Garavan, at the initial stages of training these cortical areas ‘perform the scaffolding role’
63
.  The role 
of the PFC in performing this executive and attentional ‘scaffolding’ is consistent with theories of PFC 
function
199
 and also animal models, demonstrating decreased activity in the neurons of the PFC with 
learning
63 200
.    
 As training continues, the requirement for attentional and executive resources diminishes, and 
therefore activation in this network correspondingly decreases as the ‘scaffolding falls away’
63 198
.  
This may coincide with a coordinated increase in activity within areas underlying task-specific 
processes. This has been demonstrated in motor learning paradigms, where initial PFC, AC, PPC and 
premotor activation decreased with training and an increase in motor cortex and cerebellar activation 
emerged, as the tasks under examination became more practised and automatic
201-203
. 
An interpretation of these patterns of training-related cortical deactivation has been of ‘neuro- 




A number of potential neurobiological mechanisms have been suggested to facilitate this plasticity.  At 
a synaptic level the formation of new synapses or strengthening of existing synapses may occur
205 206
. 
Changes in the intrinsic excitability of neurons
207
, or in activation patterns at the level of neural 
networks
208
 may also contribute to plasticity.  Poldrack (2000) has speculated that such effects may 
lead to increased efficiency by resulting in a ‘sharpening of the responses in a particular neural 





A summary of previously reported effects of training on cortical and subcortical areas is shown in 
Table 7-1. Many of the studies examining the effects of practice have described a decrease in cortical 
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activation within the course of a single session
62 209-211
.  This suggests that functional redistribution 
can occur over short timescales of around an hour.  However other studies have also demonstrated 
similar redistribution dynamics that developed over longer training periods of several weeks
177 212 213
.  
This was the case in the current study, where the observed changes in cortical activation were 
observed following an average period of 82 days.  As the current study was not longitudinal it cannot 
answer the question of whether such redistribution over longer periods may be longer lasting, or be 
the consequence of more permanent underlying neuronal processes.  However, longitudinal cognitive 
training studies in healthy older adults have found long lasting training effects, with limited booster 
training, which suggests this may be a possibility
57 214
. 
The initial increase in activation in the PFC-PPC network predicted by the scaffolding/efficiency theory 
may also explain the results observed in control participants.  Although these participants were 
exposed to an active control intervention, this was a low level demand task of only three digits.  
Therefore the five digit span task performed in the scanner would represent a considerable increase 
in task difficulty from the control intervention.  In keeping with this theory, control participants would 
require increased executive resources to perform the five digit task, which would be reflected in 
increased PFC-PPC activity, in contrast to the training participants, who had been adaptively trained.  
However, while this may explain an increase in activity in the PFC-PPC in untrained participants 
performing the WM task, the observation that the activation in control participants increased from 
baseline to follow up, rather than remaining at a constant level, needs to be explained.  It has been 
observed that, in line with the efficiency theory, activation in PFC and PPC areas may follow an 
inverted U-shaped quadratic function, with activity increasing early in training, prior to decreasing
212
.  
It is probable that control participants, due to the low level training they received, were still at a point 
near the top of the inverted U shaped curve, and that adaptive training led to participants in the 
training group being much further along the curve with decreasing activation being observed
212
.  It 
may also be that the increase in activity reflects the improved span performance seen in controls, as 
they may have been more engaged and trying harder at the task at follow up compared to baseline.  
As has been suggested, according to the efficiency theory, training leads to decrease in cortical 
activation as the procedure becomes increasingly implicit.  Reflecting this, there may be an increase 
in activation elsewhere in the distributed network underlying task performance. 
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As shown in Table 7-1, some studies of cognitive training involving WM or other higher-level cognitive 
training have demonstrated a decrease in cortical activation but an increase in subcortical activation 
with training
177
 .  Subcortical areas are implicated in more implicit processes
215
, which would be in 
keeping with the overall theory that practice results in a transfer from initial attention heavy explicit to 
less executive and more implicit processes. 
It has been suggested that changes in connectivity both within and between brain areas are important 
in functional redistribution observed within training
211
.  The decrease in cortical activity may be 
associated with a decrease in connectivity between separate cortical regions as they become more 
efficient, and an increase in functional connectivity between cortical and subcortical regions
64 211
.  
This fits with the results of the current study - where training resulted in decreased cortical activation, 
and decreased connectivity between PFC and PPC regions, as chunking became more learned and 
implicit.   Although there were no significant training-related changes in functional connectivity (as 
measured by PPI values) between the RDLPFC and the LDLPFC or RPC, there was a near-
significant time x trial x group interaction between the RDLPFC and LPC (p=0.052). In the training 
group the PPI value reduced for structured trials, however increased non-significantly for random 
trials.  This may reflect a reduction in connectivity that corresponds to the reduced executive load 
required to perform structured trials following training. 
Evidence in support of this is found in a study by Fletcher et al., whereby a decrease in right fronto-
parietal connectivity was demonstrated with rule learning during an artificial grammar task; however 
these authors also found an increase in connectivity between left and right PFC
216
. 
The exploratory subcortical results in the current study do not clearly reflect an increase in activation 
as learning is established, and therefore do not convincingly fit into the pattern reported by Dahlin et 
al
177
.  This may simply reflect a lack of power to identify such effects in the current study, or may 
reflect a difference in training-related plasticity in older adults or in AD. 
 
Critically however, the current study provides evidence of the potential for functional plasticity 
following training in an Alzheimer’s population.  Functional plasticity is increasingly reported in older 
adults and in MCI
61 217
; however the extent to which training-related plasticity is possible in AD 




STUDY TASK TRAINING  TRANSFER FRONTO-PARIETAL SUBCORTICAL 
CHUNKING (not training studies) 
BOR et al 2004
26
 Digit Span 
Str vs. Rand trials 
n/a n/a Increased during encoding 
 
Caudate nucleus increased in 
encoding 
BOR et al 2003
24
 Spatial chunking 
Str vs. Rand trials 




DAHLIN et al 2008 
177
 WM ‘updating’ 15 sess (5 wks) 
T=16, C=7 









WM- visual WM, 
Backward DS and 
letter span 
25 days (5 wks) 










WM- spatial 20 days (5 weeks) 
T=11, C=11 
(healthy elderly) 








Dual task 5 sess (2-3 wks) 
T=16, C=15 
(healthy elderly) 
no Decreased No change 




Pitch memory 5 sess (5 days) 
T=14, C=10 
(young healthy) 
no Decreased Increased 




n-back Daily for 4 wks 
T=9, C=0 
(healthy) 
no Increased at 2 weeks, decreased after 
4 weeks 
 

















(Activation change correlated 
with behavioural improvement) 
SINGLE SESSION 







Motor  (tracing 
maze) 
1 sess novel task, 
10 min practice 
and novel task 
after practice 
n/a Shift in activity from frontal, AC and 
cerebellum to sylvian-insular cortex’ 
 
JANSMA et al 2001
209
 Verbal WM  Single session- 45 n/a Decreased  
231 
 
min of practice,  
T=15 (healthy) 










trial runs 1-4, 21-
24 and 41-44 
T=12  
n/a Decreased n/a 
BUCHEL et al 1999
211





and late per 
session 
 Decrease  but increase in effective 
connectivity between dorsal and 
ventral visual pathways 
n/a 
LANDAU et al 2004
62
 Visual WM (faces) Single session- 
early to late in 
scanning session 
across low or high 
memory loads  
n/a Decreased  
IN HEALTHY ELDERLY/ MCI/ AD 




Mnemonic training 3 sessions  
18 MCI 
16 healthy elderly 
 Analyses restricted to hippocampus. 
MCI- increased activity following training. Control group decreased activity.  
Healthy elderly:  Decreased activity in exp group, no change in control group  





(face-name pairs ) 
8 weeks 
T=7, C=12 
No behavioural  
change 
Exp: Increased  
Cont- decrease  
 
increased  
Table 7-1: Summary of fMRI findings in chunking and cognitive training studies 





7.7 WERE BEHAVIOURAL CHUNKING EFFECTS ASSOCIATED 
WITH ANY CHANGE IN FUNCTIONAL ACTIVITY?  
 
There were no significant differences in functional activation in the regions of interest between 
structured or random trials at baseline. Therefore although there was a significant difference between 
behavioural performance on structured and random trials, this was not reflected in any underlying 
significant differences in activation in the ROIs.  There was a significant time x trial type x group 
interaction in the LPC (p = 0.04), and when structured trials were examined independently, there were 
significant or near significant time x group interactions in the RDLPFC, LPC and RPC.  This was in 
contrast to no significant time x group interactions when random trials were examined independently.  
These results reflected the trend of greater reduction in activation with structured compared to 
random trials in the training group.  
In the whole brain analysis, there were clusters of increased significance in the parietal cortex (BA40)  
and occipital regions for the random compared to structured trials 
Therefore the results during encoding demonstrated the opposite effect to that seen in chunking 
studies in healthy young participants 
24 26
, whereby chunking was associated with a increase rather 
than decrease in DLPFC and PPC activation, however this difference did not reach significance in the 
current study. 
 
During the delay phase, however, the pattern of activation with chunking was of increased activation 
across all 4 ROIs for structured compared to random trials.  Therefore the delay phase showed a 
reversal in the pattern of chunking effects, with structured trials showing an increased activation 
compared with random trials. Interpretation of these data needs to be made with caution, as none of 
the group and time interactions were significant.  
 
It is possible that the chunking activation pattern differs from that seen in younger patients due to  
task difficulty effects.  It has been found that activation during episodic memory tasks increases with 
task difficulty
155 156
, and a number of further studies have demonstrated how increased task difficulty 
or load is associated with increased BOLD activation
222 223
.  This may explain the relatively greater 
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activation seen with random compared with structured trials during encoding.  Consistent with this, the 
behavioural evidence both during and outside the fMRI sessions was that participants scored lower 
on random trials compared with structured trials, which is likely to reflect that they were more difficult.  
An alternative explanation is that the increased activation seen with chunking in previous studies in 
healthy young participants reflected a more explicit, conscious awareness of the intrinsic patterns 
within the structured trials.  In contrast AD participants in the current study, although using chunking, 
may have been doing so more implicitly, resulting in the activation changes reflecting task difficulty 
rather than explicit use of chunking.    
 
7.8 WERE THERE ANY GROUP OR TRAINING-RELATED 
STRUCTURAL DIFFERENCES?  
 
Voxel based morphology analysis demonstrated no significant baseline, post intervention or training-
related differences between groups, either in ROI or whole brain analysis.   
There was a significant overall effect of time on whole brain analysis, with multiple areas 
demonstrating a reduction in size with time, however there were no significant time by group 
interactions.  The observed significant effect of time would be expected in an AD population
224
, 
however no significant effects of training were found on underlying brain structure. 
This means that the reduction in activation in the training group cannot be explained by a differential 
reduction in the size of the examined ROIs in the training group during the study compared to 
controls. 
 
7.9 WAS USE OF CHUNKING EXPLICIT OR IMPLICIT?  
 
 Explicit awareness of strategy use and performance was assessed in three ways.  Firstly by the 
meta-memory in adulthood (MIA) questionnaire, particularly the strategy sub-score, secondly by 
examining subjective reporting of strategy use and performance during testing blocks and thirdly by 




Firstly, on the MIA questionnaire, training participants significantly improved their score on the 
strategy sub-score compared with controls, suggesting a perceived increased use of strategy 
following training.  However this assesses a generic sense of increased strategy use and does not 
necessarily refer to a participant’s use of chunking or other strategies during the training or outcome 
assessments. 
Secondly, subjective reporting of strategy use and performance at baseline revealed that the majority 
of participants did not report using chunking and noticed no difference between trial types, despite 
performing significantly better on structured compared to random trials.  This suggests that the 
advantage on structured trials was more of an implicit that explicit process.   
Thirdly, although participants were generally poor at monitoring their performance during the blocks of 
trials during testing, they were accurate on a trial by trial level, with an 80.7% correct matching of 
confidence report to performance for both groups.  Of note, both groups were more accurate at 
predicting performance with structured than random trials. 
 
Following training, the percentage of participants in the training group who reported that structured 
trials were easier than random increased (from 20% to 40%), however the majority still failed to notice 
a difference between trial types.  Training participants who stated that they used chunking marginally 
increased; however the majority still reported not using chunking or other strategies.  Training 
participants improved at correctly monitoring performance during testing, however again over half 
incorrectly matched perceived with actual performance during testing.   Correct monitoring of 
performance on a trial by trial basis improved marginally in both groups, however the training group 
improved at correctly monitoring structured trials, but not random trials.  In contrast, control 
participants improved in correctly monitoring random, but not structured trials. 
The most striking finding in this data,  was that despite scoring higher on a strategy score post 
training, participants did not significantly report using chunking after testing sessions, nor did the 
majority seem to find structured testing easier than random, despite having trained for 18 sessions 
and performing better on structured compared with random trials.  This is further evidence that 
participants use chunking without being explicitly aware they were doing so.  
The evidence overall appears to be for a mixture of implicit and explicit awareness of strategy use, but 
with implicit processes being more common.   
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7.10 IS WORKING MEMORY TRAINING CLINICALLY USEFUL? 
 
A criticism of cognitive training regimes is that they focus on laboratory based training tools and 
assessments and may lack ecological validity
49 180
.  A previous meta-analysis has reported limited 
transfer effects of cognitive training to activities of daily living
187
. The current study also found no 
significant training-related effects on IADLs, however as suggested above, the IADL measure may not 
have been sensitive to more subtle effects on function.  More importantly however, are the training-
related improvements that were seen on general cognitive function. The between group difference on 
the ADAS-Cog score of -3.6 points is near the 4 point criteria for a minimally clinically important 
change and is of a similar magnitude to reported effects of general cognition seen in pharmacological 
trials
225
. Therefore this study provides support for working memory training providing an equivalent 
level of general cognitive benefit to currently available therapies. 
This study also demonstrated that this type of training is acceptable to participants with AD and their 
carers.  Once training had commenced, no participants dropped out of the study, despite the 
commitment required, and DEMQOL scores improved in both groups.  Anecdotally participants 
enjoyed engaging with the training and control intervention and felt empowered that they were 
investing in a potentially useful exercise. 
The major barrier to expanding a similar training regime in its current state is the resource implication 
of using clinical staff to oversee the training.  However, similar training could be performed online and 






7.11 LIMITATIONS OF THE STUDY 
 
7.11.1 DIAGNOSTIC DIFFICULTY 
This study included individuals at the very early stages of Alzheimer’s disease.  Effort was made to 
recruit only participants that clinical services had diagnosed with possible or probable AD, or those at 
the point of progression from MCI to an AD diagnosis.  The differentiation of patients between 
deteriorating multi-domain MCI and early AD involves skilled clinical assessment, based on the 
history of functional and cognitive deterioration and progression
12 13
.  Three participants (two training 
and one control participant) were assessed by their clinical teams to have been at the point of 
progression from MCI to AD at the time of recruitment.  It is acknowledged that patients at this very 
early stage of AD are likely to overlap with the criteria for MCI.  However by primarily considering pre -
post intervention performance within the same individuals and analysing within participant 
performance, any initial heterogeneity in cognitive profile or deterioration was controlled for in the 
study design.   
 
7.11.2 INCONSISTENCY OF PARTICIPANT AVAILABILITY 
 Some participants found it difficult to commit to 3 training sessions per week.  Therefore some 
participants had 2 or occasionally only 1 session per week.  It was decided that the number of training 
sessions should remain fixed at 18, rather than insisting on a strict weekly timetable, as this did not 
appear feasible for many participants.  The mean overall time in the study was 73.2 days (SD 21.6) 
for the control group and 92.7 days (SD 31.07) for the training group.  Both groups were positively 
skewed by one participant in each group who had a longer involvement, and the actual average 
length of involvement remained within the pre-set 12 weeks, with the difference between groups being 
non significant (Mann-Whitney U p =0.077). 
One of the reasons for differences in the length of time some participants were involved in the study 
was due to periods of no contact.  Three participants had breaks in the training of 1-2 weeks due to 
holidays, illness, and in one case, bereavement.  Again it was decided that these individuals would 
remain in the study and these events would be included in the overall time in the study and frequency 




7.11.3 INTERRUPTIONS DURING SESSIONS   
As all training and assessment sessions were completed in participants’ homes there were 
environmental variables that may have interfered with task performance.  Examples included the 
doorbell or telephone ringing, distraction from a member of the family or event outside, or events that 
had occurred prior to the session which may have affected energy levels or attention during the 
sessions.  These were impossible to predict or avoid and were only of consequence during timed 
tasks or those that required an element of sustained attention.  On the rare occasion where a timed 
assessment task was significantly interrupted, the task was repeated.   Although the majority of 
participants were willing to complete most tasks at the time and in the order requested by the 
researcher, if a participant requested that the baseline or follow up assessment session be terminated 
early due to tiredness, or due to other time commitments, any remaining tasks were completed at a 
subsequent session, however this was not a significant issue. 
A consequence of allowing a degree of flexibility, for the reasons listed above, was that some of the 
baseline tasks were completed during the initial 4 training/control sessions, rather than all being 
completed prior to the first training session.  Post assessments were also allowed to be commenced 
within the last 3 training sessions, providing that these all fell within 2 weeks of the final session.  This 
did not include any of the primary outcome measures which were strictly performed prior to any 
training session and after the final session had been completed.  
 
7.11.4 BLINDING   
A further weakness of the study is that due to one researcher being responsible for conducting all 
assessments and interventions, it was not possible for outcome assessments to be blinded.  This 
therefore introduces a source of potential bias, despite many of the behavioural assessments being 
standardised computerised tasks.  Therefore future validation of the results in the study would require 
a randomised double blinded design. 
 
7.11.5 CORRECTING FOR MULTIPLE COMPARISONS  
 Overall the behavioural primary outcome measures consisted of 4 scores.  In addition there were a 
total of 12 secondary cognitive outcome measures and 3 non cognitive outcome measures (one of 
238 
 
which had 7 sub scores).  Therefore there were a total of 19 main outcome measures examined in the 
study. 
The α value of 0.05 should therefore be adjusted for these multiple comparisons to < 0.003.  At this 
significance level, only the time x group interaction for the ADAS-Cog would remain significant.  It 
could also be argued that the correction for multiple comparisons should include all statistical tests 
performed on both behavioural and functional imaging data, thus adjusting the level of alpha for all 
examined results.  
It is acknowledged that by not performing a correction for multiple comparisons in this way there is a 
risk of type 1 errors.  However the results reported in the study are consistent with a priori 
hypotheses, and largely consistent within cognitive domains and with previously reported theoretical 
interpretations.  As the study is an fMRI study and also required intensive logistical input from the 
researcher for the cognitive training (> 600 home visits), it was powered based on previous fMRI and 
cognitive training studies to detect results at α= 0.05 and was also at risk of being under- powered, 
with a risk of type 2 errors being made.  Therefore on balance it was decided to report the significance 
values as uncorrected for multiple comparisons and acknowledge the risk of error this entails. 
 
7.12 NOVEL CONTRIBUTIONS AND FUTURE DIRECTIONS 
 
The results of this study provide several clear directions for future study. 
The investigation of computerised cognitive training to improve cognitive function in early dementia is 





strong support for further investigation of cognitive training.  This study makes several important novel 
contributions.   
Firstly, it highlights the importance of focusing cognitive training tools on cognitive functions that 
remain relatively intact.  As has been stated by other authors, cognitive training is likely to be more 
efficacious if based on improving or attenuating existing skills in the context of early AD
49
. The finding 
that executive strategy use in working memory is intact in early AD, and can demonstrate 
improvement with training is evidence for this approach in general and for targeting WM in particular.   
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Secondly this study provides a specific evidence–based strategic tool for improving working memory 
and general cognitive function.  Chunking training is an effective approach that could easily be 
adapted into existing cognitive training batteries. 
 Thirdly, the demonstration of functional plasticity in the WM network following training provides 
important evidence for the continued ability of the ageing brain to exhibit plasticity, even in the context 
of early AD. This provides support for the field to actively pursue further evidence for plasticity within 
AD, conditions that encourage beneficial plasticity, and the underlying processes behind such 
plasticity at a cellular, synaptic, neural network, functional and cognitive level.   
Fourthly, this study provides further evidence for the efficiency theory of cognitive training, and 
extends these findings to an AD population. It also demonstrates that implicit processes may underpin 
successful training of higher cognitive processes such as working memory and should encourage 
future studies to consider both implicit and explicit approaches when designing cognitive training 
tools.    
Fifthly, this study demonstrates that improvement in WM and general cognitive function, and 
underlying functional plasticity can occur with a relatively low load of training - just 30 minutes of 
simple chunking training, 2-3 times per week for 18 sessions.   
Finally this study provides evidence that computerised cognitive training is both acceptable and 
enjoyable to an elderly AD population, and therefore is a potential approach to pursue further. 
 
In light of this, the obvious next step is to investigate methods of overcoming the logistical difficulties 
and increasing access to cognitive training materials in a more flexible way.  Online cognitive training 
would provide such flexibility and would also allow a range of tasks to be performed, by a much larger 
number of participants, with data collected remotely.  This approach has already successfully led to 
some very large cognitive training studies 
50
, and there is an urgent need for open access, evidence 
based online cognitive training tools, in a growing market of expensive options with limited evidence
227
 
and an exponentially growing need
1
. 
Chunking training can easily be incorporated into the existing online battery of Hampshire and Owen 
(www.cambridgebrainsciences.com) and a follow-on study to examine online training using a tablet 
interface is planned.   
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It is also likely that cognitive training is most useful in combination with other strategies.  There is 
increasing evidence that physical exercise in conjunction with cognitive training can improve 
cognition
228
, and there is a need to examine the combination of cognitive training strategies with diet, 
lifestyle modification, socialisation and pharmacological agents. 
As early diagnosis of AD and detection of people at increased risk of developing cognitive impairment 
and dementia is becoming more urgently required, there is an obvious need to assess whether 
cognitive training can be used either for primary prevention in healthy elderly people, or secondary 
prevention in preventing people with MCI from progressing to dementia. 
Chunking training may be a useful strategy or adjunct and should therefore be incorporated into future 
studies of cognitive training in these groups. 
This study also raises questions regarding the contribution of meta-cognitive processes in cognitive 
training, and further studies to investigate metacognition in early AD would be useful in clearly 
exploring how implicit and explicit processes can be used most efficaciously in cognitive interventions.   
The extent of impairment of implicit learning in early AD, and the relationship between this and meta-




This single blinded parallel RCT demonstrated that 18 sessions of chunking training successfully 
improved verbal WM, episodic memory and general cognitive outcomes.  Further, successful 
cognitive training was associated with functional plasticity in a DLPFC- PPC network, with evidence 
for increased efficiency in this network following training, and training effects being both explicitly and 
implicitly mediated. 
 
This study therefore provides evidence for the usefulness and validity of a novel cognitive training 
regime involving chunking as a therapeutic strategy during the early stages of dementia, and for the 
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APPENDIX 1 - CONSENT FORMS AND INFORMATION 
SHEETS 
BRIEF INFORMATION LEAFLET 
 
VOLUNTEERS NEEDED FOR MEMORY RESEARCH IN ALZHEIMER’S DISEASE 
Investigating memory training in early Alzheimer’s disease  
Alzheimer’s disease is a common disease that affects older people.  In the early stages of the 
disease, people often notice difficulties with their memory, however it is not known whether simple 
training in the use of memory strategies can lead to an improvement in memory.   
 
We are currently looking for volunteers who are at the very early stages of Alzheimer’s Disease to 
take part in our study.  We will be investigating whether a simple 6 week memory training program 
can improve memory.  The study has 3 main components: 
 
1) Firstly we will be asking volunteers to complete a series of standard questionnaires and 
memory tests that look at their memory and abilities to do everyday tasks.  These 
questionnaires and tests will be done at the beginning and end of the study.   
 
2) Secondly we will be asking volunteers to ‘train’ their memory three times a week for six 
weeks.  This will require meeting with the researcher at your home for about half an hour on 
each occasion to practice memory tasks using a computer. 
 
3) Finally we will be asking volunteers to have 2 brain scans, one at the beginning and one at 
the end of the study to look at how memory training affects brain activity.  The brain scans will 
take place at the Institute of Psychiatry, London. (All transport and refreshments will be 
provided for the volunteer and a friend or relative).  
 
This research is important as it will help our understanding of how memory is affected at the early 
stages of Alzheimer’s disease and assess whether memory training may be a useful treatment. 
If you think you might be interested in taking part in this study or if you would like further information 
then please contact: 
 
Dr Jonathan Huntley  
Department of Old Age Psychiatry, Box P070, Institute of Psychiatry, De Crespigny Park 
London SE5 8AF 
Tel. 020 7848 0508 (office) 
Mobile: 07854 451 519 
Email: jonathan.huntley@kcl.ac.uk 
 





SHORT CONSENT FORM FOR MEDICAL RECORDS 
 
 
Investigating the benefits of memory training using ‘chunking’ in 
people with early Alzheimer’s Disease 
 
Name of researcher: ……………………………………..  Date: ………………… 
I understand that I will be asked to complete screening questionnaires that will ask questions about 
my medical history, memory and mood.  
 
 




I understand that Dr Huntley may contact my GP or access my medical records to clarify aspects of 
my medical history if necessary.  I understand my GP will only be informed if any of the results of 
the investigations carried out as a part of the research are important for my health and this has 
been discussed with me. 
 
 
I understand that my participation is voluntary and that I am free to withdraw from the study at any 
time, without having to give a reason for withdrawing and without affecting my future medical care 




Name of participant …………………………………….……………………………… 
(IN CAPITALS) 
 
Participant’s signature ...................................................... Date: .......  Time....................... 
 
Name of researcher ………………………………………….………………………… 
(IN CAPITALS) 
 
Researcher’s signature .......................................................… Date: .............................. 
Time…………………. 
 
Thank you for helping with this research. 
Version 2 (24
th










FULL CONSENT FORM FOR STUDY 
 
Investigating the benefits of memory training using ‘chunking’ in 
people with early Alzheimer’s Disease 
 
Name of researcher: ……………………………………..  Date: ………………… 
I understand that I will be asked to complete screening questionnaires that will ask questions about 
my medical history, memory and mood.  
 
 




I understand that Dr Huntley may contact my GP or access my medical records to clarify aspects of 
my medical history if necessary.  I understand my GP will only be informed if any of the results of 
the investigations carried out as a part of the research are important for my health and this has 
been discussed with me. 
 
 
I understand that my participation is voluntary and that I am free to withdraw from the study at any 
time, without having to give a reason for withdrawing and without affecting my future medical care 
or legal rights. 
 
 
I confirm that I have read the Information Sheet on the above project dated 20/09/10 (Version 2) 
and have been given a copy of the document to keep. 
 
 
I confirm that I have read the MRI Information Sheet (‘your functional MRI scan) dated 13/07/10 
(Version 1) and have been given a copy of the document to keep. 
 
 
I understand that the study involves 21 visits for assessments and memory training and 2 MRI 
brain scans that will take place at the Institute of Psychiatry.  
 
 
I understand that my doctor will be informed if any of the results of the investigations carried out as 
a part of the research are important for my health. 
 
 
I understand that my participation is voluntary and that I am free to withdraw from the study at any 
time, without having to give a reason for withdrawing and without affecting my future medical care 
or legal rights. 
 
 




Name of participant …………………………………….……………………………… 
(IN CAPITALS) 
 
Participant’s signature ...................................................... Date: .......  Time....................... 
 
The researcher has explained why the research is being carried out and has answered the 
participant’s questions about the study. 
 





Researcher’s signature .......................................................… Date: .............................. 
Time…………………. 
 
Thank you for helping with this research. 
Version 2 (24
th




INFORMATION SHEET FOR PARTICIPANT 
 
 
Participant Information Sheet 
 
Investigating memory training in early Alzheimer’s Disease 
 
Version 2 (20th September 2010) 
 
 
You are being invited to take part in a research study.  Before you make a decision, it is important for 
you to understand why the research is being carried out and what it will involve.  Please take time to 
read the following information carefully and discuss it with your relatives, friends or GP if you wish.  
Please ask us if there is anything that is not clear or if you would like more information.  Thank you for 
reading this. 
 
What is the purpose of the study? 
It is unclear whether memory training leads to a general improvement in memory, particularly in 
people with Alzheimer’s Disease.  ‘Chunking’ is a strategy that can help us remember things, by 
breaking information up into ‘chunks’.  An example of this is how we remember telephone numbers.  
We find it easier to remember:  0207 848 0346, than a list of 11 separate numbers.  There is some 
evidence that people at the very early stage of Alzheimer’s disease can use chunking as a strategy to 
help their memory.  We are therefore going to study whether a 6 week period of memory training by 
either learning chunking techniques or practicing memory games leads to an improvement in memory.  
Using brain scans we will also look at whether this memory training will lead to changes in brain 
activity. 
The aim is to learn more about whether memory training may be a useful treatment for Alzheimer’s 
disease.   
 
Why have I been chosen? 
We are asking 30 people at the very early stages of Alzheimer’s disease to take part in the study.  
You have been approached because you have expressed some interest in the study. 
 
Do I have to take part? 
It is up to you to decide whether or not you want to take part.  If you decide to take part you are free to 
withdraw at any time and without having to give a reason.  A decision to withdraw at any time, or a 
decision not to take part, will not affect the standard of care you receive or your legal rights.  
If you decide to take part then you will be asked to sign a consent form and given a copy of this.   
 
 
What will happen to me if I take part? 
The study has 3 main parts: 
 
1) INITIAL SCREENING AND ASSESSMENTS:   
 
You will be asked for your consent to take part in this initial screening interview and it is possible that 
following this you or the researcher may decide that you are not suitable for the study.  You will be 
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asked to take part in an interview that will last approximately one hour.  In this interview you will be 
asked questions about yourself and will be asked to take part in some standard psychological tests.  
These will be done to assess whether you are eligible to take part in the study.   
 
If you are eligible and wish to take part in the study, we will then arrange a second appointment to 
complete further questionnaires and memory tests.  These will ask more detailed questions about 
your memory and how you manage everyday tasks.  You will also be shown and asked to complete 2 
memory tests on a computer.   In one task you will be shown a sequence of numbers, which you will 
be asked to hold in your memory and then repeat back to the researcher.  In the other task you will be 
shown a pattern of squares on the screen and then be asked to remember and immediately recall the 
pattern by pressing on the computer screen.  These tasks will form the basis of the period of memory 
training and also be the tests you will be asked to do whilst undergoing brain scans.  This 
appointment will last approximately two hours. 
After the memory training period we will arrange a final assessment session, where the same memory 
tests will be done, to see if there has been any change 
 
2) MEMORY TRAINING 
 
The memory training programme will take a total of 6 weeks.  It will be quite intensive and require you 
to meet with the researcher (Dr Huntley) for one hour, three times per week for 6 weeks.  Each 
meeting will be arranged at your convenience in advance and all meetings could take place in your 
home if that is convenient or at the Institute of Psychiatry if you would prefer. 
We will be comparing 2 types of memory training in the study.  In one type of training, volunteers will 
be taught how to use ‘chunking’ to improve memory, as described above.  In the other type of training 
volunteers will practice simpler memory tests.  In order to make sure we can accurately compare 
these two types of training, all volunteers will be allocated to one group or the other randomly.  We do 
not yet know if either of these types of memory training are effective and it is important that we are 
able to compare them to each other, which is why volunteers will be allocated to the groups by 
chance. 
 
3) BRAIN SCANS 
 
Each volunteer will have a brain scan before and after the 6 week memory training period.  A 
technique called functional magnetic resonance imaging (fMRI) will be used.  Functional MRI is a non-
invasive imaging technique for taking pictures of the brain and has no known side-effects.  The 
procedure does not involve any injections or X-rays.  Using functional MRI, we are able to learn about 
how the brain works by looking at the blood flow to different parts of the brain whilst the brain 
performs different memory tasks.  Volunteers will be asked to do the memory task involving 
remembering a list of 4 numbers during the scan, so we can see if memory training has had an effect 
on brain activity.  The brain scans will take place at the Institute of Psychiatry, London.  Transport for 
you and a friend or relative will be provided to travel to and from the Institute of Psychiatry on 2 
occasions for the scans. 
Please see the separate ‘your functional MRI scan’ leaflet for further information on having a brain 
scan.   
 
There is no payment for the study, however all transport will be provided or travel expenses 























































There will therefore be a total of 23 visits over approximately 12 weeks  
 
What are the possible disadvantages and risks of taking part? 
There are no known risks or side-effects associated with carrying out the questionnaires or 
computerized tasks.  You may feel anxious before or tired after taking part in the tasks, but we will do 
everything we can to prevent this.  You will be asked about your well-being at all times, and you will 
be given the opportunity to have either a short rest break or for the testing or training to be stopped if 
necessary. 
 
There are no known risks involved in undergoing an fMRI scan. No radiation or injections are involved 
and you will not feel anything during the scan, however you would be required to lie still for 
approximately an hour. The MRI scans can be noisy and will not be ideal for anyone who suffers from 
claustrophobia, as you will be require to lie in a relatively small space. There is a possibility you may 
feel anxious or tired after taking part, but again we will do everything we can to prevent this.  The 
scans will take place at the Institute of Psychiatry and therefore require you to travel there with a 
friend or relative on two occasions.  All transport and refreshments on the day will be provided.  You 
may find the travel to and from the Institute of Psychiatry tiring or inconvenient, however the timing of 
these visits will be arranged when convenient for you and by providing all transport by taxis we will 
aim to reduce any inconvenience as much as possible. 
 
 
Initial screening interview 
 
Baseline questionnaires and memory 
tests 
 
Brain scan   
 
(in Cambridge Memory training 
 
1 hour each session 
 
3 times per week 
 
For 6 weeks 
 






Brain scan   




What are the possible benefits of taking part? 
The study is designed to investigate whether memory training can improve memory in people at the 
early stages of Alzheimer’s disease.  There is therefore a possibility that your memory may benefit 
from the intervention.  However there is no current evidence for this and there may be no benefits 
from this type of memory training.  We hope that the research might lead to new understanding of 
how memory is affected at the early stages of Alzheimer’s disease and ways that it might be 
improved. 
 
What if something goes wrong? 
In the unlikely event that you are harmed due to our negligence or if you have a complaint or any 
concerns about any aspect of the way you have been approached or treated during the course of this 
study then please don’t hesitate to raise this with us or contact us at the addresses below:  
 
Dr. Jonathan Huntley  
Section of Old Age Psychiatry, Box P070, Institute of Psychiatry, De Crespigny Park, London SE5 
8AF, Tel: 020 7848 0508 (office)  
 
Professor Robert Howard, Section of Old Age Psychiatry, Box P070, Institute of Psychiatry, De 
Crespigny Park, London SE5 8AF, Tel: 020 7848 0508 (office). 
 
If you have a complaint and are under the care of the South London and Maudsley Foundation Trust 
(for example you attend a memory clinic or outpatient community mental health service) and wish to 
speak to an independent person please contact the Patient Advice and liason service (PALS) on 0800 
731 2864  
 
Alternatively you can contact the KCL Research Ethics Office (contact details below) who will re-direct 
your complaint as appropriate. 
Contact details for KCL Research Ethics Office: Research Ethics Office, King's College London, 




The design, management and conduct of the study is covered by the Kings College London 
Professional indemnity scheme for clinical studies and NHS indemnity scheme. 
 
Will my taking part in this study be kept confidential? 
All information collected about you during the course of the research will be kept strictly confidential.  
All information we collect is only seen by members of the research team.  Any research data that is 
collected will be assigned a unique identification number, and personal information will be removed so 
that you cannot be recognized from your data.  If you withdraw your consent at any time, your data 
will no longer be used in the study. If you consent to take part in the study then Dr Jonathan Huntley 
may ask for your permission to inspect your medical records in order to ensure you are eligible for the 
study, but if this is necessary your permission will be sought for this explicitly. 
 
 
Will my doctor be informed? 
With your permission we will let your GP know you are participating in the study. We will not pass any 
other information to your doctor unless it is important for your health and you have agreed that we do 
so.  
 
What will happen to the results of the research study? 
When we have collected all the results for this study we will analyse them and then publish and 
present the results.  We will send you a summary of the research findings.  You will not be identified 
in any publication or presentation. 
 
Who has reviewed the study? 
This study is being funded by the Medical Research Council.  The ethics of the study have been 
reviewed by the Cambridgeshire 1 Research Ethics Committee. 
 
Contact for Further Information 
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If you have any questions or require any further information about this study then please do not 
hesitate to contact: 
 
Dr. Jonathan Huntley,  
Section of Old Age Psychiatry, Box P070, Institute of Psychiatry, De Crespigny Park, London SE5 
8AF, Tel: 020 7848 0508 (office)  
 
We are very grateful to you for considering taking part in this study. 
 
Version  2 (20
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Information Sheet for GP 
 
Investigating the benefits of memory training using ‘chunking’ in people with early Alzheimer’s 
Disease 
 
Your patient xxxxxxxx has been invited to take part in a research study investigating whether memory 
training using chunking, a mnemonic strategy, may be a useful treatment for Alzheimer’s disease.   
 
What does the study involve? 
The study has 3 main parts: 
1)Firstly volunteers will complete a series of standard questionnaires and memory tests that examine 
their memory and abilities to do everyday tasks.  These questionnaires and tests will be done at the 
beginning and end of the study.   
 
2)Secondly we will be asking volunteers to ‘train’ their memory three times a week for six weeks, to 
learn and practice chunking strategies.  This will require meeting with the researcher for an hour on 
each occasion to practice memory tasks using a computer. 
 
3)Finally we will be asking volunteers to have 2 fMRI brain scans, one at the   beginning and one at 
the end of the study to look at how memory training  
affects brain activity.   
 
Why has my patient been chosen? 
We are asking 30 people at the early stages of Alzheimer’s disease to take part in the study.  Your 
patient has been approached because they have expressed some interest in the study. It is up to your 
patient to decide whether or not they want to take part and they will be asked to provide informed 
consent.  If they do decide to take part they are free to withdraw at any time and without having to 
give a reason  
 
What are the possible disadvantages and risks of taking part? 
There are no known risks or side-effects associated with carrying out the questionnaires or 
computerized tasks or undergoing an fMRI scan.  Your patient may feel anxious before or tired after 
taking part in the tasks, but we will do everything we can to prevent this.   
 
What are the possible benefits of taking part? 
The study is designed to investigate whether memory training can improve memory in people at the 
early stages of Alzheimer’s disease.  There is therefore a possibility that your patient’s memory may 
benefit from the intervention.  However there is no current evidence for this and there may be no 
benefits from this type of memory training.  We hope that the research might lead to new 
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understanding of how memory is affected at the early stages of Alzheimer’s disease and ways that it 
might be improved. 
 
Who has reviewed the study? 
This study is being funded by the Medical Research Council.  The ethics of the study have been 
reviewed by the Cambridgeshire 1 Research Ethics Committee. 
 
If you have any questions or require any further information about this study or if you have any 
concerns about any aspect of the way your patient has been approached or treated during the course 
of this study then please contact: 
 
Dr. Jonathan Huntley  
Section of Old Age Psychiatry, Box P070, Institute of Psychiatry, De Crespigny Park, London SE5 
8AF, Tel: 020 7848 0346 (office)  
 
 
We are very grateful to your patient for considering taking part in this study. 
 







APPENDIX 2 - FMRI QUALITY AND BEHAVOURAL TABLES 
 
FMRI BEHAVIOURAL DESCRIPTIONS 
 
Subjects who had a reduced number of trials are as follows: 
 
TRAINING GROUP 
1) CH06A- Only 1 functional run, therefore only 20 trials. 
2) CH06B- Only 2 functional runs, therefore only 40 trials. 
3) CH24A- Only 2 functional runs, therefore only 40 trials. 
4) CH30B- run 3: No response to trials 52-60, therefore deleted blank images: 162-299                             
   
CONTROL GROUP 
1) CH02B: RUN 1 stopped after trial 12, RUN 2 stopped after trial 16, RUN 3: stopped after 
trial 16, all due to subject stating he saw double. Therefore 44 attempted trials included in 
imaging analysis. 
2) CH04A: RUN 2 stopped after 14 trials, therefore 54 attempted trials included in analysis 
3) CH04B: RUN 3 stopped after 18 trials, therefore 58 attempted trials included in analysis 
4) CH20B: RUN 3 stopped after 12 trials, therefore 52 attempted trials included in analysis 
5) CH23A- Only 2 spans (40 trials in total) 
6) CH23B- Only 2 spans (40 trials in total) 
 
Details on quality of data as assessed by the time series difference analysis (TSDiffANA) toolbox, 
number of functional runs, behavioural notes, additional movement regressors added to model, 

















CH05A OK N/A NO ALL UNIQUE 
30 RAND (10 IN 20 COR) 
30 STR (10 INC 20 COR) 
CONF 24 
N/R 5 
NOT CONF 31 
CH05B OK N/A NO 
RUN 1: not conf and  
incorrect trials non 
unique 
30 RAND (11 IN 19 COR) 
30 STR (1 INC 29 COR) 
CONF 43 
N/R 0 
NOT CONF 17 
CH06A OK ONLY 1 RUN 
NO 
 
RUN 1 no notconf trials 
 
10 RAND (1 IN 9 COR) 




RUN 1- one variance 
spike to 400 on 
graphs 2 and 4, 
otherwise ok 
 
ONLY 2 RUNS 
NO 
 
both runs, no notconf 
trials 
 
20 RAND (4 IN 16 COR) 
20 STR (1 IN 19 COR) 
CONF 35 
N/R 5 
CH09A OK N/A NO NO NOTCONF TRIALS 
30 RAND (2 IN 28 COR) 
30 STR (2 INC 28 COR) 
CONF- 60 
CH09B OK NONE NO 
RUN 1 no incorrect 
trials 
30 RAND ( 2 IN 28 COR) 
30 STR (1 IN 29 COR) 
CONF 55 
NOT CONF 4 
BLANK 1 
CH10A 
RUN 2- variance 
spikes to 600 at 
image 1,2,3 
 
RUN 3- one spike to 
500 around image 
240 
NONE 1 (RUN 2, IM 2) RUN 2 no notconf trials 
30 RAND (9 IN 21 COR) 
30 STR (6 IN 24 COR) 
CONF 57 
NOT CONF 3 
CH10B 
RUN 1- variance 
spike to 500 around 
image 240 
NONE 1 (RUN 1 IM 241) 
RUN 1 AND 2 no 
notconf trials: 
30 RAND (10 IN 20 COR) 
30 STR (8 IN 22 COR) 
CONF 58 
N/R 1 
NOT CONF 1 
CH11A 
RUN 1- 3 variance 
spikes to 600 around 
image 190 
 
RUN 2- variance 
spike to 1200 around 
Answered early 
either in encoding 
or delay in all 
trials apart from 
14,21,22,41,42,44
,45 
1 (RUN 2 IM 216) 
NO CONF RESPONSE 
 
30 RAND (7 IN 23 COR) 










spike to 1000 around 
image 80 
 
RUN 3- variance 




repeated early in 
maintenance then 
again in response 
in all trials except 
trial 21 




30 RAND (4 IN 26 COR) 




RUN 1- variance 





2 (RUN 1 IM 124 
AND 128) 
ALL UNIQUE 
30 RAND (7 IN 23 COR) 
30 STR (8 IN 22 COR) 
CONF 53 
N/R 0 
NOT CONF 7 
CH14B OK N/A NO ALL UNIQUE 
30 RAND (11 IN 19 COR) 
30 STR (15 IN 15 COR) 
CONF 54 
NOT CONF 6 
CH15A OK N/A NO ALL UNIQUE 
30 RAND (3 IN 27 COR) 
30 STR (3 IN 27 COR) 
CONF 44 
NOT CONF 15 
BLANK 1 
CH15B OK N/A NO NO NOTCONF TRIALS 
30 RAND (1 IN 29 CORR) 









30 RAND (17 IN 13 COR) 
30 STR (16 IN 14 COR) 
CONF 30 








NO ALL UNIQUE 
30 RAND (14 IN 16 COR) 
30 STR (18 IN 12 COR) 
CONF 32 
N/R 11 
NOT CONF 17 
CH18A OK N/A NO ALL UNIQUE 
30 RAND (4 IN 26 COR) 
30 STR (6 IN (24 COR) 
CONF 45 
NOT CONF 15 
CH18B OK N/A NO 
RUN 3: NO 
INCORRECT TRIALS 
30 RAND (3 IN 27 COR) 
30 STR (1 IN 29 COR) 
CONF 45 





RUN 1: no notconf 
trials 
RUN 2 no notconf or 
incorrect trials 
30 RAND (4 IN 26 COR) 
30 STR (3 IN 27 COR) 
CONF 50 
N/R 9 






Spoke early in 
trials 12,40 ,57 
NO ALL UNIQUE 
30 RAND (12 IN 18 COR) 
30 STR (12 IN 18 COR) 
CONF 40 
N/R 1 
NOT CONF 19 
CH24A OK 
ONLY 2 RUNS 
Spoke early in 
trials: 
1-16, 24, 28-30, 
33-35, 37, 39, 40. 
None 
 
NO NOT CONF 
TRIALS 
20 RAND (4 IN 16 CORR) 








IN TRIALS 2, 29, 
42 
NO 
NO NOTCONF TRIALS 
 
30 RAND (5 IN 25 COR) 





RUN 1- one variance 
spike to 500 around 
image 298-300 
RUN 3 –variance 
spikes to 3000 










30 RAND (25 IN 5 COR) 
30 STR (22 IN 8 COR) 
CONF 41 
N/R 6 
NOT CONF 13 
CH27B 
RUN 3- variance 
spike to 700 around 
images 295, 296 
 
spoke early on 
trials 3,8,30,32 
2 (RUN 3 IM 
295,296) 
ALL UNIQUE 
30 RAND (24 IN 6 COR) 
30 STR (16 IN 14 COR) 
CONF 44 
N/R 2 
NOT CONF 14 
CH28A OK 




NO ALL UNIQUE 
30 RAND (17 IN 13 COR) 
30 STR (17 IN 13 COR) 
CONF 38 
N/R 1 
NOT CONF 21 
CH28B OK  NO ALL UNIQUE 
30 RAND (14 IN 16 COR) 
30 STR (8 IN 22 COR) 
CONF 45 
N/R 1 
NOT CONF 14 
CH29A OK  NO 
RUN 1: no incorrect 
trials 
RUN 2 no notconf 
TRIALS 
RUN 3: no notconf or 
incorrect trials 
30 RAND (1 IN 29 COR) 
30 STR (0 IN 30 COR) 
CONF 58 
NOT CONF 2 
CH29B OK  NO 
NO NOTCONF OR 
INCORRECT TRIALS 
30 RAND (0 IN 30 CORR) 




CH30A OK NONE NO ALL UNIQUE 
30 RAND (11 IN 19 COR 
30 STR (8 IN 22 COR) 
CONF 31 
N/R 4 
NOT CONF 25 
CH30B OK 
No response trials 
52-60 all images 
blank after 161 
therefore deleted 
162-299 
NO ALL UNIQUE 
25 RAND (8 IN 17 COR) 
26 STR (6 IN 20 COR) 
CONF 34 
N/R 2 









RUN 3 : NO 
NOTCONF 
RESPONSE 
30 RAND (19IN,11COR) 
30 STR (10 IN, 20 COR) 
CONF 12 
N/R 38 




RUN 2- variance 








ALL  UNIQUE 
30 RAND (19 IN 11 COR) 
30 STR (18IN, 12 COR) 
CONF 19 
N/R 9 





NONE ALL UNIQUE 
30 RAND (1 IN, 29 COR) 
30 STR (5 IN, 25 COR) 
CONF 47 
N/R 4 








NONE ALL UNIQUE 
22 RAND (7 IN,15 COR) 




NOT CONF 9 
CH04A OK 
RUN 2 –stopped 




NONE ALL UNIQUE 
27 RAND (12 IN,15 COR) 




NOT CONF 11 
BLANK 7 
CH04B OK 
RUN 3 – 
stopped after 18 
trials, therefore 
only 58 trials 
included 
NONE ALL UNIQUE 
29 RAND (15 IN,14 COR) 
29 STR (8 IN, 21 COR) 
CONF 44 




CH07A OK  NONE ALL UNIQUE 
30 RAND (24 IN 6 COR) 





RUN 1- variance 
spike to 600 around 
image 70 
Spoke early in 
trials 29,55,56 
 1 (RUN 1 IM 70) 
 
ALL UNIQUE 
30 RAND (13 IN,17 COR) 
30 STR (12 IN, 18 COR) 
CONF 36 
N/R 3 
NOT CON 21 
CH08A 
RUN 3- one variance 
spike to 500 around 
image 180. 
Spoke early in 
trials 10,50 
NO ALL UNIQUE 
30 RAND (8 IN, 22 COR) 
30 STR (6 IN, 24 COR) 
CONF 56 NOT 
CONF 4 
CH08B 
RUN 3- variance 
spike to 500 
 NO 
NO NOTCONF TRIALS 
 
30 RAND (4 IN, 26 COR) 
30 STR (3 IN, 27 COR) 
CONF 59 
N/R 1 
CH12A OK  NO ALL UNIQUE 
30 RAND (12 IN 18 COR) 
30 STR (12 IN, 18 COR) 
CONF 44 
N/R 1 
NOT CONF 15 
CH12B OK 
Spoke early in 
one trial (58) 
then repeated 
NO ALL UNIQUE 
30 RAND (12 IN,28 COR) 
30 STR (9 IN, 21 COR) 
CONF 51 
NOT CONF 9 
CH13A 
RUN 1- variance 
spike to 800 around 
image 160 
 
Spoke early in 









NO ALL UNIQUE 
30 RAND (14 IN,16 COR) 
30 STR (9 IN, 21 COR) 
CONF 35 
N/R 13 
NOT CONF 12 
CH13B 
RUN 2- one variance 









NO ALL UNIQUE 
30 RAND (10 IN,20 COR) 
30 STR (12 IN, 18 COR) 
CONF 47 
N/R 4 
NOT CON 8 
BLANK 1 
CH19A 
RUN 1- slice by slice 
variance one spike of 
700 around image 
212 
 NO 
No incorrect trials in 
RUN 1 and 2. 
30 RAND (1 IN, 29 COR) 
30 STR (0 IN, 30 COR) 
CONF 57 
N/R 0 
NOT CONF 3 
CH19B OK  NO No unique incorrect 30 RAND (1 IN, 29 COR) CONF 58 
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and not conf trials in 
run 1, no incorrect trials 
in runs 2 and 3. 
30 STR (1 IN, 29 COR) N/R 0 
NOT CONF 2 
CH20A OK  NO ALL UNIQUE 
30 RAND (11IN, 19 COR) 
30 STR (8 IN, 22 COR) 
CONF 49 
N/R 2 
NOT CONF 9 
CH20B 
RUN 1- max 
variance to 800 
RUN 3 –variance 
spike around 113 
RUN 3 stopped 
after trial 12, 
therefore 52 
trials included in 
analysis 
4 (RUN 1, IM 
12,97,154 
RUN 3, IM) 
Run 1, no not conf 
trials.  Run 2 no unique 
incorrect or not conf 
trials 
26 RAND (4 IN, 22 COR) 
26 STR (2 IN, 24 COR) 
CONF 50 
N/R 1 
NOT CONF 1 
BLANK 8 
CH23A 
RUN 1- variance 
spike to 700 around 
image 280 
Only 2 Runs None ALL UNIQUE 
20 RAND (5 IN, 15 COR) 
20 STR (4 IN, 16 COR) 
CONF 33 
NOT CONF 7 
BLANK 20 
CH23B 
RUN 1 – variance 
spike to 900 around 
image 299 
Only 2 runs 
RUN 1- images 
294 and 299 
 
RUN 2 – incorrect and 
not conf trials not 
unique 
20 RAND (5 IN, 15 COR) 
20 STR (2 IN, 18 COR) 
CONF 34 
NOT CONF 6 
BLANK 20 
CH25A 
RUN 1 – spike to 800 
at image 152-155 
RUN 2- spike to 700 
RUN 3- spike to 
1000 
 NO ALL UNIQUE 
0 RAND (13 IN, 17 COR) 
30 STR (15 IN, 15 COR) 
CONF 36 
N/R 11 
NOT CONF 13 
CH25B 
RUN 1 – spike to 700 
RUN 2- spike to 600 
 NO ALL UNIQUE 
30 RAND (10 INC,20 
CORR) 








 NO ALL UNIQUE 
30 RAND (17 IN,13 COR) 
30 STR (22 IN, 8 COR) 
CONF 24 
N/R 3 
NOT CONF 33 
CH26B OK  NO ALL UNIQUE 
30 RAND (19 IN,11 COR) 
30 CORR (24 IN, 6 COR) 
CONF 41 
N/R 2 





 ALL UNIQUE 
30 RAND (7 IN, 23 COR) 
30 STR (6 INC, 24 COR) 
CONF 42 
NOT CONF 18 
CH31B 
RUN 1, one spike to 





 ALL UNIQUE 
30 RAND (6 IN, 24 COR) 
30 STR (9 IN, 21 COR) 
CONF 45 
N/R 2 




CH32A OK  NO 
RUN 2 no notconf trials  
RUN 3 not conf and 
incorrect trials not 
unique 
30 RAND (3 IN, 27 COR) 
30 STR (2 IN, 28 COR) 
CONF 59 
N/R 0 
NOT CONF 1 
CH32B 
RUN 2- variance 
spike to 800 around 
image 127 
 
2 (RUN 2 IM 127, 
129) 
RUN 1 no incorrect and 
notconf trials 
30 RAND (2 IN, 28 COR) 
30 STR (0 INC, 30 COR) 
CONF 59 







RUN 2 no unique 
incorrect and notconf 
trials 
30 RAND (6 IN, 24 COR) 
30 STR (4 IN, 26 COR) 
CONF 41 
N/R 9 




Spoke early on 
trials 7,32,41,56 
NO 
RUN 1 no unique 
incorrect/notconf trials 
RUN 2 no incorrect 
trials 
30 RAND (2 IN, 28 COR) 
30 STR (2 IN, 28 COR) 
CONF 54 
NOT CONF 6 
Table 0-1: Table of fMRI performance and quality of data 
RUN = Each fMRI session had 3 functional runs.  IM = image. RAND = random trial. STR = structured trials. 




EXAMPLE OF MODELLING MOVEMENT ARTEFACT AS REGRESSOR OF NO 
INTEREST.  
The example below is of subject CH14A who demonstrated a movement spike around images 123-
128 during the first span session.  This is seen as a spike in z translation and pitch rotation on the 
image realignment output graphs and also as a spike in slice by slice and scaled variance at the 
corresponding images.  Checking the images revealed artefact present on images 123-128. 
The design matrix therefore involved an additional two regressors after the 6 movement regressors in 
span 1, corresponding to images 124 and 128, where the amount of movement exceeded the stated 
maximums allowed. 
 
Figure 0-1: Preprocessed functional images 123- 131 from subject CH14A 









Figure 0-2: Output of TSDiffANA analysis 





Figure 0-3:  Movement output graphs from realignment preprocessing step in SPM8 




APPENDIX 3 – COMPUTER SCRIPTS  
 
All code was adapted from scripts written by Dr Adam Hampshire. 
 
MAIN FIRST LEVEL ANALYSIS CODE 
subs = {'CHUNK05/CHUNK05B/UNC/011189/CH05B_'... 
    }%'010874'   
nsubs = length(subs); 
nsess = 3;  
sessname = {'SPAN_1' 'SPAN_2' 'SPAN_3'} 
eventroot = '/home/spsljth/Documents/CHUNK'%you will need to change this to 
point to a folder containing all of the onsets and durations folders  
cnames{1} = { 'STRCORRECT' 'INCSTR' 'RANDCORR' 'INCORRAND' 'CONFCORRECT' 
'CONFWRONG' 'NOTCONFCORRECT' 'NOTCONFWRONG'}; 
cnames{2} = cnames{1};  
cnames{3} = cnames{1};  
ncond = length(cnames{1}); 
TR = 2; 
   
 dataroot = '/home/spsljth/Documents/CHUNK'%this should point to where your 
subject folders are 
statsdir = fullfile(dataroot,'stats'); 
hpf = 180; 
incmoves = 1; 
modeldur = 1; 
imgfilt = '^swa.*\.img$'; 
movefilt = '^rp.*\.txt$'; 






 % basis functions and timing parameters 
%--------------------------------------------------------------------------
-% OPTIONS:'hrf' 
%         'hrf (with time derivative)' 
%         'hrf (with time and dispersion derivatives)' 
%         'Fourier set' 
%         'Fourier set (Hanning)' 
%         'Gamma functions' 
%         'Finite Impulse Response' 
%--------------------------------------------------------------------------
- xBF.name       = 'hrf'; 
xBF.length     = 32.2;              % length in seconds 
xBF.order      = 1;                 % order of basis set 
xBF.T          = 16;                % number of time bins per scan 
xBF.T0         = 1;                 % first time bin (see slice timing) - 
middle of TA 
xBF.UNITS      = 'secs';           % OPTIONS: 'scans'|'secs' for onsets 
xBF.Volterra   = 1;                 % OPTIONS: 1|2 = order of convolution 
   
failed = {}; 
 for sub = 1:nsubs 
    %try 
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     clear SPM 
    disp(subs{sub}) 
    SPM.xY.RT = TR; 
    SPM.xGX.iGXcalc = 'None'; 
    SPM.xVi.form = 'AR(1)'; 
    SPM.xBF = xBF; 
    csub = subs{sub}; 
     
    %subdata = fullfile(dataroot, csub); 
    cd (dataroot) 
      subdata = fullfile(dataroot, csub) 
      anadir = [subdata 'DanModelcomplexxtramoves']; 
    if exist(anadir)~=7; mkdir(anadir);end 
    cd(anadir); 
      tc = 0; 
    allfiles=''; 
     for sess = 1:nsess 
        evorder = cnames{sess} 
        clear ffiles; 
         
        evdir = [eventroot '/' subs{sub} 'onsets']; 
         tc = tc+1; 
        sessdata = [subdata  sessname{sess}];%+5 to get past other task         
          files = spm_select('List', sessdata, imgfilt); 
        if incmoves==1 
            clear mfname; 
            clear moves; 
            mfname = spm_select ('List', sessdata, movefilt); 
            moves = load(fullfile(sessdata,mfname)); 
        end 
  
        for f =1:size(files,1) 
            ffiles(f,:) = fullfile(sessdata,files(f,:)); 
        end 
         
        allfiles = strvcat(allfiles,ffiles); 
         %essentially, we want to control for any variance that is due to 
        %error 
        %And capture variance related to uncertainty 
        %whilst retatining the originalmodel 
         %that means we have 2 main trial type * 3 stages = 6 
        %plus an error regressor * 3         
        %plus a certainty regressor * 3 
        %that makes a total of 12 regressors per level reworked by 
        %combining the above text files... 
        
        %cnames{1} = { 'STRCORRECT' 'INCSTR' 'RANDCORR' 'INCORRAND' 
'CONFCORRECT' 'CONFWRONG' 'NOTCONFCORRECT' 'NOTCONFWRONG'}; 
         
        for c = 1:12 
             if c == 1 %then have all random sequences  
                name = 'AllRandE' 
               efile1 = [evdir '/RANDCORR_SPAN'  num2str(sess) '_1.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_1.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
284 
 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
            if c == 2 %then have all random sequences  
                name = 'AllStrE' 
                efile1 = [evdir '/STRCORR_SPAN'  num2str(sess) '_1.txt']  ; 
               efile2 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_1.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
             
            if c == 3 %then have all random sequences  
                name = 'AllRandM' 
               efile1 = [evdir '/RANDCORR_SPAN'  num2str(sess) '_2.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_2.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
               efile1 = [evdir '/RANDCORR_SPAN'  num2str(sess) '_3.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_3.txt']  ; 
                durs = []; 
                try 
                    durs = [durs load(efile1)]; 
                catch 
                end 
                try 
                    durs = [durs' load(efile2)]; 
                catch 
                end  
            end 
            if c == 4 %then have all random sequences  
                name = 'AllStrM' 
                efile1 = [evdir '/STRCORR_SPAN'  num2str(sess) '_2.txt']  ; 
               efile2 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_2.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                efile1 = [evdir '/STRCORR_SPAN'  num2str(sess) '_3.txt']  ; 
               efile2 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_3.txt']  ; 
                durs = []; 
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                try 
                    durs = [durs load(efile1)]; 
                catch 
                end 
                try 
                    durs = [durs' load(efile2)]; 
                catch 
                end  
            end 
             
            if c == 5 %then have all random sequences  
                name = 'AllRandR' 
               efile1 = [evdir '/RANDCORR_SPAN'  num2str(sess) '_4.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_4.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end   
               durs = ons - ons + 7; 
                  
            end 
            if c == 6 %then have all random sequences  
                name = 'AllStrR' 
                efile1 = [evdir '/STRCORR_SPAN'  num2str(sess) '_4.txt']  ; 
               efile2 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_4.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
            if c == 7 %then have all random sequences  
                name = 'NOTCONFE' 
         efile1 = [evdir '/NOTCONFCORRECT_SPAN'  num2str(sess) '_1.txt']  ; 
         efile2 = [evdir '/NOTCONFWRONG_SPAN'  num2str(sess) '_1.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
            if c == 8 %then have all random sequences  
                name = 'INCORRECTE' 
               efile1 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_1.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_1.txt']  ; 
                ons = []; 
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                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
             
            if c == 9 %then have all random sequences  
                name = 'NOTCONFM' 
         efile1 = [evdir '/NOTCONFCORRECT_SPAN'  num2str(sess) '_2.txt']  ; 
         efile2 = [evdir '/NOTCONFWRONG_SPAN'  num2str(sess) '_2.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
        efile1 = [evdir '/NOTCONFCORRECT_SPAN'  num2str(sess) '_3.txt']  ; 
        efile2 = [evdir '/NOTCONFWRONG_SPAN'  num2str(sess) '_3.txt']  ; 
                durs = []; 
                try 
                    durs = [durs load(efile1)]; 
                catch 
                end 
                try 
                    durs = [durs' load(efile2)]; 
                catch 
                end  
            end 
            if c == 10 %then have all random sequences  
                name = 'INCORRM' 
               efile1 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_2.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_2.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
               efile1 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_3.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_3.txt']  ; 
                durs = []; 
                try 
                    durs = [durs load(efile1)]; 
                catch 
                end 
                try 
                    durs = [durs' load(efile2)]; 
                catch 
                end  
            end 
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            if c == 11 %then have all random sequences  
                name = 'CONFR' 
         efile1 = [evdir '/NOTCONFCORRECT_SPAN'  num2str(sess) '_4.txt']  ; 
         efile2 = [evdir '/NOTCONFWRONG_SPAN'  num2str(sess) '_4.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end   
                durs = ons - ons + 7; 
                  
            end 
            if c == 12 %then have all random sequences  
                name = 'INCORRR' 
               efile1 = [evdir '/INCORSTR_SPAN'  num2str(sess) '_4.txt']  ; 
              efile2 = [evdir '/INCORRAND_SPAN'  num2str(sess) '_4.txt']  ; 
                ons = []; 
                try 
                    ons = [ons load(efile1)]; 
                catch 
                end 
                try 
                    ons = [ons' load(efile2)]; 
                catch 
                end                        
                durs = ons - ons + 7; 
            end 
             
            cnames{sess}(1) = {name}; 
                 SPM.Sess(tc).U(c) = struct(... 
                'ons',ons,... 
                'dur',durs,... 
                'name',{cnames{sess}(1)},... 
                'P',struct('name','none')) 
        end 
  
        
        SPM.nscan(tc) = length(ffiles); 
        SPM.xX.K(tc).HParam = hpf; 
        if incmoves==1 
            clear moves2; 
            moves2 = zeros(length(moves),6); 
            moves2(2:length(moves),:) = moves(2:length(moves),:) - 
moves(1:length(moves) - 1,:);  
            moves2 = sqrt(moves2.*moves2); 
            mnames2 = mnames; 
         %the first 3 are translations (4) the second 3 are rotations (0.1) 
            for i = 1:SPM.nscan(tc) 
               maxtrans = max(moves2(i,1:3)); 
               maxrot = max(moves2(i,4:6)); 
                
               if maxtrans > 4 || maxrot > 0.1 
                  moves = [moves zeros(SPM.nscan(tc),1)]; 
                  moves(i,length(moves(1,:))) = 1; 
                  mnames2 = [mnames2 num2str(i)]; 
               end 
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            end 
             
              SPM.Sess(tc).C.C    = moves;     % [n x c double] covariates 
            SPM.Sess(tc).C.name = mnames2; % [1 x c cell]   names 
        else 
          SPM.Sess(tc).C.C = []; 
            SPM.Sess(tc).C.name = {}; 
        end 
    end 
  
  
    cd (anadir) 
     
  
        SPM.xY.P = allfiles; 
        SPMdes = spm_fmri_spm_ui(SPM); 
        spm_unlink(fullfile('.', 'mask.img')); % avoid overwrite dialog 
        SPMest = spm_spm(SPMdes); 
  
  
   % catch 
   %     failed(sub) = subs(sub) 






BASIC ANALYSIS CODE FOR CONTRASTS 
 
%----------------------------------------------------------------------- 





subs = { 'CHUNK16/CHUNK16B/UNC/013006/CH16B_' ... 
      }%'010874'  
nsubs = length(subs); 
  
dataroot = '/home/spsljth/Documents/CHUNK'; 
 for sub = 1:nsubs 
    display(sub) 
    datadir = [dataroot '/' subs{sub} 'DanModel1xtramoves'] 
  
    cd (dataroot) 
    cd (datadir) 
     
        cons{1} = [0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0] 
        cons{2} = [1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0] 
        cons{3} = [1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 
0 0 0 0 0] 
        cons{4} = [-1 0 1 0 0 0 0 0 0 0 -1 0 1 0 0 0 0 0 0 0 -1 0 1 0 0 0 0 
0 0 0 0 0 0] 
        cons{5} = [1 0 -1 0 0 0 0 0 0 0 1 0 -1 0 0 0 0 0 0 0 1 0 -1 0 0 0 0 
0 0 0 0 0 0] 
        cons{6} = [0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 1 0 1 0 0 0 0 
0 0 0 0 0] 
  
               
        cname{1} = 'STRENC'; 
        cname{2} = 'RANDENC'; 
        cname{3} = 'ALLTRIALSENC'; 
        cname{4} = 'ALLSTR>RANDE'; 
        cname{5} = 'ALLRAND>STRE'; 
        cname{6} = 'ALLRECALL';         
       clear SPM 
  
  
        SPMest=load('SPM.mat'); 
        SPMest=SPMest.SPM; 
        % use this to make the con images 
        SPMest.xCon =[]; 
        for i = 1:size(cons,2) 
            if length(SPMest.xCon)==0 
                SPMest.xCon = 
spm_FcUtil('Set',cname{i},'T','c',cons{i}',SPMest.xX.xKXs); 
            else 
                SPMest.xCon(end+1) = 
spm_FcUtil('Set',cname{i},'T','c',cons{i}',SPMest.xX.xKXs); 
            end 
        end 
        spm_contrasts(SPMest); 






MAIN ANALYSIS CODE FOR CONTRASTS 
 
%----------------------------------------------------------------------- 





subs = {'CHUNK01/CHUNK01A/UNC/010560/CH01A_'... 
         }%'010874'  
nsubs = length(subs); 
  
dataroot = '/home/spsljth/Documents/CHUNK'; 
 datadir = [dataroot '/' subs{sub} 'DMCXSTRICTRESULTS'] 
  
for sub = 1:nsubs 
    display(sub) 
  
    cd (dataroot) 
    cd (datadir) 
     
        cons{1} = [1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{2} = [0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{3} = [1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{4} = [-1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{5} = [1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{6} = [0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{7} = [0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
         
        cons{8} = [0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{9} = [0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{10} = [0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{11} = [0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{12} = [0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{13} = [0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{14} = [0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0]; 
         
        cons{15} = [0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{16} = [0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{17} = [0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{18} = [0 0 0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 -1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
        cons{19} = [0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 
0 0 0 0 0 0 0 0 0 0 0 0 0 1 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0]; 
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        cons{20} = [0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0]; 
        cons{21} = [0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0]; 
             
         
        cname{1} = 'ALLRANDE'; 
        cname{2} = 'ALLSTRE'; 
        cname{3} = 'ALLTRIALSE'; 
        cname{4} = 'ALLSTR>RANDE'; 
        cname{5} = 'ALLRAND>STRE'; 
        cname{6} = 'NOTCONFE';         
        cname{7} = 'INCORRECTE'; 
         
        cname{8} = 'ALLRANDM'; 
        cname{9} = 'ALLSTRM'; 
        cname{10} = 'ALLTRIALSM'; 
        cname{11} = 'ALLSTR>RANDM'; 
        cname{12} = 'ALLRAND>STRM'; 
        cname{13} = 'NOTCONFM'; 
        cname{14} = 'INCORRECTM'; 
         
        cname{15} = 'ALLRANDR'; 
        cname{16} = 'ALLSTRR'; 
        cname{17} = 'ALLTRIALSR'; 
        cname{18} = 'ALLSTR>RANDR'; 
        cname{19} = 'ALLRAND>STRR'; 
        cname{20} = 'NOTCONFR'; 
        cname{21} = 'INCORRECTR'; 
       clear SPM 
  
  
        SPMest=load('SPM.mat'); 
        SPMest=SPMest.SPM; 
        % use this to make the con images 
        SPMest.xCon =[]; 
        for i = 1:size(cons,2) 
            if length(SPMest.xCon)==0 
                SPMest.xCon = 
spm_FcUtil('Set',cname{i},'T','c',cons{i}',SPMest.xX.xKXs); 
            else 
                SPMest.xCon(end+1) = 
spm_FcUtil('Set',cname{i},'T','c',cons{i}',SPMest.xX.xKXs); 
            end 
        end 
        spm_contrasts(SPMest); 
   
     
     











% Set paths *************************************************************** 
  
groupresultsdir = 'home/spsljth/Documents/PPI/PPIresults/';% this is my 
directory 
batchlocation = (cd('.')); 
resultsfolder = (''); 
incmoves = 1; 
movefilt = '^rp_.*\.txt$'; 
names = {'x_trans' 'y_trans' 'z_trans' 'x_rot' 'y_rot' 'z_rot'}; 
moveparamdir = 'onsets'; 
  
  
%set to true to skip stages 
skiptimecourse = false; 
skipbivarcorrs = true; 
skipPPIs = false; 
skipmodels = false; 
  
%for voxelwise analysis 
skipcons = true; 
skipcollect = true; 
  
%for ROI analysis 
skipROIanalysis = false; 
  
%are we really imterested in the whole brain analysis?? if not set this to 
%0 and estimate with MarsBaR 
VoxelwiseModelEstimateFlag = 0; 
  
cons = [0 0 1 0 0 0 0 0 0 0];%nb don't right pad here, we will add 
movements & constant in later 
gwd   = '/home/spsljth/Documents/CHUNK/'; 
blocks = {'1' '2' '3'}; 
nblocks = length(blocks) ; 
TR=2; 
hpf = 180; 
  
%here we extarct data using the VOI approach for our seed regions 
position = {[39 43 33]'}; 
%roi_name = {'left_LOFCsr' 'right_LOFCsr'};%different contrast  
roi_name = {'RDLPFC' }; 
nrois = 1; 
radius = 10;%radius of roi in mm 
  
  
%here we define ROI variables for MarsBaR if we are estimating ROIs not 
%Whole Brain 
roidirM = '/home/spsljth/Documents/ROI/basicmodelROI/'; 
roisM = spm_select('List',roidirM,'roi.mat$'); 
nroisM = size(roisM,1); 
roisM = [repmat([roidirM filesep],nroisM,1) roisM] 
  
for r = 1:nroisM 
    croiM = deblank(roisM(r,:)); 
    R{r} = maroi(croiM); 




   % Get subs 
**************************************************************** 
  
%subs = dir(fullfile(statsdir,'CBU0*')); 
%subs = dir(fullfile(rootdir,'CBU070502*')) 
%subs = cellstr(deblank(char(subs.name))) 
%exsubs = {} 
%for s = 1:length(exsubs) 
%    exi = strfind(subs,exsubs{s}); 
%    exi = char(exi{:})==' '; 
%    subs = subs(exi==1); 
%end 
  
%or just define manually*************************************************** 
subjects={... 
     
    'CHUNK14/CHUNK14A/UNC/012301/CH14A_DanModel1xtramoves' ... 
        }%'010874'  
          
    nsubjects = length(subjects); 
  
addpath(batchlocation); 
if skiptimecourse == false 
  
    cd (batchlocation); 
    failedtimecourses = get_VOI_timecourse(subjects, nsubjects, gwd, 
blocks, nblocks, resultsfolder, radius, position, roi_name, nrois); 
  
    stage = 'ROI timecourses extracted' 
else 
    stage = 'ROI extraction skipped' 
end 
  
if skipbivarcorrs == false 
  
    cd (batchlocation); 
    [failedBiVars, CorrColl] = make_bivarcorrs(subjects, nsubjects, gwd, 
resultsfolder, roi_name, nrois, hpf); 
  
    stage = 'BiVarCorrs calculated' 
else 
    stage = 'BiVarCorrs skipped' 
end 
  
if skipPPIs == false 
    cd (batchlocation); 
    failedmakeppis = make_ppis(subjects, nsubjects, cons, gwd, blocks, 
nblocks, nrois, roi_name, resultsfolder); 
  
    stage = 'PPIs calculated' 
else 
    stage = 'PPI calculation skipped' 
end 
  
if skipmodels == false 
    cd (batchlocation); 
    [failedmakemodels xfiles] = make_models2(subjects, nsubjects, gwd, 
blocks, nblocks, nrois, roi_name,TR, hpf, incmoves, resultsfolder, 
VoxelwiseModelEstimateFlag);%(subjects, nsubjects, gwd, blocks, nblocks, 
nrois, roi_name,TR, hpf, incmoves, movefilt, names, moveparamdir); 
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    stage = 'models run' 
else 
    stage = 'models skipped' 
end 
  
if skipcons == false 
    cd (batchlocation); 
    %failedmakecons =  
    make_cons(subjects, nsubjects, gwd, blocks, nblocks, nrois, roi_name, 
TR); 
  
    stage = 'contrasts run' 
else 




if skipcollect == false 
    cd (batchlocation); 
    %failedcollectcons =  
    collect_cons(subjects, nsubjects, gwd, blocks, nblocks, nrois, 
roi_name, TR, groupresultsdir); 
  
    stage = 'contrasts collected' 
else 




if skipROIanalysis == false 
    [PPI, Phys] = roi_analysis(subjects, nsubjects, gwd, nblocks, 
roi_nameM, nroisM, R, roi_name, nrois); 
  
  
    %kcount = 0; 
    %k = zeros(20,30) 
    %for a = 1:nrois 
    %for b = 1:nroisM 
    %kcount = kcount + 1 
    %k(:,kcount) = PPI(:,a,b) 
    %end 
    %end 
else 
    stage = 'MarsBaR ROI analysis skipped' 
end 
  
%failedtimecourses 
%failedmakeppis 
%failedmakemodels 
%failedmakecons 
%failedcollectcons 
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